Header

UZH-Logo

Maintenance Infos

Browse by Scopus Subject Areas

Navigate back| Up a level
Export as
Number of items at this level: 1353.

2016

Hensel, Tim; Giorgi, Chiara; Schmidt, Oxana; Calzada-Wack, Julia; Neff, Frauke; Buch, Thorsten; Niggli, Felix K; Schäfer, Beat W; Burdach, Stefan; Richter, Günther H S (2016). Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma. OncoTarget, 7(2):1451-1463.

König, Matthias A; Canepa, Daisy D; Cadosch, Dieter; Casanova, Elisa; Heinzelmann, Michael; Rittirsch, Daniel; Plecko, Michael; Hemmi, Sonja; Simmen, Hans-Peter; Cinelli, Paolo; Wanner, Guido A (2016). Direct transplantation of native pericytes from adipose tissue: A new perspective to stimulate healing in critical size bone defects. Cytotherapy, 18(1):41-52.

Auvinen, Anssi; Moss, Sue M; Tammela, Teuvo L J; Taari, Kimmo; Roobol, Monique J; Schröder, Fritz H; Bangma, Chris H; Carlsson, Sigrid; Aus, Gunnar; Zappa, Marco; Puliti, Donella; Denis, Louis J; Nelen, Vera; Kwiatkowski, Maciej; Randazzo, Marco; Paez, Alvaro; Lujan, Marcos; Hugosson, Jonas (2016). Absolute effect of prostate cancer screening: balance of benefits and harms by center within the European randomized study of prostate cancer screening. Clinical Cancer Research, 22(1):243-249.

Greuter, T; Biedermann, L; Rogler, G; Sauter, B; Seibold, F (2016). Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series. United European Gastroenterology journal, 4(1):97-104.

Roelcke, U; Wyss, M T; Nowosielski, M; Rudà, R; Roth, P; Hofer, S; Galldiks, N; Crippa, F; Weller, M; Soffietti, R (2016). Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas. Neuro-Oncology, 18(5):744-751.

Richter, Andre; Jenewein, J; Krayenbühl, N; Woernle, C; Bellut, D (2016). Are preoperative sex-related differences of affective symptoms in primary brain tumor patients associated with postoperative histopathological grading? Journal of Neuro-Oncology, 126(1):151-156.

Hofer, Silvia; Berthod, Grégoire; Riklin, Christian; Rushing, Elisabeth; Feilchenfeldt, Jonas (2016). BRAF V600E mutation: A treatable driver mutation in pleomorphic xanthoastrocytoma (PXA). Acta Oncologica, 55(1):122-123.

Ren, Wuwei; Elmer, Andreas; Buehlmann, David; Augath, Mark-Aurel; Vats, Divya; Ripoll, Jorge; Rudin, Markus (2016). Dynamic measurement of tumor vascular permeability and perfusion using a hybrid system for simultaneous magnetic resonance and fluorescence imaging. Molecular Imaging and Biology, 18(2):191-200.

Clifford, Gary M; Franceschi, Silvia; Keiser, Olivia; Schöni-Affolter, Franziska; Lise, Mauro; Dehler, Silvia; Levi, Fabio; Mousavi, Mohsen; Bouchardy, Christine; Wolfensberger, Aline; Darling, Katharine E; Staehelin, Cornelia; Bertisch, Barbara; Kuenzli, Esther; Bernasconi, Enos; Pawlita, Michael; Egger, Matthias (2016). Immunodeficiency and the risk of cervical intra-epithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV Cohort Study. International Journal of Cancer, 138(7):1732-1740.

Prater, Julia; Valeri, Fabio; Korol, Dimitri; Rohrmann, Sabine; Dehler, Silvia (2016). Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry. Journal of Cancer Research and Clinical Oncology, 142(2):365-371.

Furtner, J; Schöpf, V; Seystahl, K; Le Rhun, E; Rudà, R; Roelcke, U; Koeppen, S; Berghoff, A S; Marosi, C; Clement, P; Faedi, M; Watts, C; Wick, W; Soffietti, R; Weller, M; Preusser, M (2016). Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma. Neuro-Oncology, 18(3):401-407.

Eichholzer, Monika; Richard, Aline; Rohrmann, Sabine; Schmid, Seraina; Güth, Uwe (2016). Overweight, obesity, and breast cancer screening: results from the 2012 Swiss Health Survey. European Journal of Cancer Prevention, 25(2):130-136.

Hundsberger, T; Hottinger, A F; Roelcke, U; Roth, P; Migliorini, D; Dietrich, P Y; Conen, K; Pesce, G; Hermann, E; Pica, A; Gross, M W; Brügge, D; Plasswilm, L; Weller, M; Putora, P M (2016). Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes. Journal of Neuro-Oncology, 126(1):175-183.

Weber, Damien C; Ares, Carmen; Albertini, Francesca; Frei-Welte, Martina; Niggli, Felix K; Schneider, Ralf; Lomax, Antony J (2016). Pencil beam scanning proton therapy for pediatric parameningeal rhabdomyosarcomas: Clinical outcome of patients treated at the Paul Scherrer Institute. Pediatric Blood & Cancer, 63(10):1731-1736.

Drabe, Natalie; Steinert, Hans; Moergeli, Hanspeter; Weidt, Steffi; Strobel, Klaus; Jenewein, Josef (2016). Perception of treatment burden, psychological distress, and fatigue in thyroid cancer patients and their partners - effects of gender, role, and time since diagnosis. Psycho-Oncology, 25(2):203-209.

Engeli, L; Moergeli, H; Binder, M; Drabe, N; Meier, C; Buechi, S; Dummer, R; Jenewein, J (2016). Resilience in patients and spouses faced with malignant melanoma. A qualitative longitudinal study. European Journal of Cancer Care, 25(1):122-131.

Rozati, Sima; Cheng, Phil F; Widmer, Daniel S; Fujii, Kazuyasu; Levesque, Mitchell Paul; Dummer, Reinhard (2016). Romidepsin and azacitidine synergize in their epigenetic modulatory effects to induce apoptosis in CTCL. Clinical Cancer Research, 22(8):2020-2031.

2015

Feilchenfeldt, J; Varga, Z; Siano, M; Grabsch, H I; Held, U; Schuknecht, B; Trip, A; Hamaguchi, T; Gut, P; Balague, O; Khanfir, K; Diebold, J; Jochum, W; Shoji, H; Kushima, R; Wagner, D; Shimada, Y; Cats, A; Knuth, A; Moch, H; Aebi, S; Hofer, S (2015). Corrigendum: Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). British Journal of Cancer, 113(12):1747.

Roth, P; Keller, A; Hoheisel, J D; Codo, P; Bauer, A S; Backes, C; Leidinger, P; Meese, E; Thiel, E; Korfel, A; Weller, M (2015). Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients. European Journal of Cancer, 51(3):382-390.

Ghadjar, P; Hyoz, S; Bernhard, J; Zwahlen, D; Holscher, T; Gut, P; Guckenberger, M; Hildebrandt, G; Muller, A; Plasswilm, J; Papachristofilou, A; Stalder, L; Biaggi-Rudolf, C; Sumila, M; Kranzbuhler, H; Najafi, Y; Ost, P; Azinwi, N; Reuter, C; Bodis, S; Kaouthar, K; Wust, P; Thalmann, G; Aebersold, D (2015). Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10. Journal of Clinical Oncology, 33(35):4158-4166.

Fankhauser, Christian Daniel; Honecker, Friedemann; Beyer, Jörg; Bode, Peter Karl (2015). Emerging therapeutic targets for male germ cell tumors. Current Oncology Reports, 17(12):54.

Ruf, Melanie; Moch, Holger; Schraml, Peter (2015). Interaction of tumor cells with infiltrating lymphocytes via CD70 and CD27 in clear cell renal cell carcinoma. OncoImmunology, 4(12):e1049805.

Guckenberger, Matthias; Andratschke, Nicolaus (2015). Körperstereotaxie und Lobektomie im randomisierten Vergleich beim NSCLC Stadium I – endlich Level-I-Evidenz? Strahlentherapie und Onkologie, 191(12):988-990.

Stahel, Rolf A; Riesterer, Oliver; Xyrafas, Alexandros; Opitz, Isabelle; Beyeler, Michael; Ochsenbein, Adrian; Früh, Martin; Cathomas, Richard; Nackaerts, Kristiaan; Peters, Solange; Mamot, Christoph; Zippelius, Alfred; Mordasini, Carlo; Caspar, Clemens B; Eckhardt, Katrin; Schmid, Ralph A; Aebersold, Daniel M; Gautschi, Oliver; Nagel, Wolfgang; Töpfer, Michael; Krayenbuehl, Jerome; Ribi, Karin; Ciernik, Llja F; Weder, Walter (2015). Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. Lancet Oncology, 16(16):1651-1658.

Guckenberger, Matthias (2015). Dose and fractionation in stereotactic body radiation therapy for stage i non-small cell lung cancer: lessons learned and where do we go next? International Journal of Radiation Oncology, Biology, Physics, 93(4):765-768.

Krayenbuehl, Jerome; Norton, Ian; Studer, Gabriela; Guckenberger, Matthias (2015). Evaluation of an automated knowledge based treatment planning system for head and neck. Radiation Oncology, 10(1):226.

Creutzig, U; Dworzak, M N; Zimmermann, M; Bourquin, J-P; Gruhn, B; Fleischhack, G; Graf, N; Klingebiel, T; Kremens, B; Lehrnbecher, T; von Neuhoff, C; Stackelberg, A V; Starý, J; Reinhardt, D (2015). Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival. Leukemia, 29(11):2260-2263.

Reardon, D A; Weller, M (2015). Dedication: Andrew T. Parsa. Neuro-Oncology, 17 Suppl:vii2.

Nduom, E K; Weller, M; Heimberger, A B (2015). Immunosuppressive mechanisms in glioblastoma. Neuro-Oncology, 17 Suppl:vii9-vii14.

Okada, H; Weller, M; Huang, R; Finocchiaro, G; Gilbert, M R; Wick, W; Ellingson, B M; Hashimoto, N; Pollack, I F; Brandes, Al A; Franceschi, E; Herold-Mende, C; Nayak, L; Panigrahy, A; Pope, W B; Prins, R; Sampson, J H; Wen, P Y; Reardon, D A (2015). Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncology, 16(15):e534-e542.

Wirsching, H G; Happold, C; Roth, P; Weller, M (2015). Management of diffusely infiltrating glioma in the elderly. Current Opinion in Oncology, 27(6):502-509.

Koch, Andreas; Lang, Sven Arke; Wild, Peter Johannes; Gantner, Susanne; Mahli, Abdo; Spanier, Gerrit; Berneburg, Mark; Müller, Martina; Bosserhoff, Anja Katrin; Hellerbrand, Claus (2015). Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells. OncoTarget, 6(32):32748-60.

Wein, Axel; Emmert, Martin; Merkel, Susanne; Harich, Hanns-Detlev; Siebler, Juergen; Thiemann, Roland; Lamberti, Christof; Göttler, Bernhard; Fries, Stefan; Kiani, Alexander; Schlag, Rudolf; Grüner, Marcus; Steinbild, Simone; Eberl, Sonja; Pohl-Dernick, Katharina; Dörje, Frank; Horbach, Thomas; Schöffski, Oliver; Neurath, Markus F; Hohenberger, Werner (2015). Palliative treatment of colorectal cancer with secondary metastasis resection in Germany - impact of the multidisciplinary treatment approach on prognosis and cost: The Northern Bavaria IVOPAK I project. Oncology, 88(2):103-121.

Levesque, Mitchell P; Dummer, Reinhard; Beerenwinkel, Niko (2015). Perturbing resistance: a network perspective. Pigment Cell & Melanoma Research, 29(1):5-7.

Pomp, Victoria; Leo, Cornelia; Mauracher, Andrea; Korol, Dimitri; Guo, Wenjun; Varga, Zsuzsanna (2015). Differential expression of epithelial-mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer. Breast Cancer Research and Treatment, 154(1):45-55.

Giorgi, Chiara; Boro, Aleksandar; Rechfeld, Florian; Lopez-Garcia, Laura A; Gierisch, Maria E; Schäfer, Beat W; Niggli, Felix K (2015). PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1. OncoTarget, 6(30):28895-28910.

Nesteruk, Marta; Lang, Stephanie; Veit-Haibach, Patrick; Studer, Gabriela; Stieb, Sonja; Glatz, Stefan; Hemmatazad, Hossein; Ikenberg, Kristian; Huber, Gerhard; Pruschy, Martin; Guckenberger, Matthias; Klöck, Stephan; Riesterer, Oliver (2015). Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma. Radiotherapy and Oncology, 117(1):125-131.

Grob, Jean Jacques; Amonkar, Mayur M; Karaszewska, Boguslawa; Schachter, Jacob; Dummer, Reinhard; Mackiewicz, Andrzej; Stroyakovskiy, Daniil; Drucis, Kamil; Grange, Florent; Chiarion-Sileni, Vanna; Rutkowski, Piotr; Lichinitser, Mikhail; Levchenko, Evgeny; Wolter, Pascal; Hauschild, Axel; Long, Georgina V; Nathan, Paul; Ribas, Antoni; Flaherty, Keith; Sun, Peng; Legos, Jeffrey J; McDowell, Diane Opatt; Mookerjee, Bijoyesh; Schadendorf, Dirk; Robert, Caroline (2015). Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial. Lancet Oncology, 16(13):1389-1398.

Sala, Evis; Micco, Maura; Burger, Irene A; Yakar, Derya; Kollmeier, Marisa A; Goldman, Debra A; Gonen, Mithat; Park, Kay J; Abu-Rustum, Nadeem R; Hricak, Hedvig; Vargas, Hebert Alberto (2015). Complementary prognostic value of pelvic magnetic resonance imaging and whole-body fluorodeoxyglucose positron emission tomography/computed tomography in the pretreatment assessment of patients with cervical cancer. International Journal of Gynecological Cancer, 25(8):1461-1467.

Rohrmann, Sabine; Nimptsch, Katharina; Sinha, Rashmi; Willett, Walter C; Giovannucci, Edward L; Platz, Elizabeth A; Wu, Kana (2015). Intake of Meat Mutagens and Risk of Prostate Cancer in a Cohort of U.S. Health Professionals. Cancer Epidemiology Biomarkers & Prevention, 24(10):1557-1563.

Dantonello, Tobias M; Stark, Monika; Timmermann, Beate; Fuchs, Jörg; Selle, Barbara; Linderkamp, Christin; Handgretinger, Rupert; Hagen, Rudolf; Feuchtgruber, Simone; Kube, Stefanie; Kosztyla, Daniel; Kazanowska, Bernarda; Ladenstein, Ruth; Niggli, Felix; Ljungman, Gustaf; Bielack, Stefan S; Klingebiel, Thomas; Koscielniak, Ewa (2015). Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma. Pediatric Blood & Cancer, 62(1):16-23.

Dummer, Reinhard; Schadendorf, Dirk; Ascierto, Paolo A; Larkin, James; Lebbé, Celeste; Hauschild, Axel (2015). Integrating first-line treatment options into clinical practice: what's new in advanced melanoma? Melanoma research, 25(6):461-469.

Hermann, Silke; Friedrich, Susanne; Haug, Ulrike; Rohrmann, Sabine; Becker, Nikolaus; Kaaks, Rudolf (2015). Association between socioeconomic and demographic characteristics and utilization of colonoscopy in the EPIC-Heidelberg cohort. European Journal of Cancer Prevention, 24(2):81-88.

Shalaby, Tarek; Grotzer, Michael A (2015). MCY as Therapeutic Target for Embryonal Tumors: Potential and Challenges. Current Cancer Drug Targets, 16(1):2-21.

Krishnan, S; Szabo, E; Burghardt, I; Frei, K; Tabatabai, G; Weller, M (2015). Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition. OncoTarget, 6(26):22480-22495.

Gautschi, Oliver; Mach, Nicholas; Rothschild, Sacha I; Li, Qiyu; Stahel, Rolf A; Zippelius, Alfred; Cathomas, Richard; Früh, Martin; Betticher, Daniel C; Peters, Solange; Rauch, Daniel; Feilchenfeldt, Jonas; Bubendorf, Lukas; Savic, Spasenija; Jaggi, Rolf; Leibundgut, Elisabeth Oppliger; Largiadèr, Carlo; Brutsche, Martin; Pilop, Christiane; Stalder, Lukas; Pless, Miklos; Ochsenbein, Adrian F (2015). Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical Lung Cancer, 16(5):358-365.

Ellingson, B M; Bendszus, M; Boxerman, J; Barboriak, D; Erickson, B J; Smits, M; Nelson, S J; Gerstner, E; Alexander, B; Goldmacher, G; Wick, W; Vogelbaum, M; Weller, M; Galanis, E; Kalpathy-Cramer, J; Shankar, L; Jacobs, P; Pope, W B; Yang, D; Chung, C; Knopp, M V; Cha, S; van den Bent, M J; Chang, S; Yung, W K; Cloughesy, T F; Wen, P Y; Gilbert, M R (2015). Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro-Oncology, 17(9):1188-1198.

Dummer, R; Hauschild, A; Lindenblatt, N; Pentheroudakis, G; Keilholz, U (2015). Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Annals of Oncology, 26 Suppl:v126-v132.

Freiberger, Sandra N; Cheng, Phil F; Iotzova-Weiss, Guergana; Neu, Johannes; Liu, Qinxiu; Dziunycz, Piotr; Zibert, John R; Dummer, Reinhard; Skak, Kresten; Levesque, Mitchell P; Hofbauer, Günther F L (2015). Ingenol mebutate signals via PKC/MEK/ERK in keratinocytes and induces interleukin decoy receptors IL1R2 and IL13RA2. Molecular Cancer Therapeutics, 14(9):2132-2142.

Schandelmaier, S; Conen, K; von Elm, E; You, J J; Blümle, A; Tomonaga, Y; Amstutz, A; Briel, M; Kasenda, B (2015). Planning and reporting of quality-of-life outcomes in cancer trials. Annals of Oncology, 26(9):1966-1973.

Simões-Wüst, Ana Paula; Hassani, Taziri Al; Müller-Hübenthal, Boris; Pittl, Sandra; Kuck, Angela; Meden, Harald; Eberhard, Jutta; Decker, Michael; Fürer, Karin; von Mandach, Ursula (2015). Sleep quality improves during treatment with bryophyllum pinnatum: an observational study on cancer patients. Integrative cancer therapies, 14(5):452-459.

Pentheroudakis, G; Cardoso, F; Arnold, D; Sessa, C; Peters, S; Horwich, A; Pavlidis, N; Stahel, R; Cervantes, A (2015). The ESMO guideline strategy: an identity statement and reflections on improvement. Annals of Oncology, 26 Suppl:v1-v7.

Opitz, Isabelle; Friess, Martina; Kestenholz, Peter; Schneiter, Didier; Frauenfelder, Thomas; Nguyen-Kim, Dan Linh; Seifert, Burkhardt; Hoda, Mir Alireza; Klepetko, Walter; Stahel, Rolf A; Weder, Walter (2015). A new prognostic score supporting treatment allocation for multimodality therapy for malignant pleural mesothelioma- A review of 12 years' experience. Journal of Thoracic Oncology, 10(11):1634-1641.

Feilchenfeldt, J; Varga, Z; Siano, M; Grabsch, H I; Held, U; Schuknecht, B; Trip, A; Hamaguchi, T; Gut, P; Balague, O; Khanfir, K; Diebold, J; Jochum, W; Shoji, H; Kushima, R; Wagner, D; Shimada, Y; Cats, A; Knuth, A; Moch, H; Aebi, S; Hofer, S (2015). Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). British Journal of Cancer, 113(5):716-721.

Fontana, Andrea O; Augsburger, Marc A; Grosse, Nicole; Guckenberger, Matthias; Lomax, Anthony J; Sartori, Alessandro A; Pruschy, Martin N (2015). Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation. Radiotherapy and Oncology, 116(3):374-380.

Peskoe, Sarah B; Joshu, Corinne E; Rohrmann, Sabine; McGlynn, Katherine A; Nyante, Sarah J; Bradwin, Gary; Dobs, Adrian S; Kanarek, Norma; Nelson, William G; Platz, Elizabeth A (2015). Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer. The Prostate, 75(11):1167-1176.

Eberhardt, W E E; De Ruysscher, D; Weder, W; Le Péchoux, C; De Leyn, P; Hoffmann, H; Westeel, V; Stahel, R; Felip, E; Peters, S (2015). 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Annals of Oncology, 26(8):1573-1588.

Güth, Uwe; Arndt, Volker; Stadlmann, Sylvia; Huang, Dorothy Jane; Singer, Gad (2015). Epidemiology in ovarian carcinoma: Lessons from autopsy. Gynecologic Oncology, 138(2):417-420.

van Wezel, Esther M; Stutterheim, Janine; Vree, Florentien; Zappeij-Kannegieter, Lily; Decarolis, Boris; Hero, Barbara; Berthold, Frank; Schumacher-Kuckelkorn, Roswitha; Simon, Thorsten; Fiocco, Marta; Voermans, Carlijn; van Noesel, Max M; Caron, Huib N; van der Schoot, C Ellen; Tytgat, Godelieve A M (2015). Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma. Pediatric Blood & Cancer, 62(8):1368-1373.

Eckert, C; Hagedorn, N; Sramkova, L; Mann, G; Panzer-Grümayer, R; Peters, C; Bourquin, J-P; Klingebiel, T; Borkhardt, A; Cario, G; Alten, J; Escherich, G; Astrahantseff, K; Seeger, K; Henze, G; von Stackelberg, A (2015). Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment. Leukemia, 29(8):1648-1655.

Aigner, Elmar; Stadlmayr, Andreas; Huber-Schönauer, Ursula; Zwerina, Jochen; Husar-Memmer, Emma; Niederseer, David; Eder, Sebastian K; Stickel, Felix; Pirich, Christian; Schett, Georg; Patsch, Wolfgang; Datz, Christian (2015). Parathyroid hormone is related to dysplasia and a higher rate of distal colorectal adenoma in women but not men. Hormones and Cancer, 6(4):153-160.

Ribas, Antoni; Puzanov, Igor; Dummer, Reinhard; Schadendorf, Dirk; Hamid, Omid; Robert, Caroline; Hodi, F Stephen; Schachter, Jacob; Pavlick, Anna C; Lewis, Karl D; Cranmer, Lee D; Blank, Christian U; O'Day, Steven J; Ascierto, Paolo A; Salama, April K S; Margolin, Kim A; Loquai, Carmen; Eigentler, Thomas K; Gangadhar, Tara C; Carlino, Matteo S; Agarwala, Sanjiv S; Moschos, Stergios J; Sosman, Jeffrey A; Goldinger, Simone M; Shapira-Frommer, Ronnie; Gonzalez, Rene; Kirkwood, John M; Wolchok, Jedd D; Eggermont, Alexander; Li, Xiaoyun Nicole; Zhou, Wei; Zernhelt, Adriane M; Lis, Joy; Ebbinghaus, Scot; Kang, S Peter; Daud, Adil (2015). Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. Lancet Oncology, 16(8):908-918.

Berghoff, A S; Kiesel, B; Widhalm, G; Rajky, O; Ricken, G; Wöhrer, A; Dieckmann, K; Filipits, M; Brandstetter, A; Weller, M; Kurscheid, S; Hegi, M E; Zielinski, C C; Marosi, C; Hainfellner, J A; Preusser, M; Wick, W (2015). Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma. Neuro-Oncology, 17(8):1064-1075.

Stahel, R A; Weder, W; Felley-Bosco, E; Petrausch, U; Curioni-Fontecedro, A; Schmitt-Opitz, I; Peters, S (2015). Searching for targets for the systemic therapy of mesothelioma. Annals of Oncology, 26(8):1649-1660.

Thomas, Lena; Lapa, Constatin; Bundschuh, Ralph Alexander; Polat, Bülent; Sonke, Jan-Jakob; Guckenberger, Matthias (2015). Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers. Radiotherapy and Oncology, 116(2):269-275.

Fankhauser, C D; Curioni-Fontecedro, A; Allmann, V; Beyer, J; Tischler, V; Sulser, T; Moch, H; Bode, P K (2015). Frequent PD-L1 expression in testicular germ cell tumors. British Journal of Cancer, 113(3):411-413.

van den Bos, Willemien; Muller, Berrend G; de Bruin, Daniel M; de Castro Abreu, Andre Luis; Chaussy, Christian; Coleman, Jonathan A; Finelli, Antonio; Gill, Inderbir S; Gross, Mitchell E; Jenniskens, Sjoerd F M; Kahmann, Frank; Laguna-Pes, M Pilar; Rastinehad, Ardeshir R; Simmons, Lucy A; Sulser, Tullio; Villers, Arnauld; Ward, John F; de la Rosette, Jean J M C H (2015). Salvage ablative therapy in prostate cancer: International multidisciplinary consensus on trial design. Urologic oncology, 33(11):495.e1-495.e7.

Levy, Antonin; Guckenberger, Matthias; Hurkmans, Coen; Nestle, Ursula; Belderbos, José; De Ruysscher, Dirk; Faivre-Finn, Corinne; Le Péchoux, Cécile (2015). SBRT dose and survival in non-small cell lung cancer: in regard to koshy et al. International Journal of Radiation Oncology, Biology, Physics, 92(4):945-946.

Weber, Achim; O'Connor, Tracy; Heikenwalder, Mathias (2015). Next Generation of Preclinical Liver Cancer Models. Clinical Cancer Research, 21(19):4254-4256.

Devaud, Christel; John, Liza B; Westwood, Jennifer A; Yong, Carmen Sm; Beavis, Paul A; Schwendener, Reto A; Darcy, Phillip K; Kershaw, Michael H (2015). Cross-talk between tumors can affect responses to therapy. OncoImmunology, 4(7):e975572.

Hoang-Xuan, K; Bessell, E; Bromberg, J; Hottinger, A F; Preusser, M; Rudà, R; Schlegel, U; Siegal, T; Soussain, C; Abacioglu, U; Cassoux, N; Deckert, M; Dirven, C M; Ferreri, A J; Graus, F; Henriksson, R; Herrlinger, U; Taphoorn, M; Soffietti, R; Weller, M (2015). Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncology, 16(7):e322-332.

Surace, Laura; Guckenberger, Matthias; van den Broek, Maries (2015). Radiation holidays stimulate tumor immunity. OncoTarget, 6(18):15716-15717.

Nayan, Madhur; Bhindi, Bimal; Yu, Julie L; Hermanns, Thomas; Mohammed, Aza; Hamilton, Robert J; Finelli, Antonio; Jewett, Michael A S; Zlotta, Alexandre R; Fleshner, Neil E; Kulkarni, Girish S (2015). The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Urologic oncology, 33(9):386.e7-386.e13.

Burger, Irene A; Goldman, Debra A; Vargas, Hebert Alberto; Kattan, Michael W; Yu, Changhon; Kou, Lei; Andikyan, Vaagn; Chi, Dennis S; Hricak, Hedvig; Sala, Evis (2015). Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer. Gynecologic Oncology, 138(3):554-559.

Preusser, M; Weller, M (2015). Brain metastasis research: a late awakening. Chinese Clinical Oncolog, 4(2):17.

Roth, P; Weller, M (2015). Management of neoplastic meningitis. Chinese Clinical Oncology, 4(2):26.

Migden, Michael R; Guminski, Alexander; Gutzmer, Ralf; Dirix, Luc; Lewis, Karl D; Combemale, Patrick; Herd, Robert M; Kudchadkar, Ragini; Trefzer, Uwe; Gogov, Sven; Pallaud, Celine; Yi, Tingting; Mone, Manisha; Kaatz, Martin; Loquai, Carmen; Stratigos, Alexander J; Schulze, Hans-Joachim; Plummer, Ruth; Chang, Anne Lynn S; Cornélis, Frank; Lear, John T; Sellami, Dalila; Dummer, Reinhard (2015). Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncology, 16(6):716-728.

Basset-Seguin, Nicole; Hauschild, Axel; Grob, Jean-Jacques; Kunstfeld, Rainer; Dréno, Brigitte; Mortier, Laurent; Ascierto, Paolo A; Licitra, Lisa; Dutriaux, Caroline; Thomas, Luc; Jouary, Thomas; Meyer, Nicolas; Guillot, Bernard; Dummer, Reinhard; Fife, Kate; Ernst, D Scott; Williams, Sarah; Fittipaldo, Alberto; Xynos, Ioannis; Hansson, Johan (2015). Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial. Lancet Oncology, 16(6):729-736.

Wagner, N B; Weide, B; Reith, M; Tarnanidis, K; Kehrel, C; Lichtenberger, R; Pflugfelder, A; Herpel, E; Eubel, J; Ikenberg, K; Busch, C; Holland-Letz, T; Naeher, H; Garbe, C; Umansky, V; Enk, A; Utikal, J; Gebhardt, C (2015). Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma. International Journal of Cancer, 137(11):2607-2617.

Eggermont, Alexander M M; Chiarion-Sileni, Vanna; Grob, Jean-Jacques; Dummer, Reinhard; Wolchok, Jedd D; Schmidt, Henrik; Hamid, Omid; Robert, Caroline; Ascierto, Paolo A; Richards, Jon M; Lebbé, Céleste; Ferraresi, Virginia; Smylie, Michael; Weber, Jeffrey S; Maio, Michele; Konto, Cyril; Hoos, Axel; de Pril, Veerle; Gurunath, Ravichandra Karra; de Schaetzen, Gaetan; Suciu, Stefan; Testori, Alessandro (2015). Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Lancet Oncology, 16(5):522-530.

Wengenroth, L; Rueegg, C S; Michel, G; Gianinazzi, M E; Essig, S; von der Weid, N X; Grotzer, M; Kuehni, Claudia E (2015). Concentration, working speed and memory: cognitive problems in young childhood cancer survivors and their siblings. Pediatric Blood & Cancer, 62(5):875-882.

Vetsch, Janine; Rueegg, Corina S; Gianinazzi, Micòl E; Bergsträsser, Eva; von der Weid, Nicolas X; Michel, Gisela (2015). Information needs in parents of long-term childhood cancer survivors. Pediatric Blood & Cancer, 62(5):859-866.

Guckenberger, Matthias (2015). Oligoprogression : Eine innovative Indikation für die Körperstereotaxie bei metastasierten Tumorsituationen. Strahlentherapie und Onkologie, 191(5):453-455.

Guckenberger, Matthias (2015). Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence? Expert Review of Anticancer Therapy, 15(5):525-530.

Dettmer, Matthias S; Schmitt, Anja Maria; Steinert, Hans; Capper, David; Moch, Holger; Komminoth, Paul; Perren, Aurel (2015). Tall cell Papillary Thyroid Carcinoma: new diagnostic criteria and mutations in BRAF and TERT. Endocrine-Related Cancer, 22(3):419-429.

Zhao, Rongbao; Visentin, Michele; Goldman, I David (2015). Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis. Cancer Chemotherapy and Pharmacology, 75(6):1163-1173.

Zeimpekis, Konstantinos G; Barbosa, Felipe; Hüllner, Martin; Ter Voert, Edwin E G W; Davison, Helen; Veit-Haibach, Patrick; Delso, Gaspar (2015). Clinical evaluation of PET image quality as a function of acquisition time in a new TOF-PET/MRI compared to TOF-PET/CT-initial results. Molecular Imaging and Biology, 17(5):735-744.

Swiss HIV Cohort Study; Kouyos, R D; Hasse, B; et al (2015). Increases in condomless sex in the swiss HIV cohort study. Open Forum Infectious Diseases, 2(2):1-4.

Kreher, S; Jöhrens, K; Strehlow, F; Martus, P; Borowiec, K; Radke, J; Heppner, F; Roth, P; Thiel, E; Pietsch, T; Weller, M; Korfel, A (2015). Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma. Neuro-Oncology, 17(7):1016-1021.

Frei, K; Gramatzki, D; Tritschler, I; Schroeder, J J; Espinoza, L; Rushing, E J; Weller, M (2015). Transforming growth factor-β pathway activity in glioblastoma. OncoTarget, 6(8):5963-5977.

Vuille-Dit-Bille, Raphael N; Berger, Christoph; Meuli, Martin; Grotzer, Michael A (2015). Colostomy for perianal sepsis with ecthyma gangrenosum in immunocompromised children. Journal of Pediatric Hematology/Oncology:1-5.

Rohrmann, Sabine; et al (2015). Meat and fish consumption and the risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. International Journal of Cancer, 136(5):E423-31.

Dummer, Reinhard; Goldinger, Simone M; Paulitschke, Verena; Levesque, Mitchell P (2015). Curing advanced melanoma by 2025. Current Opinion in Oncology, 27(2):125-127.

DeSimone, Jennifer A; Sodha, Pooja; Ignatova, Desislava; Dummer, Reinhard; Cozzio, Antonio; Guenova, Emmanuella (2015). Recent advances in primary cutaneous T-cell lymphoma. Current Opinion in Oncology, 27(2):128-133.

Peulen, Heike; Belderbos, José; Guckenberger, Matthias; Hope, Andrew; Grills, Inga; van Herk, Marcel; Sonke, Jan-Jakob (2015). Target delineation variability and corresponding margins of peripheral early stage NSCLC treated with stereotactic body radiotherapy. Radiotherapy and Oncology, 114(3):361-366.

Ruf, Melanie; Mittmann, Christiane; Nowicka, Anna M; Hartmann, Arndt; Hermanns, Thomas; Poyet, Cédric; van den Broek, Maries; Sulser, Tullio; Moch, Holger; Schraml, Peter (2015). pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma. Clinical Cancer Research, 21(4):889-98.

Wegert, Jenny; Ishaque, Naveed; Vardapour, Romina; Geörg, Christina; Gu, Zuguang; Bieg, Matthias; Ziegler, Barbara; Bausenwein, Sabrina; Nourkami, Nasenien; Ludwig, Nicole; Keller, Andreas; Grimm, Clemens; Kneitz, Susanne; Williams, Richard D; Chagtai, Tas; Pritchard-Jones, Kathy; van Sluis, Peter; Volckmann, Richard; Koster, Jan; Versteeg, Rogier; Acha, Tomas; O'Sullivan, Maureen J; Bode, Peter K; Niggli, Felix; Tytgat, Godelieve A; van Tinteren, Harm; van den Heuvel-Eibrink, Marry M; Meese, Eckart; Vokuhl, Christian; Leuschner, Ivo; Graf, Norbert; Eils, Roland; Pfister, Stefan M; Kool, Marcel; Gessler, Manfred (2015). Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. Cancer Cell, 27(2):298-311.

Lassen, U; Chinot, O L; McBain, C; Mau-Sørensen, M; Larsen, V A; Barrie, M; Roth, P; Krieter, O; Wang, K; Habben, K; Tessier, J; Lahr, A; Weller, M (2015). Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma. Neuro-Oncology, 17(7):1007-1015.

Weller, Michael; Tabatabai, G; Kästner, B; Felsberg, J; Steinbach, J P; Wick, A; Schnell, O; Hau, P; Herrlinger, U; Sabel, M C; Wirsching, H G; Ketter, R; Bähr, O; Platten, M; Tonn, J C; Schlegel, U; Marosi, C; Goldbrunner, R; Stupp, R; Homicsko, K; Pichler, J; Nikkhah, G; Meixensberger, J; Vajkoczy, P; Kollias, S; Hüsing, J; Reifenberger, G; Wick, W (2015). MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial. Clinical Cancer Research, 21(9):2057-2064.

Broggini-Tenzer, Angela; Sharma, Ashish; Nytko, Katarzyna J; Bender, Sabine; Vuong, Van; Orlowski, Katrin; Hug, Daniel; O'Reilly, Terence; Pruschy, Martin (2015). Combined treatment strategies for microtubule stabilizing agent-resistant tumors. Journal of the National Cancer Institute, 107(4):dju504.

Urosevic-Maiwald, Mirjana; Barysch, Marjam J; Cheng, Phil F; Karpova, Maria B; Steinert, Hans; Okoniewski, Michal J; Dummer, Reinhard (2015). In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma. OncoImmunology, 4(2):e988458.

Henzler, Thomas; Goldstraw, Peter; Wenz, Frederik; Pirker, Robert; Weder, Walter; Apfaltrer, Paul; Meyer, Mathias; Buesing, Karen; Crino, Lucio; Fennell, Dean; Fink, Christian; Grunenwald, Dominique; Manegold, Christian; Pilz, Lothar; Schoenberg, Stefan O; Suresh, Senan; Vansteenkiste, Johan; Voigt, Wieland; Wängler, Björn; Schmid-Bindert, Gerald (2015). Perspectives of Novel Imaging Techniques for Staging, Therapy Response Assessment, and Monitoring of Surveillance in Lung Cancer: Summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop. Journal of Thoracic Oncology, 10(2):237-249.

Schanne, D H; Nestle, U; Allgaeuer, M; Andratschke, N; Appold, S; Dieckmann, U; Ernst, I; Ganswindt, U; Grosu, A L; Holy, R; Molls, M; Nevinny-Stickel, M; Semrau, S; Sterzing, F; Wittig, A; Guckenberger, M (2015). Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis. Strahlentherapie und Onkologie, 191(2):125-132.

Keller, Xavier Etienne; Kardas, Piotr; Acevedo, Claudio; Sais, Giovanni; Poyet, Cédric; Banzola, Irina; Mortezavi, Ashkan; Seifert, Burkhardt; Sulser, Tullio; Hirsch, Hans H; Provenzano, Maurizio (2015). Antibody response to BK polyomavirus as a prognostic biomarker and potential therapeutic target in prostate cancer. OncoTarget, 6(8):6459-6469.

Lewitzki, Victor; Andratschke, Nicolaus; Kuhnt, Thomas; Hildebrandt, Guido (2015). Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib. Radiation Oncology, 10(29):online.

Stieb, Sonja; Lang, Stephanie; Linsenmeier, Claudia; Graydon, Shaun; Riesterer, Oliver (2015). Safety of high-dose-rate stereotactic body radiotherapy. Radiation Oncology, 10(27):online.

Stucki, Manuel (2015). TORC2 inhibition may boost DNA-damaging chemotherapy. OncoTarget, 6(2):586-587.

Ghadjar, Pirus; Hayoz, Stefanie; Zimmermann, Frank; Bodis, Stephan; Kaul, David; Badakhshi, Harun; Bernier, Jacques; Studer, Gabriela; Plasswilm, Ludwig; Budach, Volker; Aebersold, Daniel M (2015). Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10/94). Radiation Oncology, 10(21):online.

Tsilidis, Konstantinos K; Allen, Naomi E; Appleby, Paul N; Rohrmann, Sabine; Nöthlings, Ute; Arriola, Larraitz; Gunter, Marc J; Chajes, Veronique; Rinaldi, Sabina; Romieu, Isabelle; Murphy, Neil; Riboli, Elio; Tzoulaki, Ioanna; Kaaks, Rudolf; Lukanova, Annekatrin; Boeing, Heiner; Pischon, Tobias; Dahm, Christina C; Overvad, Kim; Quirós, J Ramón; Fonseca-Nunes, Ana; Molina-Montes, Esther; Gavrila Chervase, Diana; Ardanaz, Eva; Khaw, Kay T; Wareham, Nick J; Roswall, Nina; Tjønneland, Anne; Lagiou, Pagona; Trichopoulos, Dimitrios; Trichopoulou, Antonia; Palli, Domenico; Pala, Valeria; Tumino, Rosario; Vineis, Paolo; Bueno-de-Mesquita, H Bas; Malm, Johan; Orho-Melander, Marju; Johansson, Mattias; Stattin, Pär; Travis, Ruth C; Key, Timothy J (2015). Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer, 136(2):372-381.

Otsuka, Atsushi; Dreier, Jil; Cheng, Phil F; Nägeli, Mirjam; Lehmann, Holger; Felderer, Lea; Frew, Ian J; Matsushita, Shigeto; Levesque, Mitchell P; Dummer, Reinhard (2015). Hedgehog Pathway Inhibitors Promote Adaptive Immune Responses in Basal Cell Carcinoma. Clinical Cancer Research:1289-1297.

Randazzo, Marco; Beatrice, Josef; Huber, Andreas; Grobholz, Rainer; Manka, Lukas; Chun, Felix K; Kluth, Luis A; Wyler, Stephen F; Recker, Franz; Kwiatkowski, Maciej (2015). Is further screening of men with baseline psa < 1ng/ml worthwhile? the discussion continues - results of the Swiss ERSPC (Aarau). International Journal of Cancer, 137(3):553-559.

Theocharides, A P; Dobson, S M; Laurenti, E; Notta, F; Voisin, V; Cheng, P Y; Yuan, J S; Guidos, C J; Minden, M D; Mullighan, C G; Torlakovic, E; Dick, J E (2015). Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts. Leukemia, 29(1):177-187.

Lorigan, Paul; Ascierto, Paolo A; Dummer, Reinhard; Eggermont, Alexander M; Flaherty, Keith T; Garbe, Claus; Gogas, Helen; Hauschild, Axel; Kefford, Richard F; Kirkwood, John M; Larkin, James; Long, Georgina V; Maio, Michele; McArthur, Grant A; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Sondak, Vernon K; Wolchok, Jedd D; Hudson, Andrew M (2015). Expanded access programmes: patient interests versus clinical trial integrity. Lancet Oncology, 16(1):15-17.

Swiss HIV Cohort Study; Wandeler, Gilles; Schlauri, Marion; et al (2015). Incident hepatitis C virus infections in the swiss HIV cohort study: changes in treatment uptake and outcomes between 1991 and 2013. Open Forum Infectious Diseases, 2(1):ofv026.

Church, David N; Stelloo, Ellen; Nout, Remi A; Valtcheva, Nadejda; Depreeuw, Jeroen; Ter Haar, Natalja; Noske, Aurelia; Amant, Frederic; Tomlinson, Ian P M; Wild, Peter J; Lambrechts, Diether; Jürgenliemk-Schulz, Ina M; Jobsen, Jan J; Smit, Vincent T H B M; Creutzberg, Carien L; Bosse, Tjalling (2015). Prognostic significance of POLE proofreading mutations in endometrial cancer. Journal of the National Cancer Institute, 107(1):1-8.

Brenner, Stefan; Riha, Juliane; Giessrigl, Benedikt; Thalhammer, Theresia; Grusch, Michael; Krupitza, Georg; Stieger, Bruno; Jäger, Walter (2015). The effect of organic anion-transporting polypeptides 1B1, 1B3 and 2B1 on the antitumor activity of flavopiridol in breast cancer cells. International Journal of Oncology, 46(1):324-332.

Gürsel, Demirkan B; Banu, Matei A; Berry, Nicholas; Marongiu, Roberta; Burkhardt, Jan-Karl; Kobylarz, Keith; Kaplitt, Michael G; Rafii, Shahin; Boockvar, John A (2015). Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling. Journal of Neuro-Oncology, 121(1):19-29.

Blumenthal, Deborah T; Rankin, Cathryn; Stelzer, Keith J; Spence, Alexander M; Sloan, Andrew E; Moore, Dennis F; Padula, Gilbert D A; Schulman, Susan B; Wade, Mark L; Rushing, Elisabeth J (2015). A Phase III study of radiation therapy (RT) and O6-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001. International Journal of Clinical Oncology, 20(4):650-658.

Rechsteiner, M; Wild, P; Kiessling, M K; Bohnert, A; Zhong, Q; Stahel, R A; Moch, H; Curioni-Fontecedro, A (2015). A novel germline mutation of PDGFR-β might be associated with clinical response of colorectal cancer to regorafenib. Annals of Oncology, 26(1):246-248.

Johnson, Douglas B; et al; Goldinger, Simone M (2015). Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms. European Journal of Cancer, 51(18):2792-2799.

Wanner, Miriam; Richard, Aline; Martin, Brian; Linseisen, Jakob; Rohrmann, Sabine (2015). Associations between objective and self-reported physical activity and vitamin D serum levels in the US population. Cancer Causes & Control, 26(6):881-891.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri; Szucs, Thomas; Pestalozzi, Bernhard C; Schwenkglenks, Matthias (2015). Cancer-related therapies at the end of life in hospitalized cancer patients from four swiss cantons: SAKK 89/09. Oncology, 88(1):18-27.

Curioni-Fontecedro, Alessandra; Martin, Vittoria; Vogetseder, Alexander; Knuth, Alexander; Moch, Holger; Soldini, Davide; Tinguely, Marianne (2015). Chromosomal aberrations of cancer-testis antigens in myeloma patients. Hematological oncology, 33(3):159-163.

Vulsteke, Christof; Pfeil, Alena M; Maggen, Charlotte; Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Lambrechts, Diether; Dieudonné, Anne-Sophie; Hatse, Sigrid; Neven, Patrick; Paridaens, Robert; Wildiers, Hans (2015). Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast Cancer Research and Treatment, 152(1):67-76.

Cornelissen, J J; Versluis, J; Passweg, J R; van Putten, W L; Manz, M G; Maertens, J; Beverloo, H B; Valk, P J; van Marwijk, Kooy M; Wijermans, P W; Schaafsma, M R; Biemond, B J; Vekemans, M C; Breems, D A; Verdonck, L F; Fey, M F; Jongen-Lavrencic, M; Janssen, J J; Huls, G; Kuball, J; Pabst, T; Graux, C; Schouten, H C; Gratwohl, A; Vellenga, E; Ossenkoppele, G; Löwenberg, B (2015). Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia, 29(5):1041-1050.

Huber, F; Montani, M; Sulser, T; Jaggi, R; Wild, P; Moch, H; Gevensleben, H; Schmid, M; Wyder, S; Kristiansen, G (2015). Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer-what has gone wrong? A blueprint for the way forward in biomarker studies. British Journal of Cancer, 112:140-148.

Letang, E; Muller, M C; Ntamatungiro, A J; Kimera, N; Faini, D; Furrer, H; Battegay, M; Tanner, M; Hatz, Christoph; Boulware, D R; Glass, T R (2015). Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality. Open Forum Infectious Diseases, 2(2):ofv046.

Seystahl, K; Tritschler, I; Szabo, E; Tabatabai, G; Weller, M (2015). Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma. Neuro-Oncology, 17(2):254-265.

Thon, N; Kunz, M; Lemke, L; Jansen, N L; Eigenbrod, S; Kreth, S; Lutz, J; Egensperger, R; Giese, A; Herms, J; Weller, M; Kretzschmar, H; Tonn, J C; laFougère, C; Kreth, F W (2015). Dynamic (18) F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses. International Journal of Cancer, 136(9):2132-2145.

Witt, Claudia M; Außerer, Oskar; Baier, Susanne; Heidegger, Herbert; Icke, Katja; Mayr, Oswald; Mitterer, Manfred; Roll, Stephanie; Spizzo, Gilbert; Scherer, Arthur; Thuile, Christian; Wieser, Anton; Schützler, Lena (2015). Effectiveness of an additional individualized multi-component complementary medicine treatment on health-related quality of life in breast cancer patients: a pragmatic randomized trial. Breast Cancer Research and Treatment, 149(2):449-460.

Gemuenden, Cornelia; Benz, Rudolf; Senn, Oliver; Goede, Jeroen S; Manz, Markus G; Gerber, Bernhard (2015). Efficacy of Azacitidine in de Novo and relapsed acute Myeloid Leukemia: A retrospective comparative study. Clinical Lymphoma, Myeloma & Leukemia, 15(12):811-815.

Pfeil, Alena M; Allcott, Kim; Pettengell, Ruth; von Minckwitz, Gunter; Schwenkglenks, Matthias; Szabo, Zsolt (2015). Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review. Supportive Care in Cancer, 23(2):525-545.

McKinney, Nicole; Yuan, Liangping; Zhang, Hongying; Liu, Jingbo; Cho, Yoon-Jae; Rushing, Elisabeth; Schniederjan, Matthew; MacDonald, Tobey J (2015). EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma. Journal of Neuro-Oncology, 121(1):109-118.

Kros, J M; Huizer, K; Hernandez-Lain, A; Marucci, G; Michotte, A; Pollo, B; Rushing, E J; Ribalta, T; French, P; Jamine, D; Bekka, N; Lacombe, D; van den Bent, M J; Gorlia, T (2015). Evidence-based diagnostic algorithm for glioma: analysis of the results of pathology panel review and molecular parameters of EORTC 26951 and 26882 trials. Journal of Clinical Oncology, 33(17):1943-1950.

Oing, Christoph; Lorch, Anja; Bokemeyer, Carsten; Honecker, Friedemann; Beyer, Jörg; Berger, Lars Arne; Oechsle, Karin (2015). First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database. Journal of Cancer Research and Clinical Oncology, 141(5):923-931.

Parviainen, S; Ahonen, M; Diaconu, I; Kipar, A; Siurala, M; Vähä-Koskela, M; Kanerva, A; Cerullo, V; Hemminki, A (2015). GMCSF-armed vaccinia virus induces an antitumor immune response. International Journal of Cancer, 136(5):1065-1072.

Panje, Cedric; Panje, Thierry; Putora, Paul Martin; Kim, Suk-kyum; Haile, Sarah R; Aebersold, Daniel M; Plasswilm, Ludwig (2015). Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience. Radiation Oncology, 10(47):online.

Kumar, Ram Mohan Ram; Fuchs, Bruno (2015). Hedgehog signaling inhibitors as anti-cancer agents in osteosarcoma. Cancers, 7(2):784-794.

Müller-Edenborn, Kamila; Léger, Karolin; Glaus Garzon, Jesus F; Oertli, Carole; Mirsaidi, Ali; Richards, Peter J; Rehrauer, Hubert; Spielmann, Patrick; Hoogewijs, David; Borsig, Lubor; Hottiger, Michael O; Wenger, Roland H (2015). Hypoxia attenuates the proinflammatory response in colon cancer cells by regulating IκB. OncoTarget, 6(24):20288-20301.

Meyer, Julia; Rohrmann, Sabine; Bopp, Matthias; Faeh, David (2015). Impact of smoking and excess body weight on overall and site-specific cancer mortality risk. Cancer Epidemiology Biomarkers & Prevention, 24(10):1516-1522.

Lang, Stephanie; Linsenmeier, Claudia; Brown, Michelle L; Cavelaars, Frederique; Tini, Alessandra; Winter, Christopher; Krayenbuehl, Jerome (2015). Implementation and validation of a new fixation system for stereotactic radiation therapy: An analysis of patient immobilization. Practical Radiation Oncology, 5(6):e689-e695.

Mohr, P; Hauschild, A; Trefzer, U; Enk, A; Tilgen, W; Loquai, C; Gogas, H; Haalck, T; Koller, J; Dummer, R; Gutzmer, R; Brockmeyer, N; Holzle, E; Sunderkotter, C; Mauch, C; Stein, A; Schneider, L A; Podda, M; Goppner, D; Schadendorf, D; Weichenthal, M (2015). Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma: Final analysis of a randomized phase III dermatologic cooperative oncology group trial. Journal of Clinical Oncology, 33(34):4077-4084.

Friemel, Juliane; Rechsteiner, Markus Peter; Frick, Lukas; Boehm, Friederike; Struckmann, Kirsten; Sigg, Michele; Moch, Holger; Heikenwaelder, Mathias; Weber, Achim (2015). Intratumor heterogeneity in hepatocellular carcinoma. Clinical Cancer Research, 21(8):1951-1961.

Richard, Aline; Rohrmann, Sabine; Schmid, Seraina M; Tirri, Brigitte Frey; Huang, Dorothy J; Güth, Uwe; Eichholzer, Monika (2015). Lifestyle and health-related predictors of cervical cancer screening attendance in a Swiss population-based study. Cancer Epidemiology, 39(6):870-876.

Schönknecht, Christine; Hadjamu, Miriam; Oechsner, Markus; Andratschke, Nicolaus; Duma, Marciana-Nona (2015). Long-term survival in metastasized leiomyosarcoma: a case report and review of the literature. Tumori, 101(5):e141-e144.

Collaud, Stéphane; Tischler, Verena; Atanassoff, Andrej; Wiedl, Thomas; Komminoth, Paul; Oehlschlegel, Christian; Weder, Walter; Soltermann, Alex (2015). Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN. BMC Cancer, 15(74):online.

Steinert, Hans; Dreier, Jil; Dummer, Reinhard; Schäfer, Niklaus (2015). Melanoma. In: von Schulthess, Gustav K. Molecular Anatomic Imaging. Hagerstown, MD 21740: Wolters Kluwer Health, 537-547.

Gross, C; et al; Steingotter, A (2015). Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib. Clinical Cancer Research, 21(19):4440-4450.

Drabe, Natalie; Klaghofer, Richard; Weidt, Steffi; Zwahlen, Diana; Büchi, Stefan; Jenewein, Josef (2015). Mutual associations between patients' and partners' depression and quality of life with respect to relationship quality, physical complaints, and sense of coherence in couples coping with cancer. Psycho-Oncology, 24(4):442-450.

Janssen, Stefan; Holz‑Sapra, Edna; Rades, Dirk; Moser, Alexander; Studer, Gabriela (2015). Nipple-sparing mastectomy in breast cancer patients: The role of adjuvant radiotherapy (Review). Oncology Letters, 9(6):2435-2441.

Siurala, M; Bramante, S; Vassilev, L; Hirvinen, M; Parviainen, S; Tähtinen, S; Guse, K; Cerullo, V; Kanerva, A; Kipar, A; Vähä-Koskela, M; Hemminki, A (2015). Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma. International Journal of Cancer, 136(4):945-954.

Stahel, R; Bogaerts, J; Ciardiello, F; de Ruysscher, D; Dubsky, P; Ducreux, M; Finn, S; Laurent-Puig, P; Peters, S; Piccart, M; Smit, E; Sotiriou, C; Tejpar, S; Van Cutsem, E; Tabernero, J (2015). Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development. Cancer Treatment Reviews, 41(2):129-135.

Rödel, Claus; Graeven, Ullrich; Fietkau, Rainer; Hohenberger, Werner; Hothorn, Torsten; Arnold, Dirk; Hofheinz, Ralf-Dieter; Ghadimi, Michael; Wolff, Hendrik A; Lang-Welzenbach, Marga; Raab, Hans-Rudolf; Wittekind, Christian; Ströbel, Philipp; Staib, Ludger; Wilhelm, Martin; Grabenbauer, Gerhard G; Hoffmanns, Hans; Lindemann, Fritz; Schlenska-Lange, Anke; Folprecht, Gunnar; Sauer, Rolf; Liersch, Torsten (2015). Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 16(8):979-989.

Thalhammer, Verena; Lopez-Garcia, Laura A; Herrero Martín, David; Hecker, Regina; Laubscher, Dominik; Gierisch, Maria E; Wachtel, Marco; Bode, Peter; Nanni, Paolo; Blank, Bernd; Koscielniak, Ewa; Schäfer, Beat W (2015). PLK1 phosphorylates PAX3-FOXO1 the inhibition of which triggers regression of alveolar rhabdomyosarcoma. Cancer Research, 75(1):98-110.

Poyet, Cédric; Hermanns, Thomas; Zhong, Qing; Drescher, Eva; Eberli, Daniel; Burger, Maximilian; Hofstaedter, Ferdinand; Hartmann, Arndt; Stöhr, Robert; Zwarthoff, Ellen; Sulser, Tullio; Wild, Peter (2015). Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer. Oncology Letters, 10(5):2753-2760.

Valko, P O; Siddique, A; Linsenmeier, C; Zaugg, K; Held, U; Hofer, S (2015). Prevalence and predictors of fatigue in glioblastoma: a prospective study. Neuro-Oncology, 17(2):274-281.

Rusch, Andreas; Ziltener, Gabriela; Nackaerts, Kristiaan; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2015). Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases. Lung Cancer, 87(1):77-79.

Rakha, E A; Tan, P H; Varga, Z; Tse, G M; Shaaban, A M; Climent, F; van Deurzen, C H M; Purnell, D; Dodwell, D; Chan, T; Ellis, I O (2015). Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study. British Journal of Cancer, 112(2):283-289.

Robl, Bernhard; Pauli, Chantal; Botter, Sander Martijn; Bode-Lesniewska, Beata; Fuchs, Bruno (2015). Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy. BMC Cancer, 15:379.

Ihnenfeld Arciénega, Isabel; Imesch, Patrick; Fink, Daniel; Dedes, Konstantin J (2015). Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature. Targeted oncology, 10(2):297-301.

Cathomas, Richard; Rothermundt, Christian; Bode, Beata; Fuchs, Bruno; von Moos, Roger; Schwitter, Michael (2015). RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward? Oncology, 88(4):257-260.

Hecht, M; Zimmer, L; Loquai, C; et al; Goldinger, S M (2015). Radiosensitization by BRAF inhibitor therapy--mechanism and frequency of toxicity in melanoma patients. Annals of Oncology, 26(6):1238-1244.

Bencaiova, Gabriela; Dapoto, Kristina; Zimmermann, Roland; Krafft, Alexander (2015). Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening. International Journal of Women's Health, 7:379-384.

Steliarova-Foucher, Eva; Stiller, Charles; Colombet, Murielle; Kaatsch, Peter; Zanetti, Roberto; Peris-Bonet, Rafael (2015). Registration of childhood cancer: Moving towards pan-European coverage? European Journal of Cancer, 51(9):1064-1079.

Dahele, Max; Hatton, Matthew; Slotman, Ben; Guckenberger, Matthias (2015). Stereotactic body radiotherapy: A survey of contemporary practice in six selected European countries. Acta Oncologica, 54(8):1237-1241.

Andratschke, Nicolaus Hj; Nieder, Carsten; Heppt, Franz; Molls, Michael; Zimmermann, Frank (2015). Stereotactic radiation therapy for liver metastases: factors affecting local control and survival. Radiation Oncology, 10(69):online.

Kumar, Ram Mohan Ram; Arlt, Matthias Je; Kuzmanov, Aleksandar; Born, Walter; Fuchs, Bruno (2015). Sunitinib malate (SU-11248) reduces tumour burden and lung metastasis in an intratibial human xenograft osteosarcoma mouse model. American Journal of Cancer Research, 5(7):2156-2168.

Schadde, Erik; Schnitzbauer, Andreas A; Tschuor, Christoph; Raptis, Dimitri A; Bechstein, Wolf O; Clavien, Pierre-Alain (2015). Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy. Annals of Surgical Oncology, 22(9):3109-3120.

Pyka, Thomas; Bundschuh, Ralph A; Andratschke, Nicolaus; Mayer, Benedikt; Specht, Hanno M; Papp, Laszló; Zsótér, Norbert; Essler, Markus (2015). Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy. Radiation Oncology, 10(100):online.

Satoh, Takashi; Otsuka, Atsushi; Contassot, Emmanuel; French, Lars E (2015). The inflammasome and IL-1β: implications for the treatment of inflammatory diseases. Immunotherapy, 7(3):243-254.

2014

Krug, Sebastian; Kühnemuth, Benjamin; Griesmann, Heidi; Neesse, Albrecht; Mühlberg, Leonie; Boch, Michael; Kortenhaus, Juliane; Fendrich, Volker; Wiese, Dominik; Sipos, Bence; Friemel, Juliane; Gress, Thomas M; Michl, Patrick (2014). CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms. Endocrine-Related Cancer, 21(6):879-890.

Stupp, R; Picard, M; Weller, M (2014). Does cilengitide deserve another chance?-Authors' reply. Lancet Oncology, 15(13):e585-e586.

Rieger, J; Bähr, O; Maurer, G D; Hattingen, E; Franz, K; Brucker, D; Walenta, S; Kämmerer, U; Coy, J F; Weller, M; Steinbach, J P (2014). ERGO: A pilot study of ketogenic diet in recurrent glioblastoma / Erratum. International Journal of Oncology, 45(6):2605.

Jentzsch, Thorsten; Robl, Bernhard; Husmann, Maren; Bode-Lesniewska, Beata; Fuchs, Bruno (2014). Expression of MSH2 and MSH6 on a Tissue Microarray in Patients with Osteosarcoma. Anticancer Research, 34(12):6961-6972.

Balmativola, D; Marchiò, C; Maule, M; Chiusa, L; Annaratone, L; Maletta, F; Montemurro, F; Kulka, J; Figueiredo, P; Varga, Z; Liepniece-Karele, I; Cserni, G; Arkoumani, E; Amendoeira, I; Callagy, G; Reiner-Concin, A; Cordoba, A; Bianchi, S; Decker, T; Gläser, D; Focke, C; van Diest, P; Grabau, D; Lips, E; Wesseling, J; Arisio, R; Medico, E; Wells, C; Sapino, A (2014). Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study. Breast Cancer Research and Treatment, 148(3):511-523.

Batchelor, T T; Reardon, D A; de Groot, J F; Wick, W; Weller, M (2014). Antiangiogenic therapy for glioblastoma: current status and future prospects. Clinical Cancer Research, 20(22):5612-5619.

Oehler, C; Lang, S; Dimmerling, P; Bolesch, C; Klöck, S; Tini, A; Glanzmann, C; Najafi, Y; Studer, G; Zwahlen, D (2014). PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers. Radiation Oncology, 9:229.

Chan, C; Lang, S; Rowbottom, C; Guckenberger, M; Faivre-Finn, C (2014). Intensity-modulated radiotherapy for lung cancer: current status and future developments. Journal of Thoracic Oncology, 9(11):1598-1608.

Schwendener, Reto A (2014). Liposomes as vaccine delivery systems: A review of the recent advances. Therapeutic Advances in Vaccines, 2(6):159-182.

Peters, Solange; Weder, Walter; Dafni, Urania; Kerr, Keith M; Bubendorf, Lukas; Meldgaard, Peter; O'Byrne, Kenneth J; Wrona, Anna; Vansteenkiste, Johan; Felip, Enriqueta; Marchetti, Antonio; Savic, Spasenija; Lu, Shun; Smit, Egbert; Dingemans, Anne-Marie; Blackhall, Fiona H; Baas, Paul; Camps, Carlos; Rosell, Rafael; Stahel, Rolf A (2014). Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters. Journal of Thoracic Oncology, 9(11):1675-1684.

von Laffert, Maximilian; Warth, Arne; Penzel, Roland; Schirmacher, Peter; Kerr, Keith M; Elmberger, Göran; Schildhaus, Hans-Ulrich; Büttner, Reinhard; Lopez-Rios, Fernando; Reu, Simone; Kirchner, Thomas; Pauwels, Patrick; Specht, Katja; Drecoll, Enken; Höfler, Heinz; Aust, Daniela; Baretton, Gustavo; Bubendorf, Lukas; Stallmann, Sonja; Fisseler-Eckhoff, Annette; Soltermann, Alex; Tischler, Verena; Moch, Holger; Penault-Llorca, Frederique; Hager, Hendrik; Schäper, Frank; Lenze, Dido; Hummel, Michael; Dietel, Manfred (2014). Multicenter Immunohistochemical ALK-Testing of Non-Small-Cell Lung Cancer Shows High Concordance after Harmonization of Techniques and Interpretation Criteria. Journal of Thoracic Oncology, 9(11):1685-1692.

Debbache, Julien; Sommer, Lukas (2014). Sox5 and chromatophores: switching pigment cell fates. Pigment Cell & Melanoma Research, 27(6):1004-1005.

Waespe, Nicolas; Zeilhofer, Ulrike; Güngör, Tayfun (2014). Treatment-refractory multi-lineage autoimmune cytopenia after unrelated cord blood transplantation: remission after combined bortezomib and vincristine treatment. Pediatric Blood & Cancer, 61(11):2112-2114.

Schwinger, Wolfgang; Sovinz, Petra; Benesch, Martin; Lackner, Herwig; Seidel, Markus; Strenger, Volker; Sperl, Daniela; Raicht, Andrea; Brunner-Krainz, Michaela; Paschke, Eduard; Plecko, Barbara; Urban, Christian (2014). Unrelated CD3/CD19-depleted peripheral stem cell transplantation for Hurler syndrome. Pediatric Hematology and Oncology, 31(8):723-730.

Ning, Yan; Gerger, Armin; Zhang, Wu; Hanna, Diana L; Yang, Dongyun; Winder, Thomas; Wakatsuki, Takeru; Labonte, Melissa J; Stintzing, Sebastian; Volz, Nico; Sunakawa, Yu; Stremitzer, Stefan; El-Khoueiry, Rita; Lenz, Heinz-Josef (2014). Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy. Molecular Cancer Therapeutics, 13(2):528-539.

Martin, Ernst; Werner, Beat; Bauer, Ronald; van Leyen, Karin; Coluccia, Daniel; Fandino, Javier (2014). Clinical neurological HIFU applications: The Zurich experience. Translational Cancer Research, 3(5):449-458.

Wachtel, Marco; Rakic, Jelena; Okoniewski, Michal; Bode, Peter; Niggli, Felix; Schäfer, Beat W (2014). FGFR4 signaling couples to Bim and not Bmf to discriminate subsets of alveolar rhabdomyosarcoma cells. International Journal of Cancer, 135(7):1543-1552.

Braig, M; Pällmann, N; Preukschas, M; Steinemann, D; Hofmann, W; Gompf, A; Streichert, T; Braunschweig, T; Copland, M; Rudolph, K L; Bokemeyer, C; Koschmieder, S; Schuppert, A; Balabanov, S; Brümmendorf, T H (2014). A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells. Leukemia, 28(10):2028-2039.

Roth, P; Weller, M (2014). Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies. Neuro-Oncology, 16(suppl 8):viii14-viii19.

Berberat, J; McNamara, J; Ramonda, L; Bodis, S; Rogers, S (2014). Diffusion tensor imaging for target volume definition in glioblastoma multiforme. Strahlentherapie und Onkologie, 190(10):939-943.

Vulsteke, Christof; Pfeil, Alena M; Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Lambrechts, Diether; Peeters, Marc; van Dam, Peter; Dieudonné, Anne-Sophie; Hatse, Sigrid; Neven, Patrick; Paridaens, Robert; Wildiers, Hans (2014). Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast Cancer Research and Treatment, 147(3):557-70.

Datta, N; Samiei, M; Bodis, S (2014). Radiotherapy infrastructure and human resources in Europe - Present status and its implications for 2020. European Journal of Cancer, 50(15):2735-2743.

Möhler, H; Pfirrmann, R W; Frei, K (2014). Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents (review). International Journal of Oncology, 45(4):1329-1336.

Sterzing, F; Brunner, T B; Ernst, I; Baus, W W; Greve, B; Herfarth, K; Guckenberger, M (2014). Stereotactic body radiotherapy for liver tumors: Principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlentherapie und Onkologie, 190(10):872-881.

Scharl, M; Bode, B; Rushing, E; Knuth, A; Rordorf, T (2014). Uncommon case of brain metastasis in a patient with a history of heavy smoking. Current Oncology, 21(5):e728-e731.

Scharl, M; Bode, B; Rushing, E; Knuth, A; Rordorf, Tamara (2014). Uncommon case of brain metastasis in a patient with a history of heavy smoking. Current Oncology, 21:e728-731.

Rozati, Sima; Kempf, Werner; Ostheeren-Michaelis, Sonja; Bode-Lesniewska, Beata; Zimmermann, Dieter R; Dummer, Reinhard; Cozzio, Antonio (2014). Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With Bilateral Intraocular Involvement and Infiltration to the CNS. Journal of Clinical Oncology:1-4.

Codo, P; Weller, M; Meister, G; Szabo, E; Steinle, A; Wolter, M; Reifenberger, G; Roth, P (2014). MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape. OncoTarget, 5(17):7651-7662.

Warth, A; Cortis, J; Soltermann, A; Meister, M; Budczies, J; Stenzinger, A; Goeppert, B; Thomas, M; Herth, F J F; Schirmacher, P; Schnabel, P A; Hoffmann, H; Dienemann, H; Muley, T; Weichert, W (2014). Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role. British Journal of Cancer, 111(6):1222-1229.

Suryani, Santi; Carol, Hernan; Chonghaile, Triona Ni; Frismantas, Viktoras; Sarmah, Chintanu; High, Laura; Bornhauser, Beat; Cowley, Mark J; Szymanska, Barbara; Evans, Kathryn; Boehm, Ingrid; Tonna, Elise; Jones, Luke; Manesh, Donya Moradi; Kurmasheva, Raushan T; Billups, Catherine; Kaplan, Warren; Letai, Anthony; Bourquin, Jean-Pierre; Houghton, Peter J; Smith, Malcolm A; Lock, Richard B (2014). Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts. Clinical Cancer Research, 20(17):4520-4531.

Blackhall, Fiona H; Peters, Solange; Bubendorf, Lukas; Dafni, Urania; Kerr, Keith M; Hager, Henrik; Soltermann, Alex; O'Byrne, Kenneth J; Dooms, Christoph; Sejda, Aleksandra; Hernández-Losa, Javier; Marchetti, Antonio; Savic, Spasenija; Tan, Qiang; Thunnissen, Erik; Speel, Ernst-Jan M; Cheney, Richard; Nonaka, Daisuke; de Jong, Jeroen; Martorell, Miguel; Letovanec, Igor; Rosell, Rafael; Stahel, Rolf A (2014). Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project. Journal of Clinical Oncology, 32(25):2780-2787.

Mano, Roy; Hakimi, A Ari; Zabor, Emily C; Bury, Marta A; Donati, Olivio F; Karlo, Christoph A; Bazzi, Wassim M; Furberg, Helena; Russo, Paul (2014). Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma. Canadian Urological Association. Journal, 8(9-10):E675-E680.

Xie, Shule; Bredell, Marius; Yang, Hongyu; Shen, Shiyue; Yang, Huijun (2014). Basaloid squamous cell carcinoma of the maxillary gingiva: A case report and review of the literature. Oncology Letters, 8(3):1287-1290.

Dummer, R; Duvic, M; Scarisbrick, J; Olsen, E A; Rozati, S; Eggmann, N; Goldinger, S M; Hutchinson, K; Geskin, L; Illidge, T M; Giuliano, E; Elder, J; Kim, Y H (2014). Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Annals of Oncology, 25(9):1807-1812.

Nieder, C; Andratschke, N H; Grosu, A L (2014). Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns. Oncology Letters, 8(3):972-976.

Popescu, R; Ciardiello, F; Stahel, R (2014). Reply to the letter to the editor 'Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper' by Valentini et al. Annals of Oncology, 25(9):1865.

Detterbeck, Frank C; Stratton, Kelly; Giroux, Dorothy; Asamura, Hisao; Crowley, John; Falkson, Conrad; Filosso, Pier Luigi; Frazier, Aletta A; Giaccone, Giuseppe; Huang, James; Kim, Jhingook; Kondo, Kazuya; Lucchi, Marco; Marino, Mirella; Marom, Edith M; Nicholson, Andrew G; Okumura, Meinoshin; Ruffini, Enrico; Van Schil, Paul (2014). The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. Journal of Thoracic Oncology, 9(9 Suppl 2):S65-72.

Kondo, Kazuya; Van Schil, Paul; Detterbeck, Frank C; Okumura, Meinoshin; Stratton, Kelly; Giroux, Dorothy; Asamura, Hisao; Crowley, John; Falkson, Conrad; Filosso, Pier Luigi; Giaccone, Giuseppe; Huang, James; Kim, Jhingook; Lucchi, Marco; Marino, Mirella; Marom, Edith M; Nicholson, Andrew G; Ruffini, Enrico (2014). The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. Journal of Thoracic Oncology, 9(9 Suppl 2):S81-7.

Nicholson, Andrew G; Detterbeck, Frank C; Marino, Mirella; Kim, Jhingook; Stratton, Kelly; Giroux, Dorothy; Asamura, Hisao; Crowley, John; Falkson, Conrad; Filosso, Pier Luigi; Giaccone, Giuseppe; Huang, James; Kondo, Kazuya; Lucchi, Marco; Marom, Edith M; Okumura, Meinoshin; Ruffini, Enrico; Van Schil, Paul (2014). The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. Journal of Thoracic Oncology, 9(9 Suppl 2):S73-80.

Soldini, Davide; Georgis, Antoin; Montagna, Chiara; Schüffler, Peter Johannes; Martin, Vittoria; Curioni-Fontecedro, Alessandra; Martinez, Antonio; Tinguely, Marianne (2014). The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas. Hematological oncology, 32(3):120-125.

Langen, K J; Tonn, J C; Weller, M; Galldiks, N (2014). Letter to the Editor: "The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline" [J Neurooncol 2014; 118:435-460]. Journal of Neuro-Oncology, 120(3):665-666.

Joerger, M; Baty, F; Früh, M; Droege, C; Stahel, R A; Betticher, D C; von Moos, R; Ochsenbein, A; Pless, M; Gautschi, O; Rothschild, S; Brauchli, P; Klingbiel, D; Zappa, F; Brutsche, M (2014). Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). Lung Cancer, 85(2):306-313.

Weller, M; van den Bent, M; Hopkins, K; Tonn, J C; Stupp, R; Falini, A; Cohen-Jonathan-Moyal, E; Frappaz, D; Henriksson, R; Balana, C; Chinot, O; Ram, Z; Reifenberger, G; Soffietti, R; Wick, W (2014). EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncology, 15(9):e395-e403.

Pfirrmann, M; Saussele, S; Hochhaus, A; Reiter, A; Berger, U; Hossfeld, D K; Nerl, C; Scheid, C; Spiekermann, K; Mayer, J; Hellmann, A; Lechner, K; Falge, C; Sayer, H G; Bunjes, D; Ganser, A; Beelen, D W; Baldomero, H; Schanz, U; Heimpel, H; Kolb, H J; Hasford, J; Gratwohl, A; Hehlmann, R (2014). Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia. Journal of Cancer Research and Clinical Oncology, 140(8):1367-1381.

Guckenberger, M (2014). Stellenwert der 5-FU-basierten adjuvanten Chemotherapie nach präoperativer Radiochemotherapie beim lokal fortgeschrittenen Rektumkarzinom. 10-Jahresergebnisse der EORTC-22921-Studie. Strahlentherapie und Onkologie, 190(8):772-773.

Ford, C E; Punnia-Moorthy, G; Henry, C E; Llamosas, E; Nixdorf, S; Olivier, J; Caduff, R; Ward, R L; Heinzelmann-Schwarz, V (2014). The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. Gynecologic Oncology, 134(2):338-345.

Weller, M (2014). The vanishing role of whole brain radiotherapy for primary central nervous system lymphoma. Neuro-Oncology, 16(8):1035-1036.

Jentzsch, Thorsten; Robl, Bernhard; Husmann, Maren; Bode-Lesniewska, Beata; Fuchs, Bruno (2014). Worse prognosis of osteosarcoma patients expressing IGF-1 on a tissue microarray. Anticancer Research, 34(8):3881-3889.

Samartzis, Eleftherios P; Gutsche, Katrin; Dedes, Konstantin J; Fink, Daniel; Stucki, Manuel; Imesch, Patrick (2014). Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition. OncoTarget, 5(14):5295-5303.

Hermanns, T; Bhindi, B; Wei, Y; Yu, J; Noon, A P; Richard, P O; Bhatt, J R; Almatar, A; Jewett, M A S; Fleshner, N E; Zlotta, A R; Templeton, A J; Kulkarni, G S (2014). Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. British Journal of Cancer, 111(3):444-451.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri M; Szucs, Thomas; Schwenkglenks, Matthias; Pestalozzi, Bernhard C (2014). Delivery of health care at the end of life in cancer patients of four swiss cantons a retrospective database study (SAKK 89/09). BMC Cancer, 14:306.

Dirven, Linda; Taphoorn, Martin J B; Reijneveld, Jaap C; Blazeby, Jane; Jacobs, Marc; Pusic, Andrea; La Sala, Edoardo; Stupp, Roger; Fayers, Peter; Efficace, Fabio (2014). The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: A systematic review. European Journal of Cancer, 50(14):2432-2448.

Wiestler, B; Capper, D; Hovestadt, V; Sill, M; Jones, D T W; Hartmann, C; Felsberg, J; Platten, M; Feiden, W; Keyvani, K; Pfister, S M; Wiestler, O D; Meyermann, R; Reifenberger, G; Pietsch, T; von Deimling, A; Weller, M; Wick, W (2014). Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro-Oncology, 16(12):1630-1638.

Beyer, Jörg (2014). Miracles don`t happen any more. Annals of Oncology, 25(9):1679-1680.

Patton, S; Normanno, N; Blackhall, F; Murray, S; Kerr, K M; Dietel, M; Filipits, M; Benlloch, S; Popat, S; Stahel, R; Thunnissen, E (2014). Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing. British Journal of Cancer, 111(2):413-420.

Datta, N; Samiei, M; Bodis, S (2014). Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020. International Journal of Radiation Oncology, Biology, Physics, 89(3):448-457.

Templeton, Arnoud J; Ace, Olga; McNamara, Mairéad G; Al-Mubarak, Mustafa; Vera-Badillo, Francisco E; Hermanns, Thomas; Seruga, Boštjan; Ocaña, Alberto; Tannock, Ian F; Amir, Eitan (2014). Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiology Biomarkers & Prevention, 23(7):1204-1212.

Urner-Bloch, U; Urner, M; Stieger, P; Galliker, N; Winterton, N; Zubel, A; Moutouh-de Parseval, L; Dummer, R; Goldinger, S M (2014). Transient MEK inhibitor-associated retinopathy in metastatic melanoma. Annals of Oncology, 25(7):1437-1441.

Basler, Michelle; Jetter, Alexander; Fink, Daniel; Seifert, Burkhardt; Kullak-Ublick, Gerd A; Trojan, Andreas (2014). Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast Care, 9(3):182-187.

Montavon, Gisèle; Jauquier, Nicolas; Coulon, Aurélie; Peuchmaur, Michel; Flahaut, Marjorie; Bourloud, Katia Balmas; Yan, Pu; Delattre, Olivier; Sommer, Lukas; Joseph, Jean-Marc; Janoueix-Lerosey, Isabelle; Gross, Nicole; Mühlethaler-Mottet, Annick (2014). Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells. OncoTarget, 5(12):4452-4466.

Valerio, Massimo; Emberton, Mark; Barret, Eric; Eberli, Daniel; Eggener, Scott E; Ehdaie, Behfar; Jichlinski, Patrice; Ward, John F; Ahmed, Hashim U (2014). Health technology assessment in evolution - focal therapy in localised prostate cancer. Expert Review of Anticancer Therapy, 14(11):1359-1367.

Schweizer, Riccardo; Kamat, Pranitha; Schweizer, Dennis; Dennler, Cyrill; Zhang, Shengye; Schnider, Jonas T; Salemi, Souzan; Giovanoli, Pietro; Eberli, Daniel; Enzmann, Volker; Erni, Dominique; Plock, Jan A (2014). Bone marrow-derived mesenchymal stromal cells improve vascular regeneration and reduce leukocyte-endothelium activation in critical ischemic murine skin in a dose-dependent manner. Cytotherapy, 16(10):1465-1469.

Ciardiello, F; Arnold, D; Casali, P G; Cervantes, A; Douillard, J-Y; Eggermont, A; Eniu, A; McGregor, K; Peters, S; Piccart, M; Popescu, R; Van Cutsem, E; Zielinski, C; Stahel, R (2014). Delivering Precision Medicine in Oncology Today and in Future-The Promise and Challenges of Personalised Cancer Medicine: a position paper by the European Society for Medical Oncology (ESMO). Annals of Oncology, 25(9):1673-1678.

Muendlein, Axel; Hubalek, Michael; et al (2014). Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients. European Journal of Cancer, 50(12):2134-2141.

Müller, Adrienne; Chiotellis, Aristeidis; Keller, Claudia; Ametamey, Simon M; Schibli, Roger; Mu, Linjing; Krämer, Stefanie D (2014). Imaging tumour ATB0,+ transport activity by PET with the cationic amino acid O-2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine. Molecular Imaging and Biology, 16(3):412-420.

Mwinyi, Jessica; Vokinger, Kerstin; Jetter, Alexander; Breitenstein, Urs; Hiller, Christian; Kullak-Ublick, Gerd A; Trojan, Andreas (2014). Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy. Cancer Chemotherapy and Pharmacology, 73(6):1181-1188.

Reinisch, Sabine; Kruse, Astrid; Bredell, Marius; Lübbers, Heinz-Theo; Gander, Thomas; Lanzer, Martin (2014). Is lymph-node ratio a superior predictor than lymph node status for recurrence-free and overall survival in patients with head and neck squamous cell carcinoma? Annals of Surgical Oncology, 21(6):1912-1918.

Stupp, R; Weller, M (2014). Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target. Neuro-Oncology, 16(6):765-767.

Pass, Harvey I; Giroux, Dorothy; Kennedy, Catherine; Ruffini, Enrico; Cangir, Ayten K; Rice, David; Asamura, Hisao; Waller, David; Edwards, John; Weder, Walter; Hoffmann, Hans; van Meerbeeck, Jan P; Rusch, Valerie W (2014). Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee. Journal of Thoracic Oncology, 9(6):856-864.

Weller, M; Kaulich, K; Hentschel, B; Felsberg, J; Gramatzki, D; Pietsch, T; Simon, M; Westphal, M; Schackert, G; Tonn, J C; von Deimling, A; Davis, T; Weiss, W A; Loeffler, M; Reifenberger, G (2014). Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. International Journal of Cancer, 134(10):2437-2447.

Besse, B; Adjei, A; Baas, P; Meldgaard, P; Nicolson, M; Paz-Ares, L; Reck, M; Smit, E F; Syrigos, K; Stahel, R; Felip, E; Peters, S (2014). 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease. Annals of Oncology, 25(8):1475-1484.

Vansteenkiste, J; Crinò, L; Dooms, C; Douillard, J Y; Faivre-Finn, C; Lim, E; Rocco, G; Senan, S; Van Schil, P; Veronesi, G; Stahel, R; Peters, S; Felip, E (2014). 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Annals of Oncology, 25(8):1462-1474.

Matter-Walstra, Klazien W; Achermann, Rita; Rapold, Roland; Klingbiel, Dirk; Bordoni, Andrea; Dehler, Silvia; Jundt, Gernot; Konzelmann, Isabelle; Clough-Gorr, Kerri M; Szucs, Thomas D; Schwenkglenks, Matthias; Pestalozzi, Bernhard C (2014). Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09). BMC Cancer, 14(1):306.

Delbue, Serena; Ferrante, Pasquale; Provenzano, Maurizio (2014). Polyomavirus BK and prostate cancer: an unworthy scientific effort? Oncoscience, 1(4):296-303.

Gilbert, Mark R; Dignam, James; Pugh, Stephanie; Armstrong, Terri S; Wefel, Jeffrey S; Aldape, K; Stupp, Roger; Hegi, Monika; Won, Minhee; Curran, Walter J; Mehta, Minesh (2014). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 32(15):1634-1635.

Kerr, K M; Bubendorf, L; Edelman, M J; Marchetti, A; Mok, T; Novello, S; O'Byrne, K; Stahel, R; Peters, S; Felip, E (2014). Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Annals of Oncology, 25(9):1681-1690.

Felley-Bosco, Emanuela; Stahel, Rolf (2014). Hippo/YAP pathway for targeted therapy. Translational Lung Cancer Research, 3(2):75-83.

Ruffini, Enrico; Detterbeck, Frank; Van Raemdonck, Dirk; Rocco, Gaetano; Thomas, Pascal; Weder, Walter; Brunelli, Alessandro; Guerrera, Francesco; Keshavjee, Shaf; Altorki, Nasser; Schützner, Jan; Arame, Alex; Spaggiari, Lorenzo; Lim, Eric; Toker, Alper; Venuta, Federico (2014). Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. Journal of Thoracic Oncology, 9(4):541-548.

Berger, M D; Meisel, A; Andres, M; Schanz, U; Schwarz, U; Stussi, G (2014). Unusual case of progressive multifocal leukoencephalopathy after allogeneic hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 32(9):e33-e34.

Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A (2014). A functional germline variant in GLI1 implicates Hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients. Clinical Cancer Research, 20(6):1687-1697.

Klement, R J; Allgaeuer, M; Appold, S; Dieckmann, K; Ernst, I; Ganswindt, U; Holy, R; Nestle, U; Nevinny-Stickel, M; Semrau, S; Sterzing, F; Wittig, A; Andratschke, N; Guckenberger, M (2014). Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics, 88(3):732-738.

Papatheodorou, Stefania I; Rohrmann, Sabine; Lopez, David S; Bradwin, Gary; Joshu, Corinne E; Kanarek, Norma; Nelson, William G; Rifai, Nader; Platz, Elizabeth A; Tsilidis, Konstantinos K (2014). Association between endogenous sex steroid hormones and insulin-like growth factor proteins in US men. Cancer Causes & Control, 25(3):353-363.

Brennecke, Patrick; Arlt, Matthias J E; Campanile, Carmen; Husmann, Knut; Gvozdenovic, Ana; Apuzzo, Tiziana; Thelen, Marcus; Born, Walter; Fuchs, Bruno (2014). CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice. Clinical & Experimental Metastasis, 31(3):339-349.

Kestin, L; Grills, I; Guckenberger, M; Belderbos, J; Hope, A J; Werner-Wasik, M; Sonke, J J; Bissonnette, J P; Xiao, Y; Yan, D (2014). Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance. Radiotherapy and Oncology, 110(3):499-504.

Wengenroth, L; Rueegg, C S; Michel, G; Essig, S; Ammann, R A; Bergstraesser, E; Kuehni, C E (2014). Life partnerships in childhood cancer survivors, their siblings, and the general population. Pediatric Blood & Cancer, 61(3):538-545.

Berger, Lars A; Bokemeyer, Carsten; Lorch, Anja; Hentrich, Marcus; Kopp, Hans‑Georg; Gauler, Thomas C; Beyer, Jörg; de Wit, Maike; Mayer, Frank; Boehlke, Ina; Oing, Christoph; Honecker, Friedemann; Oechsle, Karin (2014). First salvage treatment in patients with advanced germ cell cancer after cisplatin‑based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG). Journal of Cancer Research and Clinical Oncology, 140(7):1211-1220.

Fiaschetti, G; Abela, L; Nonoguchi, N; Dubuc, A M; Remke, M; Boro, A; Grunder, E; Siler, U; Ohgaki, H; Taylor, M D; Baumgartner, M; Shalaby, T; Grotzer, M A (2014). Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma. British Journal of Cancer, 110(3):636-647.

Hauselmann, Irina; Borsig, Lubor (2014). Altered tumor cell glycosylation promotes metastasis. Frontiers in Oncology:4:28.

Hoos, Alexandra; Protsyuk, Darya; Borsig, Lubor (2014). Metastatic growth progression caused by PSGL-1-mediated recruitment of monocytes to metastatic sites. Cancer Research, 74(3):695-704.

Bitanihirwe, Byron K Y; Meerang, Mayura; Friess, Martina; Soltermann, Alex; Frischknecht, Lukas; Thies, Svenja; Felley-Bosco, Emanuela; Tsao, Ming-Sound; Allo, Ghassan; de Perrot, Marc; Seifert, Burkhardt; Moch, Holger; Stahel, Rolf; Weder, Walter; Opitz, Isabelle (2014). PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy. Journal of Thoracic Oncology, 9(2):239-247.

Krayenbuehl, J; Dimmerling, P; Ciernik, I F; Riesterer, O (2014). Clinical outcome of postoperative highly conformal versus 3D conformal radiotherapy in patients with malignant pleural mesothelioma. Radiation Oncology, 9:32.

Frilling, Andrea; Modlin, Irvin M; Kidd, Mark; Russell, Christopher; Breitenstein, Stefan; Salem, Riad; Kwekkeboom, Dik; Lau, Wan-yee; Klersy, Catherine; Vilgrain, Valerie; Davidson, Brian; Siegler, Mark; Caplin, Martyn; Solcia, Enrico; Schilsky, Richard (2014). Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncology, 15(1):e8-21.

Aalbers, A M; van der Velden, V H J; Yoshimi, A; Fischer, A; Noellke, P; Zwaan, C M; Baumann, I; Beverloo, H B; Dworzak, M; Hasle, H; Locatelli, F; De Moerloose, B; Göhring, G; Schmugge, M; Stary, J; Zecca, M; Langerak, A W; van Dongen, J J M; Pieters, R; Niemeyer, C M; van den Heuvel-Eibrink, M M (2014). The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS. Leukemia, 28(1):189-92.

Popescu, R A; Schäfer, R; Califano, R; Eckert, R; Coleman, R; Douillard, J-Y; Cervantes, A; Casali, P G; Sessa, C; Van Cutsem, E; de Vries, E; Pavlidis, N; Fumasoli, K; Wörmann, B; Samonigg, H; Cascinu, S; Cruz Hernández, J J; Howard, A J; Ciardiello, F; Stahel, R A; Piccart, M (2014). The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO). Annals of Oncology, 25(1):9-15.

Kishore, Shivendra; Piscuoglio, Salvatore; Kovac, Michal B; Gylling, Annette; Wenzel, Friedel; Trapani, Francesca; Altermatt, Hans Joerg; Mele, Valentina; Marra, Giancarlo; Peltomäki, Päivi; Terracciano, Luigi; Zavolan, Mihaela; Heinimann, Karl (2014). 3'-UTR Poly(T/U) tract deletions and altered expression of EWSR1 are a hallmark of mismatch repair-deficient cancers. Cancer Research, 74(1):224-234.

Müller, Antonia M; Florek, Mareike (2014). 5-Azacytidine/5-Azacitidine. Recent Results in Cancer Research, 201:299-324.

Rodon, Jordi; Tawbi, Hussein A; Thomas, Anne L; Stoller, Ronald; Turtschi, Christian P; Baselga, Jose; Sarantopoulos, John; Mahalingam, Devalingam; Shou, Yaping; Moles, Melissa A; Yang, Lin; Granvil, Camille; Hurh, Eunju; Rose, Kristine L; Amakye, Dereck D; Dummer, Reinhard; Mita, Alain C (2014). A Phase 1, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Hedgehog Inhibitor Sonidegib (LDE225) in Patients With Advanced Solid Tumors. Clinical Cancer Research, 20(7):1900-1909.

Vonlanthen, Janine; Okoniewski, Michal J; Menigatti, Mirco; Cattaneo, Elisa; Pellegrini-Ochsner, Daniela; Haider, Ritva; Jiricny, Josef; Staiano, Teresa; Buffoli, Federico; Marra, Giancarlo (2014). A comprehensive look at transcription factor gene expression changes in colorectal adenomas. BMC Cancer, 14:46.

Wolpert, F; Tritschler, I; Steinle, A; Weller, M; Eisele, G (2014). A disintegrin and metalloproteinases 10 and 17 modulate the immunogenicity of glioblastoma-initiating cells. Neuro-Oncology, 16(3):382-391.

Montagna, Chiara. A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome. 2014, University of Zurich, Faculty of Medicine.

Mynbaev, Ospan A; Biro, Peter; Eliseeva, Marina Yu; Tinelli, Andrea; Malvasi, Antonio; Kosmas, Ioannis P; Medvediev, Mykhailo V; Babenko, Tatiana I; Mazitova, Madina I; Simakov, Sergei S; Stark, Michael (2014). A surgical polypragmasy: Koninckx PR, Corona R, Timmerman D, Verguts J, Adamyan L. Peritoneal full-conditioning reduces postoperative adhesions and pain: a randomised controlled trial in deep endometriosis surgery. J Ovarian Res. 2013 Dec 11;6(1):90. Journal of Ovarian Research, 7:29.

Tonder, Michaela; Eisele, Günter; Weiss, Tobias; Hofer, Silvia; Seystahl, Katharina; Valavanis, Antonios; Stupp, Roger; Weller, Michael; Roth, Patrick (2014). Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. Acta Oncologica, 53(10):1436-1440.

Stromberger, Carmen; Jann, David; Becker, Eva-Tessina; Raguse, Jan-Dirk; Tinhofer, Ingeborg; Marnitz, Simone; Budach, Volker (2014). Adjuvant simultaneous integrated boost IMRT for patients with intermediate- and high-risk head and neck cancer: Outcome, toxicities and patterns of failure. Oral Oncology, 50(11):1114-1121.

Friedrich, Carsten; Müller, Klaus; von Hoff, Katja; Kwiecien, Robert; Pietsch, Torsten; Warmuth-Metz, Monika; Gerber, Nicolas U; Hau, Peter; Kuehl, Joachim; Kortmann, Rolf D; von Bueren, André O; Rutkowski, Stefan (2014). Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocol. Journal of Neuro-Oncology, 116(3):567-575.

Lenggenhager, Daniela; Curioni-Fontecedro, Alessandra; Storz, Martina; Shakhova, Olga; Sommer, Lukas; Widmer, Daniel S; Seifert, Burkhardt; Moch, Holger; Dummer, Reinhard; Mihic-Probst, Daniela (2014). An aggressive hypoxia related subpopulation of melanoma cells is TRP-2 Negative. Translational Oncology, 7(2):206-212.

Harrison, C J; Bourquin, Jean-Pierre; et al (2014). An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Leukemia, 28(5):1015-1021.

Kajdi, Marie-Elisabeth; Beck-Schimmer, Beatrice; Held, Ulrike; Kofmehl, Reto; Lehmann, Kuno; Ganter, Michael Thomas (2014). Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World Journal of Surgical Oncology, 12:136.

Wyler, L; Napoli, C U; Ingold, B; Sulser, T; Heikenwälder, M; Schraml, P; Moch, H (2014). Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. British Journal of Cancer, 110(3):686-694.

Otterstrom, C; Soltermann, A; Opitz, I; Felley-Bosco, E; Weder, W; Stahel, R A; Triponez, F; Robert, J H; Serre-Beinier, V (2014). CD74: a new prognostic factor for patients with malignant pleural mesothelioma. British Journal of Cancer, 110(8):2040-2046.

Tonder, M; Weller, M; Eisele, G; Roth, P (2014). Carboplatin and Etoposide in Heavily Pretreated Patients with Progressive High-Grade Glioma. Chemotherapy, 60(5-6):375-378.

Rogler, Gerhard (2014). Chronic ulcerative colitis and colorectal cancer. Cancer Letters, 345(2):235-241.

Stupp, R; Hegi, M E; Gorlia, T; et al; Kim, C Y; Nabors, L B; Reardon, D A; van den Bent, M J; Hicking, C; Markivskyy, A; Picard, M; Weller, M (2014). Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncology, 15(10):1100-1108.

Eisele, G; Wick, A; Eisele, A C; Clément, P M; Tonn, J; Tabatabai, G; Ochsenbein, A; Schlegel, U; Neyns, B; Krex, D; Simon, M; Nikkhah, G; Picard, M; Stupp, R; Wick, W; Weller, M (2014). Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression. Journal of Neuro-Oncology, 117(1):141-145.

Janssen, S; Glanzmann, C; Bauernfeind, P; Stieb, S; Studer, G; Brown, M; Riesterer, O (2014). Clinical experience of SIB-IMRT in anal cancer and selective literature review. Radiation Oncology, 9:199.

Janssen, Stefan; Glanzmann, Christoph; Bauerfeind, Peter; Stieb, Sonja; Studer, Gabriela; Brown, Michelle; Riesterer, Oliver (2014). Clinical experience of SIB-IMRT in anal cancer and selective literature review. Radiation Oncology, 9:199.

Hundsberger, T; Tonder, M; Hottinger, A; Brügge, D; Roelcke, U; Putora, P M; Stupp, R; Weller, M (2014). Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients. Journal of Neuro-Oncology, 118(2):321-328.

Lindenblatt, Nicole; El-Rabadi, Karem; Helbich, Thomas H; Czembirek, Heinrich; Deutinger, Maria; Benditte-Klepetko, Heike (2014). Correlation between MRI results and intraoperative findings in patients with silicone breast implants. International Journal of Women's Health, 6:703-709.

Jakovljevic, Mihajlo; Gutzwiller, Florian; Schwenkglenks, Matthias; Milovanovic, Olivera; Rancic, Nemanja; Varjacic, Mirjana; Stojadinovic, Dobrivoje; Dagovic, Aleksandar; Matter-Walstra, Klazien (2014). Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 19(4):1111-1120.

Mueller, K; Schlamann, A; Guckenberger, M; Warmuth-Metz, M; Glueck, A; Pietschmann, S; Wawer, A; Kortmann, R D; Kramm, C; von Bueren, A O (2014). Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group. Strahlentherapie und Onkologie, 190(4):377-381.

Grosse, Nicole; van Loon, Barbara; Rohrer Bley, Carla (2014). DNA damage response and DNA repair - dog as a model? BMC Cancer, 14:203.

Bachmann, Samia B; Frommel, Sandra C; Camicia, Rosalba; Winkler, Hans C; Santoro, Raffaella; Hassa, Paul O (2014). DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells. Molecular Cancer, 13:125.

Grosse, Nicole; Fontana, Andrea O; Hug, Eugen B; Lomax, Antony; Coray, Adolf; Augsburger, Marc; Paganetti, Harald; Sartori, Alessandro A; Pruschy, Martin (2014). Deficiency in homologous recombination renders Mammalian cells more sensitive to proton versus photon irradiation. International Journal of Radiation Oncology, Biology, Physics, 88(1):175-181.

Nieder, C; Andratschke, N; Angelo, K; Haukland, E; Grosu, A L (2014). Development of a score predicting survival after palliative reirradiation. Journal of Oncology, 2014:128240.

Rieger, J; Bähr, O; Maurer, G D; Hattingen, E; Franz, K; Brucker, D; Walenta, S; Kämmerer, U; Coy, J F; Weller, M; Steinbach, J P (2014). ERGO: A pilot study of ketogenic diet in recurrent glioblastoma. International Journal of Oncology, 44(6):1843-1852.

Lacombe, Denis; Tejpar, Sabine; Salgado, Roberto; Cardoso, Fatima; Golfinopoulos, Vassilis; Aust, Daniela; Folprecht, Gunnar; Roth, Arnaud; Stupp, Roger (2014). European perspective for effective cancer drug development. Nature Reviews. Clinical Oncology, 11(8):492-498.

Comazzi, St; Guscetti, F; Marconato, L (2014). First meeting of the European canine lymphoma group. Workshop: state of the art and comparative aspects in canine lymphoma. CH-Lugano, 22 June 2013. Hematological oncology, 32(2):68-71.

Bosset, J F; Calais, G; Mineur, L; Maingon, P; Stojanovic-Rundic, S; Bensadoun, R J; Bardet, E; Beny, A; Ollier, J C; Bolla, M; Marchal, D; Van Laethem, J L; Klein, V; Giralt, J; Clavère, P; Glanzmann, C; Cellier, P; Collette, L (2014). Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncology, 15(2):184-190.

Schadendorf, D; Amonkar, M M; Milhem, M; Grotzinger, K; Demidov, L V; Rutkowski, P; Garbe, C; Dummer, R; Hassel, J C; Wolter, P; Mohr, P; Trefzer, U; Lefeuvre-Plesse, C; Rutten, A; Steven, N; Ullenhag, G; Sherman, L; Wu, F S; Patel, K; Casey, M; Robert, C (2014). Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study. Annals of Oncology, 25(3):700-706.

Renganathan, Arun; Kresoja-Rakic, Jelena; Echeverry, Nohemy; Ziltener, Gabriela; Vrugt, Bart; Opitz, Isabelle; Stahel, Rolf A; Felley-Bosco, Emanuela (2014). GAS5 long non-coding RNA in malignant pleural mesothelioma. Molecular Cancer, 13:119.

Zikos, Efstathios; Ghislain, Irina; Coens, Corneel; Ediebah, Divine E; Sloan, Elizabeth; Quinten, Chantal; Koller, Michael; van Meerbeeck, Jan P; Flechtner, Hans-Henning; Stupp, Roger; Czimbalmos, Agnes; Sprangers, Mirjam A G; Bottomley, Andrew (2014). Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials. Lancet Oncology, 15(2):e78-e89.

Stankov, M V; Bourquin, J P; et al (2014). Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Leukemia, 28(3):577-588.

Kristensen, Helle; Haldrup, Christa; Strand, Siri; Mundbjerg, Kamilla; Mortensen, Martin M; Thorsen, Kasper; Ostenfeld, Marie Stampe; Wild, Peter J; Arsov, Christian; Goering, Wolfgang; Visakorpi, Tapio; Egevad, Lars; Lindberg, Johan; Grönberg, Henrik; Høyer, Søren; Borre, Michael; Orntoft, Torben F; Sørensen, Karina D (2014). Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 20(8):2169-2181.

Janssen, Stefan; Glanzmann, Christoph; Lang, Stephanie; Verlaan, Sarah; Streller, Tino; Wisler, Doris; Linsenmeier, Claudia; Studer, Gabriela (2014). Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacy. Radiation Oncology, 9:165.

Helbig, L; Koi, L; Brüchner, K; Gurtner, K; Hess-Stumpp, H; Unterschemmann, K; Pruschy, M; Baumann, M; Yaromina, A; Zips, D (2014). Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation. International Journal of Radiation Oncology, Biology, Physics, 88(1):159-166.

Tinguely, Marianne; Thies, Svenja; Frigerio, Simona; Reineke, Tanja; Korol, Dimitri; Zimmermann, Dieter R (2014). IRF8 is associated with a GCB-type of DLBCL and exceptionally involved in a translocation t(14;16) (q32.33;q24.1). Leukemia & Lymphoma, 55(1):136-142.

Mohme, Malte; Neidert, Marian C; Regli, Luca; Weller, Michael; Martin, Roland (2014). Immunological challenges for peptide-based immunotherapy in glioblastoma. Cancer Treatment Reviews, 40:248-258.

Menzel, Moritz; Meckbach, Diana; Weide, Benjamin; et al; Ikenberg, Kristian; Bauer, Jürgen (2014). In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival. Pigment Cell & Melanoma Research, 27(4):671-673.

Hemminki, O; Immonen, R; et al (2014). In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders. International Journal of Cancer, 134(12):2878-2890.

Simon, Manuel; Stefan, Nikolas; Borsig, Lubor; Plückthun, Andreas; Zangemeister-Wittke, Uwe (2014). Increasing the antitumor effect of an EpCAM-targeting fusion toxin by facile click PEGylation. Molecular Cancer Therapeutics, 13(2):375-385.

Künzler, Alfred; Nussbeck, Fridtjof W; Moser, Michael T; Bodenmann, Guy; Kayser, Karen (2014). Individual and dyadic development of personal growth in couples coping with cancer. Supportive Care in Cancer, 22(1):53-62.

Janssen, S; Glanzmann, C; Huber, G; Studer, G (2014). Individualized IMRT treatment approach for cervical lymph node metastases of unknown primary. Strahlentherapie und Onkologie, 190(4):386-393.

Happold, C; Roth, P; Silginer, M; Florea, A M; Lamszus, K; Frei, K; Deenen, R; Reifenberger, G; Weller, M (2014). Interferon-β induces loss of spherogenicity and overcomes therapy resistance of glioblastoma stem cells. Molecular Cancer Therapeutics, 13(4):948-961.

Shen, C J; Sharma, A; Vuonag, D-V; Erler, J T; Pruschy, M (2014). Ionizing radiation induces tumor cell lysyl oxidase secretion. BMC Cancer, 14:532.

Richard, Aline; Faeh, David; Rohrmann, Sabine; Braun, Julia; Tarnutzer, Silvan; Bopp, Matthias (2014). Italianity is associated with lower risk of prostate cancer mortality in Switzerland. Cancer Causes & Control, 25(11):1523-1529.

Rossetti, A O; Jeckelmann, S; Novy, J; Roth, P; Weller, M; Stupp, R (2014). Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Neuro-Oncology, 16(4):584-588.

Mantel, F; Glatz, S; Toussaint, A; Flentje, M; Guckenberger, M (2014). Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases. Strahlentherapie und Onkologie, 190(12):1141-1148.

Mamlouk, Soulafa; Kalucka, Joanna; Singh, Rashim Pal; Franke, Kristin; Muschter, Antje; Langer, Anika; Jakob, Christiane; Gassmann, Max; Baretton, Gustavo B; Wielockx, Ben (2014). Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development. International Journal of Cancer, 134(4):849-858.

Palladini, G; Milani, P; Foli, A; Vidus Rosin, M; Basset, M; Lavatelli, F; Nuvolone, M; Obici, L; Perlini, S; Merlini, G (2014). Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: A matched case–control study on 174 patients. Leukemia, 28(12):2311-2316.

Gianinazzi, Micol E; Rueegg, Corina S; von der Weid, Nicolas X; Niggli, Felix K; Kuehni, Claudia E; Michel, Gisela (2014). Mental health-care utilization in survivors of childhood cancer and siblings: the Swiss childhood cancer survivor study. Supportive Care in Cancer, 22(2):339-349.

Wolf, Monika Julia; Adili, Arlind; Piotrowitz, Kira; et al; Boege, Yannick; Egger, Michèle; Moch, Holger; Kopf, Manfred; Weber, Achim; Heikenwalder, Mathias (2014). Metabolic activation of intrahepatic CD8(+) T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell, 26(4):549-564.

McCusker, Margaret; Basset-Seguin, Nicole; Dummer, Reinhard; Lewis, Karl; Schadendorf, Dirk; Sekulic, Aleksandar; Hou, Jeannie; Wang, Lisa; Yue, Huibin; Hauschild, Axel (2014). Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease. European Journal of Cancer, 50(4):774-783.

Rechsteiner, Markus; Müller, Rouven; Reineke, Tanja; Goede, Jeroen; Bohnert, Annette; Zhong, Qing; Manz, Markus G; Moch, Holger; Wild, Peter J; Zimmermann, Dieter R; Tinguely, Marianne (2014). Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by next generation sequencing. Experimental Hematology & Oncology, 3:18.

Hofer, Silvia; Rushing, Elisabeth; Preusser, Matthias; Marosi, Christine (2014). Molecular biology of high grade gliomas: what should the clinician know? Chinese Journal of Cancer, 33(1):4-7.

Reifenberger, G; Weber, R G; Riehmer, V; Kaulich, K; Willscher, E; Wirth, H; Gietzelt, J; Hentschel, B; Westphal, M; Simon, M; Schackert, G; Schramm, J; Matschke, J; Sabel, M C; Gramatzki, D; Felsberg, J; Hartmann, C; Steinbach, J P; Schlegel, U; Wick, W; Radlwimmer, B; Pietsch, T; Tonn, J C; von Deimling, A; Binder, H; Weller, M; Loeffler, M (2014). Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling. International Journal of Cancer, 135(8):1822-1831.

Pfeil, Alena M; Vulsteke, Christof; Paridaens, Robert; Dieudonné, Anne-Sophie; Pettengell, Ruth; Hatse, Sigrid; Neven, Patrick; Lambrechts, Diether; Szucs, Thomas D; Schwenkglenks, Matthias; Wildiers, Hans (2014). Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors. BMC Cancer, 14:201.

Blaes, J; Weiler, M; Sahm, F; Hentschel, B; Osswald, M; Czabanka, M; Thomé, C M; Schliesser, M G; Pusch, S; Luger, S; Winkler, F; Radbruch, A; Jugold, M; Simon, M; Steinbach, J P; Schackert, G; Tatagiba, M; Westphal, M; Tonn, J C; Gramatzki, D; Pietsch, T; Hartmann, C; Glimm, H; Vajkoczy, P; von Deimling, A; Platten, M; Weller, M; Wick, W (2014). NDRG1 prognosticates the natural course of disease in WHO grade II glioma. Journal of Neuro-Oncology, 117(1):25-32.

Seystahl, K; Weller, M; Bozinov, O; Reimann, R; Rushing, E (2014). Neuropathological characteristics of progression after prolonged response to bevacizumab in multifocal hemangioblastoma. Oncology Research and Treatment, 37(4):209-212.

Krzemieniecki, K; Sevelda, P; Erdkamp, F; Smakal, M; Schwenkglenks, Matthias; Puertas, J; Trojan, A; Szabo, Z; Bendall, K; Maenpaa, J (2014). Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy-findings from clinical practice. Supportive Care in Cancer, 22(3):667-677.

Lohri, Corinne; Hutzli Schaltegger, Claudia S; van den Broek, Maries; Wenger, Roland H; Ruegg, Curzio; Fink, Daniel; Fehr, Mathias K; Knuth, Alexander; Zweifel, Martin (2014). Neutrophil expression of ICAM1, CXCR1, and VEGFR1 in patients with breast cancer before and after adjuvant chemotherapy. Anticancer Research, 34:4693-4700.

von Braun, A; Braun, D L; Kamarachev, J; Gunthard, H F (2014). New Onset of Kaposi Sarcoma in a Human Immunodeficiency Virus-1-Infected Homosexual Man, Despite Early Antiretroviral Treatment, Sustained Viral Suppression, and Immune Restoration. Open Forum Infectious Diseases, 1(1):ofu005.

Fink, Daniel (2014). News from the San Antonio Breast Cancer Symposium 2013. Breast Care, 9(1):66-68.

Shanmugalingam, Thurkaa; Crawley, Danielle; Bosco, Cecilia; Melvin, Jennifer; Rohrmann, Sabine; Chowdhury, Simon; Holmberg, Lars; Van Hemelrijck, Mieke (2014). Obesity and cancer: the role of vitamin D. BMC Cancer, 14:712.

Hasse, B; Iff, M; Ledergerber, B; et al; Böni, J (2014). Obesity trends and body mass index changes after starting antiretroviral treatment: The Swiss HIV cohort study. Open Forum Infectious Diseases, 1(2):ofu040.

Hitz, Felicitas; Diem, Stefan; Haile, Sarah R; Ess, Silvia; Cerny, Thomas; Mey, Ulrich (2014). Outcome of mantle cell lymphoma patients treated at a single institution over the past decade. Hematological oncology, 32(4):192-196.

Wyss, Paloma; Varga, Zsuzsanna; Rössle, Matthias; Rageth, Christoph (2014). Papillary lesions of the breast: Outcomes of 156 patients managed without excisional biopsy. The Breast Journal, 20(4):394-401.

Dummer, Reinhard (2014). Precision medicine and skin cancer therapy: dealing with a moving target. Current Opinion in Oncology, 26(2):182-183.

Weller, Michael (2014). Primary central nervous system lymphoma in the elderly. Oncology Research and Treatment, 37(7-8):376-377.

Donati, Olivio F; Afaq, Asim; Mazaheri, Yousef; Vargas, Hebert Alberto; Junting, Zheng; Moskowitz, Chaya S; Hricak, Hedvig; Akin, Oguz (2014). Prostate MRI: Evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score. Clinical Cancer Research, 20(14):3705-3711.

Gerber, N U; Mynarek, M; von Hoff, K; Friedrich, C; Resch, A; Rutkowski, S (2014). Recent developments and current concepts in medulloblastoma. Cancer Treatment Reviews, 40(3):356-365.

Dehler, Silvia; Tonev, Simeon; Korol, Dimitri; Rohrmann, Sabine; Dimitrova, Nadya (2014). Recent trends in cancer incidence: impact of risk factors, diagnostic activities and data quality of registration. Tumori, 100(4):399-405.

Pauli, Chantal; Fuchs, Bruno; Pfirrmann, Christian; Bridge, Julia A; Hofer, Silvia; Bode, Beata (2014). Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to denosumab therapy. World Journal of Surgical Oncology, 12:17.

Janssen, Stefan; Glanzmann, Christoph; Huber, Gerhard; Studer, Gabriela (2014). Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer. Radiation Oncology, 9:136.

Wagner, Claudia C; Held, Ulrike; Kofmehl, Reto; Battegay, Edouard; Zimmerli, Lukas; Hofer, Silvia (2014). Role of arterial hypertension as a predictive marker for bevacizumab efficacy in recurrent glioblastoma - a prospective analysis. Acta Oncologica, 53(4):572-575.

McArthur, Grant A; Chapman, Paul B; Robert, Caroline; Larkin, James; Haanen, John B; Dummer, Reinhard; Ribas, Antoni; Hogg, David; Hamid, Omid; Ascierto, Paolo A; Garbe, Claus; Testori, Alessandro; Maio, Michele; Lorigan, Paul; Lebbé, Celeste; Jouary, Thomas; Schadendorf, Dirk; O'Day, Stephen J; Kirkwood, John M; Eggermont, Alexander M; Dréno, Brigitte; Sosman, Jeffrey A; Flaherty, Keith T; Yin, Ming; Caro, Ivor; Cheng, Suzanne; Trunzer, Kerstin; Hauschild, Axel (2014). Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study. Lancet Oncology, 15(3):323-332.

Bramante, S; Koski, A; Kipar, A; Diaconu, I; Liikanen, I; Hemminki, O; Vassilev, L; Parviainen, S; Cerullo, V; Pesonen, S K; Oksanen, M; Heiskanen, R; Rouvinen-Lagerström, N; Merisalo-Soikkeli, M; Hakonen, T; Joensuu, T; Kanerva, A; Pesonen, S; Hemminki, A (2014). Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans. International Journal of Cancer, 135(3):720-730.

Zhou, T; Georgeon, S; Moser, R; Moore, D J; Caflisch, A; Hantschel, O (2014). Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348). Leukemia, 28(2):404-407.

Hottinger, Andreas F; Stupp, Roger; Homicsko, Krisztian (2014). Standards of care and novel approaches in the management of glioblastoma multiforme. Chinese Journal of Cancer, 33(1):32-39.

Guckenberger, M (2014). Stereotactic body radiotherapy for stage I NSCLC: The challenge of evidence-based medicine. Journal of Thoracic Oncology, 9(2):E17-E18.

Kocher, M; Wittig, A; Piroth, M D; Treuer, H; Seegenschmiedt, H; Ruge, M; Grosu, A L; Guckenberger, M (2014). Stereotactic radiosurgery for treatment of brain metastases. Strahlentherapie und Onkologie, 190(6):521-532.

Riesterer, O; Guckenberger, M (2014). Stereotaktische Strahlentherapie von Metastasen : Palliativer Effekt und Tumorkontrolle. Onkologe, 20(8):757-765.

Flaherty, Keith T; Hennig, Michael; Lee, Sandra J; Ascierto, Paolo A; Dummer, Reinhard; Eggermont, Alexander M M; Hauschild, Axel; Kefford, Richard; Kirkwood, John M; Long, Georgina V; Lorigan, Paul; Mackensen, Andreas; McArthur, Grant; O'Day, Steven; Patel, Poulam M; Robert, Caroline; Schadendorf, Dirk (2014). Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials. Lancet Oncology, 15(3):297-304.

Kasenda, Benjamin; Bass, Annatina; Koeberle, Dieter; Pestalozzi, Bernhard; Borner, Markus; Herrmann, Richard; Jost, Lorenz; Lohri, Andreas; Hess, Viviane (2014). Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study. BMC Cancer, 14:728.

Aalbers, A M; van den Heuvel-Eibrink, M M; Baumann, I; Beverloo, H B; Driessen, G J; Dworzak, M; Fischer, A; Göhring, G; Hasle, H; Locatelli, F; De Moerloose, B; Noellke, P; Schmugge, M; Stary, J; Yoshimi, A; Zecca, M; Zwaan, C M; van Dongen, J J M; Pieters, R; Niemeyer, C M; van der Velden, V H J; Langerak, A W (2014). T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS. Blood Cancer Journal, 4:e209.

Georgis, Antoin. The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas. 2014, University of Zurich, Faculty of Medicine.

Van Allen, Eliezer M; Wagle, Nikhil; Sucker, Antje; Treacy, Daniel J; Johannessen, Cory M; Goetz, Eva M; Place, Chelsea S; Taylor-Weiner, Amaro; Whittaker, Steven; Kryukov, Gregory V; Hodis, Eran; Rosenberg, Mara; McKenna, Aaron; Cibulskis, Kristian; Farlow, Deborah; Zimmer, Lisa; Hillen, Uwe; Gutzmer, Ralf; Goldinger, Simone M; Ugurel, Selma; Gogas, Helen J; Egberts, Friederike; Berking, Carola; Trefzer, Uwe; Loquai, Carmen; Weide, Benjamin; Hassel, Jessica C; Gabriel, Stacey B; Carter, Scott L; Getz, Gad; Garraway, Levi A; Schadendorf, Dirk (2014). The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discovery, 4(1):94-109.

Weller, M; Soffietti, R; Brada, M (2014). The legend of cytomegalovirus and glioblastoma lives on. Neuro-Oncology, 16(1):166.

Miao, L; Fraefel, C; Sia, K C; Newman, J P; Mohamed-Bashir, S A; Ng, W H; Lam, P Y P (2014). The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy. British Journal of Cancer, 110(1):94-106.

Gerber, Nicolas U; von Hoff, Katja; Resch, Anika; Ottensmeier, Holger; Kwiecien, Robert; Faldum, Andreas; Matuschek, Christiane; Hornung, Dagmar; Bremer, Michael; Benesch, Martin; Pietsch, Torsten; Warmuth-Metz, Monika; Kuehl, Joachim; Rutkowski, Stefan; Kortmann, Rolf D (2014). Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy. International Journal of Radiation Oncology, Biology, Physics, 89(4):863-871.

Voss, M H; Bastos, D A; Karlo, C A; Ajeti, A; Hakimi, A A; Feldman, D R; Hsieh, J J; Molina, A M; Patil, S; Motzer, R J (2014). Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies. Annals of Oncology, 25(3):663-668.

Ghanjati, Foued; Beermann, Agnes; Hermanns, Thomas; Poyet, Cedric; Araúzo-Bravo, Marcos J; Seifert, Hans-Helge; Schmidtpeter, Martin; Goering, Wolfgang; Sorg, Rüdiger; Wernet, Peter; Santourlidis, Simeon (2014). Unreserved application of epigenetic methods to define differences of DNA methylation between urinary cellular and cell-free DNA. Cancer Biomarkers: Section A of Disease Markers, 14(5):295-302.

Goldinger, Simone M; Zimmer, Lisa; Schulz, Carsten; Ugurel, Selma; Hoeller, Christoph; Kaehler, Katharina C; Schadendorf, Dirk; Hassel, Jessica C; Becker, Juergen; Hauschild, Axel; Dummer, Reinhard (2014). Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients. European Journal of Cancer, 50(2):406-410.

Eichholzer, Monika; Richard, Aline; Nicastro, Holly L; Platz, Elizabeth A; Linseisen, Jakob; Rohrmann, Sabine (2014). Urinary lignans and inflammatory markers in the US National Health and Nutrition Examination Survey (NHANES) 1999–2004 and 2005–2008. Cancer Causes & Control, 25(3):395-403.

Zimmermann, Anne-Katrin; Camenisch, Ulrike; Rechsteiner, Markus P; Bode-Lesniewska, Beata; Rössle, Matthias (2014). Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma. Cancer Cytopathology, 122(1):48-58.

Dummer, Reinhard; Goldinger, Simone M; Turtschi, Christian P; Eggmann, Nina B; Michielin, Olivier; Mitchell, Lada; Veronese, Luisa; Hilfiker, Paul René; Felderer, Lea; Rinderknecht, Jeannine D (2014). Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study. European Journal of Cancer, 50(3):611-621.

Rothermundt, C; Whelan, J S; Dileo, P; Strauss, S J; Coleman, J; Briggs, T W; Haile, Sarah R; Seddon, B M (2014). What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients. British Journal of Cancer, 110(10):2420-2426.

Moch, Holger; Lukamowicz-Rajska, Magdalena (2014). miR-30c-2-3p and miR-30a-3p: New pieces of the Jigsaw puzzle in HIF2α regulation. Cancer Discovery, 4(1):22-24.

Ram Kumar, Ram Mohan; Betz, Michael M; Robl, Bernhard; Born, Walter; Fuchs, Bruno (2014). ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2. BMC Cancer, 14:559.

Berghoff, A S; Kovanda, A K; Melchardt, T; Bartsch, R; Hainfellner, J A; Sipos, B; Schittenhelm, J; Zielinski, C C; Widhalm, G; Dieckmann, K; Weller, M; Goodman, S L; Birner, P; Preusser, M (2014). αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer. Clinical & Experimental Metastasis, 31(7):841-851.

2013

Poretti, Andrea; Meoded, Avner; Cohen, Kenneth J; Grotzer, Michael A; Boltshauser, Eugen; Huisman, Thierry A G M (2013). Apparent diffusion coefficient of pediatric cerebellar tumors: A biomarker of tumor grade? Pediatric Blood & Cancer, 60(12):2036-2041.

Stahel, Rolf; Peters, Solange; Baas, Paul; Brambilla, Elisabeth; Cappuzzo, Federico; De Ruysscher, Dirk; Eberhardt, Wilfried Ernst Erich; Felip, Enriqueta; Fennell, Dean; Marchetti, Antonio; Paz-Ares, Luis; Adjei, Alex A (2013). Strategies for improving outcomes in NSCLC: a look to the future. Lung Cancer, 82(3):375-382.

Detterbeck, Frank C; Asamura, Hisao; Crowley, John; Falkson, Conrad; Giaccone, Giuseppe; Giroux, Dori; Huang, James; Kim, Jhingook; Kondo, Kazuya; Lucchi, Marco; Marino, Mirella; Marom, Edith M; Nicholson, Andrew; Okumura, Meinoshin; Ruffini, Enrico; van Schil, Paul; Stratton, Kelly (2013). The IASLC/ITMIG thymic malignancies staging project: Development of a stage classification for thymic malignancies. Journal of Thoracic Oncology, 8(12):1467-1473.

Terwijn, M; van Putten, W L; Kelder, A; van der Velden, V H; Brooimans, R A; Pabst, T; Maertens, J; Boeckx, N; de Greef, G E; Valk, P J; Preijers, F W; Huijgens, P C; Dräger, A M; Schanz, U; Jongen-Lavrecic, M; Biemond, B J; Passweg, J R; van Gelder, M; Wijermans, P; Graux, C; Bargetzi, M; Legdeur, M C; Kuball, J; de Weerdt, O; Chalandon, Y; Hess, U; Verdonck, L F; Gratama, J W; Oussoren, Y J; Scholten, W J; Slomp, J; Snel, A N; Vekemans, M C; Löwenberg, B; Ossenkoppele, G J; Schuurhuis, G J (2013). High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: Data from the HOVON/SAKK AML 42A Study. Journal of Clinical Oncology, 31(31):3889-3897.

Tschuor, Ch; Croome, K P; Sergeant, G; Cano, V; Schadde, E; Ardiles, V; Slankamenac, K; Clariá, R S; de Santibaňes, E; Hernandez-Alejandro, R; Clavien, P A (2013). Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion - An extension of the ALPPS approach. European Journal of Surgical Oncology, 39(11):1230-1235.

Buschmann, Johanna; Gao, Shuping; Härter, Luc; Hemmi, Sonja; Welti, Manfred; Werner, Clement M L; Calcagni, Maurizio; Cinelli, Paolo; Wanner, Guido A (2013). Yield and proliferation rate of adipose-derived stromal cells as a function of age, body mass index and harvest site-increasing the yield by use of adherent and supernatant fractions? Cytotherapy, 15(9):1098-1105.

Peters, Solange; Taron, Miquel; Bubendorf, Lukas; Blackhall, Fiona; Stahel, Rolf (2013). Treatment and detection of ALK-rearranged NSCLC. Lung Cancer, 81(2):145-154.

Eckert, Cornelia; Henze, Günter; Seeger, Karlheinz; Hagedorn, Nikola; Mann, Georg; Panzer-Grümayer, Renate; Peters, Christina; Klingebiel, Thomas; Borkhardt, Arndt; Schrappe, Martin; Schrauder, André; Escherich, Gabriele; Sramkova, Lucie; Niggli, Felix; Hitzler, Johann; von Stackelberg, Arend (2013). Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group. Journal of Clinical Oncology, 31(21):2736-2742.

Lee, James A; Bubendorf, Lukas; Stahel, Rolf; Peters, Solange (2013). Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives. Expert Review of Anticancer Therapy, 13(5):625-36.

Dörffel, Wolfgang; Niggli, Felix; et al (2013). Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. Journal of Clinical Oncology, 31(12):1562-1568.

Zinn, Pascal O; Colen, Rivka R; Kasper, Ekkehard M; Burkhardt, Jan-Karl (2013). Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients. International Journal of Oncology, 42(3):929-934.

Gianinazzi, Micol E; Rueegg, Corina S; Wengenroth, Laura; Bergstraesser, Eva; Rischewski, Johannes; Ammann, Roland A; Kuehni, Claudia E; Michel, Gisela (2013). Adolescent survivors of childhood cancer: are they vulnerable for psychological distress? Psycho-Oncology, 22(9):2051-2058.

Neidert, M C; Schoor, O; Trautwein, C; Trautwein, N; Christ, L; Melms, A; Honegger, J; Rammensee, H G; Herold-Mende, C; Dietrich, P Y; Stevanovic, S (2013). Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy. Journal of Neuro-Oncology, 111(3):285-294.

Heikenwalder, Mathias; Borsig, Lubor (2013). Pathways of metastasizing intestinal cancer cells revealed: How will fighting metastases at the site of cancer cell arrest affect drug development? Future Oncology (London, England), 9(1):4pp.

Melchior, Hanne; Büscher, Cathrin; Thorenz, Andrea; Grochocka, Anna; Koch, Uwe; Watzke, Birgit (2013). Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer. Psycho-Oncology, 22(1):39-45.

Demierre, Nadine; Zoete, Vincent; Michielin, Olivier; Stauffer, Edouard; Zimmermann, Dieter R; Betticher, Daniel C; Peters, Solange (2013). A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable? Lung Cancer, 80(1):81-84.

Soldini, D; Montagna, C; Schüffler, P; Martin, V; Georgis, A; Thiesler, T; Curioni-Fontecedro, A; Went, P; Bosshard, G; Dehler, Silvia; Mazzuchelli, L; Tinguely, M (2013). A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome. Annals of Oncology, 24(1):193-201.

Senn, Beate; Eicher, Manuela; Mueller, Michael D; Hornung, René; Fink, Daniel; Baessler, Kaven; Hampl, Monika; Denhaerynck, Kris; Spirig, Rebecca; Engberg, Sandra (2013). A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecologic Oncology, 129(1):234-240.

Connor, Joseph P; Cristea, Mihaela C; Lewis, Nancy L; Lewis, Lionel D; Komarnitsky, Philip B; Mattiacci, Maria R; Felder, Mildred; Stewart, Sarah; Harter, Josephine; Henslee-Downey, Jean; Kramer, Daniel; Neugebauer, Roland; Stupp, Roger (2013). A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors. BMC Cancer, 13:20.

Eisele, G; Wolpert, F; Decrey, G; Weller, M (2013). APO010, a synthetic hexameric CD95 ligand, induces death of human glioblastoma stem-like cells. Anticancer Research, 33(9):3563-3571.

Hütt-Cabezas, Marianne; Karajannis, Matthias A; Zagzag, David; Shah, Smit; Horkayne-Szakaly, Iren; Rushing, Elisabeth J; Cameron, J Douglas; Jain, Deepali; Eberhart, Charles G; Raabe, Eric H; Rodriguez, Fausto J (2013). Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target. Neuro-Oncology, 15(12):1604-1614.

Roth, P; Wick, W; Weller, M (2013). Anaplastic Oligodendroglioma: A New Treatment Paradigm and Current Controversies. Current Treatment Options in Oncology, 14(4):505-513.

Weller, M; Yung, W K A (2013). Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825. Neuro-Oncology, 15(8):971.

Jakka, Gopinadh; Schuberth, Petra C; Thiel, Markus; Held, Gerhard; Stenner, Frank; van den Broek, Maries; Renner, Christoph; Mischo, Axel; Petrausch, Ulf (2013). Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system. Anticancer Research, 33(10):4189-4201.

Aalbers, A M; van den Heuvel-Eibrink, M M; de Haas, V; Te Marvelde, J G; de Jong, A X; van der Burg, M; Dworzak, M; Hasle, H; Locatelli, F; De Moerloose, B; Schmugge, M; Stary, J; Zecca, M; Zwaan, C M; van de Loosdrecht, A A; van Dongen, J J M; Niemeyer, C M; van der Velden, V H J (2013). Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood. Leukemia, 27(9):1923-1925.

Weller, M (2013). Are we ready for a randomized trial of valproic acid in newly diagnosed glioblastoma? Neuro-Oncology, 15(7):809-810.

Weller, M (2013). Assessing the MGMT status in glioblastoma: one step forward, two steps back? Neuro-Oncology, 15(3):253-254.

Varga, Zsuzsanna; Noske, Aurelia; Ramach, Constanze; Padberg, Barbara; Moch, Holger (2013). Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study. BMC Cancer, 13:615.

Walser-Domjan, Esther; Richard, Aline; Eichholzer, Monika; Platz, Elizabeth A; Linseisen, Jakob; Rohrmann, Sabine (2013). Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey. Nutrition and Cancer, 65(6):813-819.

Nicastro, Holly L; Mondul, Alison M; Rohrmann, Sabine; Platz, Elizabeth A (2013). Associations between urinary soy isoflavonoids and two inflammatory markers in adults in the United States in 2005-2008. Cancer Causes & Control, 24(6):1185-1196.

Stupp, Roger; Hegi, Monika E (2013). Brain cancer in 2012: Molecular characterization leads the way. Nature Reviews. Clinical Oncology, 10(2):69-70.

Vetter, Marcus; Huang, Dorothy Jane; Bosshard, Georg; Güth, Uwe (2013). Breast cancer in women 80 years of age and older: a comprehensive analysis of an underreported entity. Acta Oncologica, 52(1):57-65.

Chen, Susie A; Hiley, Crispin; Nickleach, Dana; Petsuksiri, Janjira; Andic, Fundagul; Riesterer, Oliver; Switchenko, Jeffrey M; Torres, Mylin A (2013). Breast reconstruction and post-mastectomy radiation practice. Radiation Oncology, 8:45.

Anderson, T M R; Peacock, D L; Daniel, A R; Hubbard, G K; Lofgren, K A; Girard, B J; Schoerg, A; Hoogewijs, D; Wenger, R; Seagroves, T N; Lange, C A (2013). Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia- associated breast cancer progression. Cancer Research, 73(18):5810-5826.

Trojan, Andreas; Vergopoulos, Athanasios; Breitenstein, Urs; Tausch, Christoph; Seifert, Burkhardt; Joechle, Wolfgang (2013). CYP2D6 phenotype indicative for optimized antiestrogen efficacy associates with outcome in early breast cancer patients. Cancer Chemotherapy and Pharmacology, 71(2):301-306.

Tausch, C; Baege, A; Dietrich, D; Vergin, I; Heuer, H; Haldemann Heusler, R; Rageth, C (2013). Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? European Journal of Surgical Oncology, 39(8):880-886.

Lacher, Markus D; Provenzano, Maurizio (2013). Cancer T cell immunotherapy with bispecific antibodies and chimeric antigen receptors. Recent Patents on Anti-Cancer Drug Discovery, 8(3):239-254.

Doroshow, James H; Sleijfer, Stefan; Stupp, Roger; Anderson, Kenneth (2013). Cancer clinical trials - do we need a new algorithm in the age of stratified medicine? The Oncologist, 18(6):651-652.

Gatta, G; Mallone, S; van der Zwan, J M; Trama, A; Siesling, S; Capocaccia, R (2013). Cancer prevalence estimates in Europe at the beginning of 2000. Annals of Oncology, 24(6):1660-1666.

Dummer, R; Mangana, J (2013). Carboplatin, paclitaxel and sorafenib in advanced melanoma – what have we learned? Translational Cancer Research, 2:46-47.

Drabe, Natalie; Wittmann, Lutz; Zwahlen, Diana; Büchi, Stefan; Jenewein, Josef (2013). Changes in close relationships between cancer patients and their partners. Psycho-oncology, 22(6):1344-1352.

Lang, Stephanie; Shrestha, Binaya; Graydon, Shaun; Cavelaars, Frederique; Linsenmeier, Claudia; Hrbacek, Jan; Klöck, Stephan; Studer, Gabriela; Riesterer, Oliver (2013). Clinical application of flattening filter free beams for extracranial stereotactic radiotherapy. Radiotherapy and Oncology, 106(2):255-259.

Haldrup, Christa; Mundbjerg, Kamilla; Vestergaard, Else Marie; Lamy, Philippe; Wild, Peter; Schulz, Wolfgang A; Arsov, Christian; Visakorpi, Tapio; Borre, Michael; Høyer, Søren; Orntoft, Torben F; Sørensen, Karina D (2013). DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer. Journal of Clinical Oncology, 31(26):3250-3258.

Savic, Spasenija; Bode, Beata; Diebold, Joachim; Tosoni, Ivo; Barascud, Audrey; Baschiera, Betty; Grilli, Bruno; Herzog, Michelle; Obermann, Ellen; Bubendorf, Lukas (2013). Detection of ALK-Positive non-small-cell lung cancers on cytological specimens: High accuracy of immunocytochemistry with the 5A4 clone. Journal of Thoracic Oncology, 8(8):1004-1011.

Imesch, Patrick; Scheiner, David; Xie, Min; Fink, Daniel; Macas, Erwin; Dubey, Raghvendra; Imthurn, Bruno (2013). Developmental potential of human oocytes matured in vitro followed by vitrification and activation. Journal of Ovarian Research, 6:30.

Abbas, Sascha; Linseisen, Jakob; Rohrmann, Sabine; Chang-Claude, Jenny; Peeters, Petra H; Engel, Pierre; Brustad, Magritt; Lund, Eiliv; Skeie, Guri; Olsen, Anja; Tjønneland, Anne; Overvad, Kim; Boutron-Ruault, Marie-Christine; Clavel-Chapelon, Francoise; Fagherazzi, Guy; Kaaks, Rudolf; Boeing, Heiner; Buijsse, Brian; Adarakis, George; Ouranos, Vassilis; Trichopoulou, Antonia; Masala, Giovanna; Krogh, Vittorio; Mattiello, Amalia; Tumino, Rosario; Sacerdote, Carlotta; Buckland, Genevieve; Suárez, Marcial Vicente Argüelles; Sánchez, Maria-José; Chirlaque, Maria-Dolores; Barricarte, Aurelio; Amiano, Pilar; Manjer, Jonas; Wirfält, Elisabet; Lenner, Per; Sund, Malin; Bueno-de-Mesquita, H B; van Duijnhoven, Fränzel J B; Khaw, Kay-Tee; Wareham, Nick; Key, Timothy J; Fedirko, Veronika; Romieu, Isabelle; Gallo, Valentina; Norat, Teresa; Wark, Petra A; Riboli, Elio (2013). Dietary intake of vitamin D and calcium and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Nutrition and Cancer, 65(2):178-187.

Binz, Patrizia; Bodmer, Nicole; Leibundgut, Kurt; Teuffel, Oliver; Niggli, Felix K; Ammann, Roland A (2013). Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: A retrospective two-center cohort study. Pediatric Blood & Cancer, 60(5):799-805.

Fehr, Mathias K; Baumann, Marc; Mueller, Michael; Fink, Daniel; Heinzl, Siegfried; Imesch, Patrick; Dedes, Konstantin (2013). Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia. Journal of Gynecologic Oncology, 24(3):236-241.

Rueegg, Corina S; Gianinazzi, Micòl E; Michel, Gisela; von der Weid, Nicolas X; Bergstraesser, Eva; Kuehni, Claudia E (2013). Do childhood cancer survivors with physical performance limitations reach healthy activity levels? Pediatric Blood & Cancer, 60(10):1714-1720.

Kohl Schwartz, A S; Leo, C; Rufibach, Kaspar; Varga, Z; Fink, D; Gabriel, N (2013). Does increased tumor burden of sentinel nodes in breast cancer affect detection procedure? European Journal of Surgical Oncology, 39(3):266-272.

Gilbert, Mark R; Wang, Meihua; Aldape, Kenneth D; Stupp, Roger; Hegi, Monika E; Jaeckle, Kurt A; Armstrong, Terri S; Wefel, Jeffrey S; Won, Minhee; Blumenthal, Deborah T; Mahajan, Anita; Schultz, Christopher J; Erridge, Sara; Baumert, Brigitta; Hopkins, Kristen I; Tzuk-Shina, Tzahala; Brown, Paul D; Chakravarti, Arnab; Curran, Walter J; Mehta, Minesh P (2013). Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. Journal of Clinical Oncology, 31(32):4085-4091.

Rolfs, Frank; Huber, Marcel; Gruber, Florian; Böhm, Friederike; Pfister, Herbert J; Bochkov, Valery N; Tschachler, Erwin; Dummer, Reinhard; Hohl, Daniel; Schäfer, Matthias; Werner, Sabine (2013). Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis. Cancer Research, 73(11):3460-3469.

Fan, Q W; Cheng, C K; Gustafson, W C; Charron, E; Zipper, P; Wong, R A; Chen, J; Lau, J; Knobbe-Thomsen, C; Weller, M; Jura, N; Reifenberger, G; Shokat, K M; Weiss, W A (2013). EGFR Phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell, 24(4):438-449.

Schäfer, Beat W; Koscielniak, Ewa; Kovar, Heinrich; Fulda, Simone (2013). ESF-EMBO Symposium "Molecular biology and innovative therapies in sarcomas of childhood and adolescence" Sept 29-Oct 4, Polonia Castle Pultusk, Poland. Frontiers in Oncology:3:142.

Bernasconi, Michele; Ueda, Seigo; Krukowski, Patricia; Bornhauser, Beat C; Ladell, Kristin; Dorner, Marcus; Sigrist, Juerg A; Campidelli, Cristina; Aslandogmus, Roberta; Alessi, Davide; Berger, Christoph; Pileri, Stefano A; Speck, Roberto F; Nadal, David (2013). Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases. International Journal of Cancer, 133(10):2341-2350.

König, Simone; Regen, Tommy; Dittmann, Kai; Engelke, Michael; Wienands, Jürgen; Schwendener, Reto; Hanisch, Uwe-Karsten; Pukrop, Tobias; Hahn, Heidi (2013). Empty liposomes induce antitumoral effects associated with macrophage responses distinct from those of the TLR1/2 agonist Pam3CSK 4 (BLP). Cancer Immunology, Immunotherapy, 62(10):1587-1597.

Heese, O; Vogeler, E; Martens, T; Schnell, O; Tonn, J C; Simon, M; Schramm, J; Krex, D; Schackert, G; Reithmeier, T; Nikkhah, G; Sabel, M; Steiger, H J; Schlegel, U; Löffler, M; Weller, M; Westphal, M (2013). End-of-life caregivers' perception of medical and psychological support during the final weeks of glioma patients: a questionnaire-based survey. Neuro-Oncology, 15(9):1251-1256.

Roudnicky, Filip; Poyet, Cedric; Wild, Peter; Krampitz, Sarah; Negrini, Fabrizia; Huggenberger, Reto; Rogler, Anja; Stöhr, Robert; Hartmann, Arndt; Provenzano, Maurizio; Otto, Vivianne I; Detmar, Michael (2013). Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Research, 73(3):1097-1106.

Schirmer, Uwe; Fiegl, Heidi; Pfeifer, Marco; Zeimet, Alain G; Müller-Holzner, Elisabeth; Bode, Peter K; Tischler, Verena; Altevogt, Peter (2013). Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens. BMC Cancer, 13:156.

Eichelberg, Christian; Chun, Felix K; Bedke, Jens; Heuer, Roman; Adam, Meike; Moch, Holger; Terracciano, Luigi; Hinrichs, Kristin; Dahlem, Roland; Fisch, Margit; Schlomm, Thorsten; Sauter, Guido; Minner, Sarah (2013). Epithelial cell adhesion molecule (EPCAM) is an independent prognostic marker in clear cell renal carcinoma. International journal of cancer. Journal international du cancer, 132(12):2948-2955.

Ogbah, Zighereda; Badenas, Celia; Harland, Mark; Puig-Butille, Joan A; Elliot, Fay; Bonifaci, Nuria; Guino, Elisabet; Randerson-Moor, Julie; Chan, May; Iles, Mark M; Glass, Daniel; Brown, Andrew A; Carrera, Cristina; Kolm, Isabel; Bataille, Veronique; Spector, Timothy D; Malvehy, Josep; Newton-Bishop, Julia; Pujana, Miquel A; Bishop, Tim; Puig, Susana (2013). Evaluation of PAX3 genetic variants and nevus number. Pigment Cell & Melanoma Research, 26(5):666-676.

Berndt, Kersten; Campanile, Carmen; Muff, Roman; Strehler, Emanuel; Born, Walter; Fuchs, Bruno (2013). Evaluation of quercetin as a potential drug in osteosarcoma treatment. Anticancer Research, 33(4):1297-1306.

Samartzis, Nicolas. Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: A tissue microarray study. 2013, University of Zurich, Faculty of Medicine.

Schwenkglenks, Matthias; Bendall, Kate Louise; Pfeil, Alena M; Szabo, Zsolt; Pettengell, Ruth (2013). External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma. Leukemia & Lymphoma, 54(11):2426-2432.

Graf, N; Rufibach, Kaspar; Schmidt, A M; Fehr, M; Fink, D; Baege, A C (2013). Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies. European Journal of Gynaecological Oncology, 34(1):23-27.

Frew, Ian J; Smole, Zlatko; Thoma, Claudio R; Krek, Wilhelm (2013). Genetic deletion of the long isoform of the von Hippel-Lindau tumour suppressor gene product alters microtubule dynamics. European Journal of Cancer, 49(10):2433-2440.

Groux, Philippe; Szucs, Thomas D (2013). Geographic disparities in access to cancer care: Do patients in outlying areas talk about their access problems to their general practitioners and medical oncologists and how does that impact on the choice of chemotherapy? European Journal of Cancer Care, 22(6):746-753.

Crivelli-Ochsner, Susanna; Bode-Lesniewska, Beata; Nussbaumer-Ochsner, Yvonne; Fuchs, Bruno (2013). Giant cell angioblastoma in an adult: a unique presentation. Rare Tumors, 5(3):e27.

Kreth, F W; Thon, N; Simon, M; Westphal, M; Schackert, G; Nikkhah, G; Hentschel, B; Reifenberger, G; Pietsch, T; Weller, M; Tonn, J C (2013). Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy. Annals of Oncology, 24(12):3117-3123.

Wulfänger, Jens; Biehl, Katharina; Tetzner, Anja; Wild, Peter; Ikenberg, Kristian; Meyer, Stefanie; Seliger, Barbara (2013). Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma. International Journal of Cancer, 133(11):2522-2532.

Züllig, L; Roessle, M; Weber, C; Graf, N; Haerle, S K; Jochum, W; Stoeckli, S J; Moch, H; Huber, G F (2013). High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity. European Journal of Cancer, 49(8):1915-1922.

Eichholzer, Monika; Huang, Dorothy J; Modlasiak, Alexandra; Schmid, Seraina M; Schötzau, Andreas; Rohrmann, Sabine; Güth, Uwe (2013). Impact of body mass index on prognostically relevant breast cancer tumor characteristics. Breast Care, 8(3):192-198.

Kähkönen, Esa; Jambor, Ivan; Kemppainen, Jukka; Lehtiö, Kaisa; Grönroos, Tove J; Kuisma, Anna; Luoto, Pauliina; Sipilä, Henri J; Tolvanen, Tuula; Alanen, Kalle; Silén, Jonna; Kallajoki, Markku; Roivainen, Anne; Schäfer, Niklaus; Schibli, Roger; Dragic, Martina; Johayem, Anass; Valencia, Ray; Borkowski, Sandra; Minn, Heikki (2013). In vivo imaging of prostate cancer using [68Ga]-labeled bombesin analog BAY86-7548. Clinical Cancer Research, 19(19):5434-5443.

Berghoff, A S; Rajky, O; Winkler, F; Bartsch, R; Furtner, J; Hainfellner, J A; Goodman, S L; Weller, M; Schittenhelm, J; Preusser, M (2013). Invasion patterns in brain metastases of solid cancers. Neuro-Oncology, 15(12):1664-1672.

Hell, Michael P; Duda, Maria; Weber, Thomas C; Moch, Holger; Krek, Wilhelm (2013). Ischemic renal injury reveals in vivo functions for the von Hippel-Lindau tumor suppressor in mitotic fidelity control. Cancer Research:1-32.

Wottawa, M; Leisering, P; von Ahlen, Melanie; Schnelle, M; Vogel, S; Malz, C; Bordoli, R M; Camenisch, G; Hesse, A; Napp, J; Alves Cardoso, F; Kristiansen, G; Farhat, K; Katschinski, D M (2013). Knockdown of prolyl-4-hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA-MB-231 cells by affecting TGF-b1 processing. International Journal of Cancer, 132(12):2787-2798.

Misselwitz, B; Pohl, D; Fruhauf, H; Fried, M; Vavricka, S R; Fox, Mark (2013). Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment. United European Gastroenterology journal, 1(3):151-159.

Studer, G; Linsenmeier, C; Riesterer, O; Najafi, Y; Brown, M; Yousefi, B; Bredell, M; Huber, G; Schmid, S; Studer, S; Zwahlen, R; Rordorf, T; Glanzmann, C (2013). Late term tolerance in head neck cancer patients irradiated in the IMRT era. Radiation Oncology, 8:259.

Dummer, Reinhard; Rozati, Sima; Guenova, Emmanuella; Cozzio, Antonio (2013). Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas. Future Oncology (London, England), 9(8):1061-1064.

Hartmann, C; Hentschel, B; Simon, M; Westphal, M; Schackert, G; Tonn, J C; Loeffler, M; Reifenberger, G; Pietsch, T; von Deimling, A; Weller, M (2013). Longterm survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clinical Cancer Research, 19(18):5146-5157.

Pawłowski, Rafal; Mühl, Sarah M; Sulser, Tullio; Krek, Wilhelm; Moch, Holger; Schraml, Peter (2013). Loss of PBRM1 expression is associated with renal cell carcinoma progression. International Journal of Cancer, 132(2):E11-7.

Perner, Sven; Rupp, Niels J; Braun, Martin; Rubin, Mark A; Moch, Holger; Dietel, Manfred; Wernert, Nicolas; Jung, Klaus; Stephan, Carsten; Kristiansen, Glen (2013). Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course. International Journal of Cancer, 132(4):807-812.

Zimmermann, S; Curioni-Fontecedro, Alessandra; Stahel, R; Peters, S (2013). Lung Cancer. In: Dicato, M A. Side Effects of Medical Cancer Therapy. - Prevention and Treatment. London: Springer-Verlag, 119-138.

Nuber, Natko; Curioni-Fontecedro, Alessandra; Dannenmann, Stefanie R; Matter, C; von Boehmer, Lotta; Atanackovic, Djordje; Knuth, Alexander; van den Broek, Maries (2013). MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients. Leukemia, 27(8):1767-1769.

Ascierto, Paolo A; Schadendorf, Dirk; Berking, Carola; Agarwala, Sanjiv S; van Herpen, Carla Ml; Queirolo, Paola; Blank, Christian U; Hauschild, Axel; Beck, J Thaddeus; St-Pierre, Annie; Niazi, Faiz; Wandel, Simon; Peters, Malte; Zubel, Angela; Dummer, Reinhard (2013). MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. Lancet Oncology, 14(3):249-256.

Vargas, Hebert Alberto; Burger, Irene A; Donati, Olivio F; Andikyan, Vaagn; Lakhman, Yulia; Goldman, Debra A; Schöder, Heiko; Chi, Dennis S; Sala, Evis; Hricak, Hedvig (2013). Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration. International Journal of Gynecological Cancer, 23(8):1512-1519.

Wiestler, B; Claus, R; Hartlieb, S A; Schliesser, M G; Weiss, E K; Hielscher, T; Platten, M; Dittmann, L M; Meisner, C; Felsberg, J; Happold, C; Simon, M; Nikkhah, G; Papsdorf, K; Steinbach, J P; Sabel, M; Grimm, C; Weichenhan, D; Tews, B; Reifenberger, G; Capper, D; Müller, W; Plass, C; Weller, M; Wick, W (2013). Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro-Oncology, 15(8):1017-1026.

Rohrmann, Sabine; Linseisen, Jakob; Nöthlings, Ute; Overvad, Kim; Egeberg, Rikke; Tjønneland, Anne; Boutron-Ruault, Marie Christine; Clavel-Chapelon, Françoise; Cottet, Vanessa; Pala, Valeria; Tumino, Rosario; Palli, Domenico; Panico, Salvatore; Vineis, Paolo; Boeing, Heiner; Pischon, Tobias; Grote, Verena; Teucher, Birigit; Khaw, Kay-Tee; Wareham, Nicholas J; Crowe, Francesca L; Goufa, Ioulia; Orfanos, Philippos; Trichopoulou, Antonia; Jeurnink, Suzanne M; Siersema, Peter D; Peeters, Petra H M; Brustad, Magritt; Engeset, Dagrun; Skeie, Guri; Duell, Eric J; Amiano, Pilar; Barricarte, Aurelio; Molina-Montes, Esther; Rodríguez, Laudina; Tormo, María-José; Sund, Malin; Ye, Weimin; Lindkvist, Björn; Johansen, Dorthe; Ferrari, Pietro; Jenab, Mazda; Slimani, Nadia; Ward, Heather; Riboli, Elio; Norat, Teresa; Bueno-de-Mesquita, H Bas (2013). Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer, 132(3):617-624.

Raaijmakers, Marieke I G; Rozati, Sima; Goldinger, Simone M; Widmer, Daniel S; Dummer, Reinhard; Levesque, Mitchell P (2013). Melanoma immunotherapy: historical precedents, recent successes and future prospects. Immunotherapy, 5(2):169-182.

Rohrer Bley, Carla; Furmanova, Polina; Orlowski, Katrin; Grosse, Nicole; Broggini-Tenzer, Angela; McSheehy, Paul M J; Pruschy, Martin (2013). Microtubule stabilising agents and ionising radiation: Multiple exploitable mechanisms for combined treatment. European Journal of Cancer, 49(1):245-253.

Weller, M; Pfister, S M; Wick, W; Hegi, M E; Reifenberger, G; Stupp, R (2013). Molecular neuro-oncology in clinical practice: a new horizon. Lancet Oncology, 14(9):e370-e379.

Strebel, Räto T; Sulser, Tullio; Schmid, Hans-Peter; Gillessen, Silke; Fehr, Martin; Huber, Urs; Pless, Miklos; Morant, Rudolf; Winterhalder, Ralph; Cathomas, Richard (2013). Multidisciplinary care in patients with prostate cancer: room for improvement. Supportive Care in Cancer, 21(8):2327-2333.

Gorlia, Thierry; Wu, Wenting; Wang, Meihua; Baumert, Brigitta G; Mehta, Minesh; Buckner, Jan C; Shaw, Edward; Brown, Paul; Stupp, Roger; Galanis, Evanthia; Lacombe, Denis; van den Bent, Martin J (2013). New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Neuro-Oncology, 15(11):1568-1579.

Fischer, Roland; Collet, Tinh-Hai; Zeller, Andreas; Zimmerli, Lukas; Gaspoz, Jean-Michel; Giraudon, Karine; Rodondi, Nicolas; Cornuz, Jacques (2013). Obesity and overweight associated with lower rates of colorectal cancer screening in Switzerland. European Journal of Cancer Prevention, 22(5):425-430.

Laperriere, N; Weller, M; Stupp, R; Perry, J R; Brandes, A A; Wick, W; van den Bent, M J (2013). Optimal management of elderly patients with glioblastoma. Cancer Treatment Reviews, 39(4):350-357.

Duvic, Madeleine; Dummer, Reinhard; Becker, Jürgen C; Poulalhon, Nicolas; Ortiz Romero, Pablo; Grazia Bernengo, Maria; Lebbé, Celeste; Assaf, Chalid; Squier, Margaret; Williams, Denise; Marshood, Miriam; Tai, Feng; Prince, H Miles (2013). Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial. European Journal of Cancer, 49(2):386-394.

Weber, Jeffrey S; Dummer, Reinhard; de Pril, Veerle; Lebbé, Celeste; Hodi, F Stephen (2013). Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma. Cancer, 119(9):1675-1682.

Buchinger, Katharina; Stahel, Rolf; Niggemeier, Verena; Gubler, Christoph; Franzen, Daniel (2013). Pemetrexed-induced neutropenic enteritis and severe cutaneous hyperpigmentation in a patient with malignant pleural mesothelioma. Lung Cancer, 80(3):347-349.

Corti, Natascia; Rudiger, Alain; Chiesa, Alessandro; Marti, Isabelle; Jetter, Alexander; Rentsch, Katharina; Müller, Daniel; Béchir, Markus; Maggiorini, Marco (2013). Pharmacokinetics of daily daptomycin in critically ill patients undergoing continuous renal replacement therapy. Chemotherapy, 59(2):143-151.

Steindorf, Karen; Ritte, Rebecca; Eomois, Piia-Piret; Lukanova, Annekatrin; Tjonneland, Anne; Johnsen, Nina Føns; Overvad, Kim; Ostergaard, Jane Nautrup; Clavel-Chapelon, Françoise; Fournier, Agnès; Dossus, Laure; Teucher, Birgit; Rohrmann, Sabine; Boeing, Heiner; Wientzek, Angelika; Trichopoulou, Antonia; Karapetyan, Tina; Trichopoulos, Dimitrios; Masala, Giovanna; Berrino, Franco; Mattiello, Amalia; Tumino, Rosario; Ricceri, Fulvio; Quirós, J Ramón; Travier, Noémie; Sánchez, María-José; Navarro, Carmen; Ardanaz, Eva; Amiano, Pilar; Bueno-de-Mesquita, H B As; van Duijnhoven, Franzel; Monninkhof, Evelyn; May, Anne M; Khaw, Kay-Tee; Wareham, Nick; Key, Tim J; Travis, Ruth C; Borch, Kristin Benjaminsen; Sund, Malin; Andersson, Anne; Fedirko, Veronika; Rinaldi, Sabina; Romieu, Isabelle; Wahrendorf, Jürgen; Riboli, Elio; Kaaks, Rudolf (2013). Physical activity and risk of breast cancer overall and by hormone receptor status: The European prospective investigation into cancer and nutrition. International Journal of Cancer, 132(7):1667-1678.

Ghadjar, P; Sun, H; Zimmermann, F; Bodis, S; Bernier, J; Studer, G; Aebersold, D M (2013). Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94). Oral Oncology, 49(10):1006-1009.

Haerle, Stephan K; Hany, Thomas F; Ahmad, Nader; Burger, Irene; Huber, Gerhard F; Schmid, Daniel T (2013). Physiologic [18F]fluorodeoxyglucose uptake of floor of mouth muscles in PET/CT imaging: a problem of body position during FDG uptake? Cancer Imaging, 13(1):1-7.

Graf, Anna; Bergstraesser, Eva; Landolt, Markus A (2013). Posttraumatic stress in infants and preschoolers with cancer. Psycho-Oncology, 22(7):1543-1548.

Gigineishvili, David; Shengelia, Nino; Shalashvili, Giorgi; Rohrmann, Sabine; Tsiskaridze, Alexander; Shakarishvili, Roman (2013). Primary brain tumour epidemiology in Georgia: first-year results of a population-based study. Journal of Neuro-Oncology, 112(2):241-246.

Curioni-Fontecedro, A; Husmann, L; Soldini, D; Stahel, R A (2013). Primary non-small cell lung cancer response upon treatment with denosumab. Lung Cancer, 82(3):506-508.

Eichholzer, Monika; Platz, Elizabeth A; Bienstock, Jessica L; Monsegue, Deborah; Akereyeni, Folasade; Hollis, Bruce W; Horst, Ronald; Rifai, Nader; Pollak, Michael N; Barbir, Aline; Agurs-Collins, Tanya; Rohrmann, Sabine (2013). Racial variation in vitamin D cord blood concentration in white and black male neonates. Cancer Causes & Control, 24(1):91-98.

Lopez, David S; Peskoe, Sarah B; Joshu, Corinne E; Dobs, Adrian; Feinleib, Manning; Kanarek, Norma; Nelson, William G; Selvin, Elizabeth; Rohrmann, Sabine; Platz, Elizabeth A (2013). Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males. Cancer Causes & Control, 24(4):817-826.

Sharma, Anu; Bode, Beata; Moch, Holger; Okoniewski, Michal; Knuth, Alexander; von Boehmer, Lotta; van den Broek, Maries (2013). Radiotherapy of human sarcoma promotes an intratumoral immune effector signature. Clinical Cancer Research, 19(17):4843-4853.

Minetti, Giampaolo; Egée, Stephane; Mörsdorf, Daniel; Steffen, Patrick; Makhro, Asya; Achilli, Cesare; Ciana, Annarita; Wang, Jue; Bouyer, Guillaume; Bernhardt, Ingolf; Wagner, Christian; Thomas, Serge; Bogdanova, Anna; Kaestner, Lars (2013). Red cell investigations: Art and artefacts. Blood Reviews, 27(2):91-101.

Bert, Saul A; Robinson, Mark D; Strbenac, Dario; Statham, Aaron L; Song, Jenny Z; Hulf, Toby; Sutherland, Robert L; Coolen, Marcel W; Stirzaker, Clare; Clark, Susan J (2013). Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell, 23(1):9-22.

Cronin, Julia C; Watkins-Chow, Dawn E; Incao, Art; Hasskamp, Joanne H; Schönewolf, Nicola; Aoude, Lauren G; Hayward, Nicholas K; Bastian, Boris C; Dummer, Reinhard; Loftus, Stacie K; Pavan, William J (2013). SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis. Cancer Research, 73(18):5709-5718.

Robert, Caroline; Dummer, Reinhard; Gutzmer, Ralf; Lorigan, Paul; Kim, Kevin B; Nyakas, Marta; Arance, Ana; Liszkay, Gabriella; Schadendorf, Dirk; Cantarini, Mireille; Spencer, Stuart; Middleton, Mark R (2013). Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study. Lancet Oncology, 14(8):733-740.

Dooley, Christopher M; Schwarz, Heinz; Mueller, Kaspar P; Mongera, Alessandro; Konantz, Martina; Neuhauss, Stephan C F; Nüsslein-Volhard, Christiane; Geisler, Robert (2013). Slc45a2 and V-ATPase are regulators of melanosomal pH homeostasis in zebrafish, providing a mechanism for human pigment evolution and disease. Pigment Cell & Melanoma Research, 26(2):205-217.

Rohrmann, S; Linseisen, J; Allen, N; Bueno-de-Mesquita, H B; Johnsen, N F; Tjønneland, A; Overvad, K; Kaaks, R; Teucher, B; Boeing, H; Pischon, T; Lagiou, P; Trichopoulou, A; Trichopoulos, D; Palli, D; Krogh, V; Tumino, R; Ricceri, F; Argüelles Suárez, M V; Agudo, A; Sánchez, M J; Chirlaque, M D; Barricarte, A; Larrañaga, N; Boshuizen, H; van Kranen, H J; Stattin, P; Johansson, M; Bjartell, A; Ulmert, D; Khaw, K T; Wareham, N J; Ferrari, P; Romieux, I; Gunter, M J R; Riboli, E; Key, T J (2013). Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. British Journal of Cancer, 108(3):708-714.

Luszczynska, Aleksandra; Pawlowska, Izabela; Cieslak, Roman; Knoll, Nina; Scholz, Urte (2013). Social support and quality of life among lung cancer patients: a systematic review. Psycho-Oncology, 22(10):2160-2168.

Tiwari, Neha; Tiwari, Vijay K; Waldmeier, Lorenz; Balwierz, Piotr J; Arnold, Phil; Pachkov, Mikhail; Meyer-Schaller, Nathalie; Schübeler, Dirk; van Nimwegen, Erik; Christofori, Gerhard (2013). Sox4 is a master regulator of epithelial-mesenchymal transition by controlling ezh2 expression and epigenetic reprogramming. Cancer Cell, 23(6):768-83.

Weller, M; Cloughesy, T; Perry, J R; Wick, W (2013). Standards of care for treatment of recurrent glioblastoma - are we there yet? Neuro-Oncology, 15(1):4-27.

Pfrommer, Sarah; Weber, Achim; Dutkowski, Philipp; Schäfer, Niklaus G; Müllhaupt, Beat; Bourquin, Jean-Pierre; Breitenstein, Stefan; Pestalozzi, Bernhard C; Stenner, Frank; Renner, Christoph; D'Addario, Giannicola; Graf, Hans-Jörg; Knuth, Alexander; Clavien, Pierre-Alain; Samaras, Panagiotis (2013). Successful salvage chemotherapy with FOLFIRINOX for recurrent mixed acinar cell carcinoma and ductal adenocarcinoma of the pancreas in an adolescent patient. Case Reports in Oncology, 6(3):497-503.

Guenova, Emmanuella; Watanabe, Rei; Teague, Jessica E; Desimone, Jennifer A; Jiang, Ying; Dowlatshahi, Mitra; Schlapbach, Christoph; Schaekel, Knut; Rook, Alain H; Tawa, Marianne; Fisher, David C; Kupper, Thomas S; Clark, Rachael A (2013). TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clinical Cancer Research, 19(14):3755-3763.

Stoehlmacher-Williams, Jan; Ehninger, Gerhard; Zimmermann, Dieter R; Merkelbach-Bruse, Sabine; Schildhaus, Hans-Ulrich; Buettner, Reinhard (2013). Targeting TKI-resistance in NSCLC: importance of rebiopsy and molecular diagnostics — A case study. Cancer Treatment Communications, 1(1):1-5.

Eisele, G; Weller, M (2013). Targeting apoptosis pathways in glioblastoma. Cancer Letters, 332(2):335-345.

Wojtalla, Anna; Fischer, Barbara; Kotelevets, Nataliya; Mauri, Francesco A; Sobek, Jens; Rehrauer, Hubert; Wotzkow, Carlos; Tschan, Mario P; Seckl, Michael J; Zangemeister-Wittke, Uwe; Arcaro, Alexandre (2013). Targeting the phosphoinositide 3-kinase p110-α isoform impairs cell proliferation, survival, and tumor growth in small cell lung cancer. Clinical Cancer Research, 19(1):96-105.

Shakhova, Olga; Sommer, Lukas (2013). Testing the cancer stem cell hypothesis in melanoma: The clinics will tell. Cancer Letters, 338(1):74-81.

Brandt, Simone; Montagna, Chiara; Georgis, Antoin; Schüffler, Peter J; Bühler, Marco M; Seifert, Burkhardt; Thiesler, Thore; Curioni-Fontecedro, Alessandra; Hegyi, Ivan; Dehler, Silvia; Martin, Vittoria; Tinguely, Marianne; Soldini, Davide (2013). The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma. Experimental Hematology & Oncology, 2:27.

Schwizer, W; Menne, D; Schutze, K; Vieth, M; Goergens, R; Malfertheiner, P; Leodolter, A; Fried, M; Fox, M R (2013). The effect of Helicobacter pylori infection and eradication in patients with gastro-oesophageal reflux disease: A parallel-group, double-blind, placebo-controlled multicentre study. United European Gastroenterology journal, 1(4):226-235.

Furmanova-Hollenstein, Polina; Broggini-Tenzer, Angela; Eggel, Matthias; Millard, Anne-Laure; Pruschy, Martin (2013). The microtubule stabilizer patupilone counteracts ionizing radiation-induced matrix metalloproteinase activity and tumor cell invasion. Radiation Oncology, 8:105.

Teleki, Ivett; Krenacs, Tibor; Szasz, Marcell A; Kulka, Janina; Wichmann, Barna; Leo, Cornelia; Papassotiropoulos, Barbel; Riemenschnitter, Cosima; Moch, Holger; Varga, Zsuzsanna (2013). The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer. BMC Cancer, 13(1):50.

Burger, Irene A; Vargas, Hebert Alberto; Donati, Olivio F; Andikyan, Vaagn; Sala, Evis; Gonen, Mithat; Goldman, Debra A; Chi, Dennis S; Schöder, Heiko; Hricak, Hedvig (2013). The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration. Gynecologic Oncology, 129(3):586-592.

Mertens, Joachim C; Fingas, Christian D; Christensen, John D; Smoot, Rory L; Bronk, Steven F; Werneburg, Nathan W; Gustafson, Michael P; Dietz, Allan B; Roberts, Lewis R; Sirica, Alphonse E; Gores, Gregory J (2013). Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. Cancer Research, 73(2):897-907.

Sabatino, G; Rigante, L; Minella, D; Novelli, G; Della Pepa, G M; Esposito, G; Albanese, A; Maira, G; Marchese, E (2013). Transcriptional profile characterization for the identification of peripheral blood biomarkers in patients with cerebral aneurysms. Journal of Biological Regulators and Homeostatic Agents, 27(3):729-38.

Dummer, Reinhard (2013). Treating basal-cell carcinoma in a real life setting. Lancet Oncology, 14(7):572-573.

Joerger, M; Thürlimann, B; Savidan, A; Frick, H; Rageth, C; Lütolf, U; Vlastos, G; Bouchardy, C; Konzelmann, I; Bordoni, A; Probst-Hensch, N; Jundt, G; Ess, S (2013). Treatment of breast cancer in the elderly: A prospective, population-based Swiss study. Journal of Geriatric Oncology, 4(1):39-47.

Friedrich, Carsten; von Bueren, André O; von Hoff, Katja; Gerber, Nicolas U; Ottensmeier, Holger; Deinlein, Frank; Benesch, Martin; Kwiecien, Robert; Pietsch, Torsten; Warmuth-Metz, Monika; Faldum, Andreas; Kuehl, Joachim; Kortmann, Rolf D; Rutkowski, Stefan (2013). Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro-Oncology, 15(2):224-234.

Lyons, A J; Crichton, S; Pezier, T (2013). Trismus following radiotherapy to the head and neck is likely to have distinct genotype dependent cause. Oral Oncology, 49(9):932-6.

Roth, P; Regli, L; Tonder, M; Weller, M (2013). Tumor-associated edema in brain cancer patients: pathogenesis and management. Expert Review of Anticancer Therapy, 13(11):1319-1325.

Dannenmann, Stefanie Regine; Thielicke, Julia; Stöckli, Martina; Matter, Claudia; von Boehmer, Lotta; Cecconi, Virginia; Hermanns, Thomas; Hefermehl, Lukas; Schraml, Peter; Moch, Holger; Knuth, Alexander; van den Broek, Maries (2013). Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma. OncoImmunology, 2(3):e23562.

Ozdemir, Cevdet; Kucuksezer, Umut C; Akdis, Mübeccel; Akdis, Cezmi A (2013). Under the skin or under the tongue: differences and similarities in mechanisms of sublingual and subcutaneous immunotherapy. Immunotherapy, 5(11):1151-1158.

Sassowsky, M; Gut, P; Hölscher, T; Hildebrandt, G; Müller, A C; Najafi, Y; Kohler, G; Kranzbühler, H; Guckenberger, M; Zwahlen, D R; Azinwi, N C; Plasswilm, L; Takacs, I; Reuter, C; Sumila, M; Manser, P; Ost, P; Böhmer, D; Pilop, C; Aebersold, D M; Ghadjar, P (2013). Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. International Journal of Radiation Oncology, Biology, Physics, 87(3):534-541.

Gautschi, Oliver; Dingemans, Anne-Marie; Crowe, Susanne; Peters, Solange; Roder, Heinrich; Grigorieva, Julia; Roder, Joanna; Zappa, Francesco; Pless, Miklos; Brutsche, Martin; Baty, Florent; Bubendorf, Lukas; Hsu Schmitz, Shu-Fang; Na, Kyung-Jae; Carbone, David; Stahel, Rolf; Smit, Egbert (2013). VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528. Lung Cancer, 79(1):59-64.

Studer, Gabriela; Glanzmann, Christoph (2013). Volumetric staging in oropharyngeal cancer patients treated with definitive IMRT. Oral Oncology, 49(3):269-276.

Studer, G; Glanzmann, C (2013). Volumetric stratification of cT4 stage head and neck cancer. Strahlentherapie und Onkologie, 189(10):867-873.

Vogetseder, A; Thies, S; Ingold, B; Roth, P; Weller, M; Schraml, P; Goodman, S L; Moch, H (2013). αv-Integrin isoform expression in primary human tumors and brain metastases. International Journal of Cancer, 133(10):2362-2371.

2012

Gupta, Anurag; Sharma, Anu; von Boehmer, Lotta; Surace, Laura; Knuth, Alexander; van den Broek, Maries (2012). Radiotherapy supports protective tumor-specific immunity. OncoImmunology, 1(9):1610-1611.

Zappa, F; Droege, C; Betticher, D; von Moos, R; Bubendorf, L; Ochsenbein, A; Gautschi, O; Oppliger Leibundgut, E; Froesch, P; Stahel, R; Hess, T; Rauch, D; Schmid, P; Mayer, M; Crowe, S; Brauchli, P; Ribi, K; Pless, M (2012). Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05). Lung Cancer, 78(3):239-244.

Ziegler, P; Chahoud, T; Wilhelm, T; Pällmann, N; Braig, M; Wiehle, V; Ziegler, S; Schröder, M; Meier, C; Kolodzik, A; Rarey, M; Panse, J; Hauber, J; Balabanov, S; Brümmendorf, T H (2012). Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias. Investigational New Drugs, 30(6):2274-2283.

Petrausch, U; Schuberth, P C; Hagedorn, C; Soltermann, A; Tomaszek, S; Stahel, R; Weder, W; Renner, C (2012). Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1). BMC Cancer, 12:615.

Collaud, Stéphane; Stahel, Rolf; Inci, Ilhan; Hillinger, Sven; Schneiter, Didier; Kestenholz, Peter; Weder, Walter (2012). Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage. Lung Cancer, 78(3):234-238.

Fischer, Eliane; Chaitanya, Krishna; Wüest, Thomas; Wadle, Andreas; Scott, Andrew M; van den Broek, Maries; Schibli, Roger; Bauer, Stefan; Renner, Christoph (2012). Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies. Clinical Cancer Research, 18(22):6208-6218.

Oberholzer, P A; Kee, D; Dziunycz, P; Sucker, A; Kamsukom, N; Jones, R; Roden, C; Chalk, C J; Ardlie, K; Palescandolo, E; Piris, A; Macconaill, L E; Robert, C; Hofbauer, G F L; McArthur, G A; Schadendorf, D; Garraway, L A (2012). RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors. Journal of Clinical Oncology, 30(3):316-321.

Schott, Sarah; Niessner, Heike; Sinnberg, Tobias; Venturelli, Sascha; Berger, Alexander; Ikenberg, Kristian; Villanueva, Jessie; Meier, Friedegund; Garbe, Claus; Busch, Christian (2012). Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells. International Journal of Cancer, 131(9):2165-2174.

von Bueren, A O; Bacolod, M D; Hagel, C; Heinimann, K; Fedier, A; Kordes, U; Pietsch, T; Koster, J; Grotzer, M A; Friedman, H S; Marra, G; Kool, M; Rutkowski, S (2012). Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours. British Journal of Cancer, 107(8):1399-1408.

Dummer, R; Hauschild, A; Guggenheim, M; Keilholz, U; Pentheroudakis, G (2012). Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 23(Sup7):vii86-vii91.

Fischer, B; Frei, C; Moura, U; Stahel, R; Felley-Bosco, E (2012). Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy. Lung Cancer, 78(1):23-29.

Weder, W (2012). Advances in surgery. Annals of Oncology, 23 Suppl:x43-x45.

Hoos, A; Wolf, M J; Bauer, J; Borsig, L; Heikenwalder, M (2012). Endothelial chemokine receptors as facilitators of tumor cell extravasation? OncoTarget, 3(9):919-920.

Hofer, S; Mengele, K; Stemmler, H J; Schmitt, M; Pestalozzi, B (2012). Intrathecal trastuzumab: dose matters. Acta Oncologica, 51(7):955-956.

Kuehni, Claudia E; Strippoli, Marie-Pierre F; Rueegg, Corina S; Rebholz, Cornelia E; Bergstraesser, Eva; Grotzer, Michael; von der Weid, Nicolas X; Michel, Gisela (2012). Educational achievement in Swiss childhood cancer survivors compared with the general population. Cancer:1439-1449.

Boller, Danielle; Doepfner, Kathrin T; De Laurentiis, Angela; Guerreiro, Ana S; Marinov, Marin; Shalaby, Tarek; Depledge, Paul; Robson, Anthony; Saghir, Nahid; Hayakawa, Masahiko; Kaizawa, Hiroyuki; Koizumi, Tomonobu; Ohishi, Takahide; Fattet, Sarah; Delattre, Olivier; Schweri-Olac, Anelia; Höland, Katrin; Grotzer, Michael A; Frei, Karl; Spertini, Olivier; Waterfield, Michael D; Arcaro, Alexandre (2012). Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours. Anticancer Research, 32(8):3015-3027.

von Bueren, André O; Gerss, Joachim; Hagel, Christian; Cai, Haoyang; Remke, Marc; Hasselblatt, Martin; Feuerstein, Burt G; Pernet, Sarah; Delattre, Olivier; Korshunov, Andrey; Rutkowski, Stefan; Pfister, Stefan M; Baudis, Michael (2012). DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis. Journal of Neuro-Oncology, 109(2):415-423.

Widenmeyer, M; Griesemann, H; Stevanović, S; Feyerabend, S; Klein, R; Attig, S; Hennenlotter, J; Wernet, D; Kuprash, D V; Sazykin, A Y; Pascol, S; Stenzl, A; Gouttefangeas, C; Rammensee, H G (2012). Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients. International Journal of Cancer, 131(1):140-149.

Lüthi, Fabienne; Leibundgut, Kurt; Niggli, Felix K; Nadal, David; Aebi, Christoph; Bodmer, Nicole; Ammann, Roland A (2012). Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: Results of the prospective multicenter SPOG 2003 FN study. Pediatric Blood & Cancer, 59(1):90-95.

Felley-Bosco, Emanuela; Opitz, Isabelle (2012). Mesothelioma. In: Stahel, Rolf A. Lung Cancer Therapy Annual 7. London: Informa Healthcare, 141-150.

Rödel, Claus; Liersch, Torsten; Becker, Heinz; Fietkau, Rainer; Hohenberger, Werner; Hothorn, Torsten; Graeven, Ullrich; Arnold, Dirk; Lang-Welzenbach, Marga; Raab, Hans-Rudolf; Sülberg, Heiko; Wittekind, Christian; Potapov, Sergej; Staib, Ludger; Hess, Clemens; Weigang-Köhler, Karin; Grabenbauer, Gerhard G; Hoffmanns, Hans; Lindemann, Fritz; Schlenska-Lange, Anke; Folprecht, Gunnar; Sauer, Rolf (2012). Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. The lancet oncology, 13(7):679-687.

Shi, Yandong; Moura, Ubiratan; Opitz, Isabelle; Soltzermann, Alex; Rehrauer, Hubert; Thies, Svenja; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2012). Role of hedgehog signaling in malignant pleural mesothelioma. Clinical Cancer Research, 18(17):4646-4656.

Studer, G; Brown, M; Bredell, M; Graetz, K W; Huber, G; Linsenmeier, C; Najafi, Y; Riesterer, O; Rordorf, T; Schmid, S; Glanzmann, C (2012). Follow up after IMRT in oral cavity cancer: update. Radiation Oncology, 7:84.

Kovar, Heinrich; et al; Schäfer, Beat W; Ventura, Selena (2012). The first European interdisciplinary ewing sarcoma research summit. Frontiers in Oncology:2:54.

Künkele, Annette; De Preter, Katleen; Heukamp, Lukas; Thor, Theresa; Pajtler, Kristian W; Hartmann, Wolfgang; Mittelbronn, Michel; Grotzer, Michael A; Deubzer, Hedwig E; Speleman, Frank; Schramm, Alexander; Eggert, Angelika; Schulte, Johannes H (2012). Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas. Neuro-oncology, 14(7):859-869.

Turato, Cristian; Buendia, Marie Annick; Fabre, Monique; Redon, Marie Josè; Branchereau, Sophie; Quarta, Santina; Ruvoletto, Mariagrazia; Perilongo, Giorgio; Grotzer, Michael Andreas; Gatta, Angelo; Pontisso, Patrizia (2012). Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? European Journal of Cancer, 48(8):1219-1226.

Braun, S; Oppermann, H; Mueller, A; Renner, C; Hovhannisyan, A; Baran-Schmidt, R; Gebhardt, R; Hipkiss, A; Thiery, J; Meixensberger, J; Gaunitz, F (2012). Hedgehog signaling in glioblastoma multiforme. Cancer Biology & Therapy, 13(7):487-495.

Credé, Aleksandra; Locher, Michael; Bredell, Marius (2012). Tongue cancer in young patients: case report of a 26-year-old patient. Head & Neck Oncology, 4:20.

Soyka, M B; Holzmann, D; Akdis, C A (2012). Regulatory cells in allergen-specific immunotherapy. Immunotherapy, 4(4):389-396.

Noguchi, T; Kato, T; Wang, L; Maeda, Y; Ikeda, H; Sato, E; Knuth, A; Gnjatic, S; Ritter, G; Sakaguchi, S; Old, L J; Shiku, H; Nishikawa, H (2012). Intracellular tumor-associated antigens represent effective targets for passive immunotherapy. Cancer Research, 72(7):1672-1682.

Steinmann, Patrick; Walters, Denise K; Arlt, Matthias J E; Banke, Ingo J; Ziegler, Urs; Langsam, Bettina; Arbiser, Jack; Muff, Roman; Born, Walter; Fuchs, Bruno (2012). Antimetastatic activity of honokiol in osteosarcoma. Cancer, 118(8):2117-2127.

Belloni, B; Johansen, N; Glass, L F; Dummer, R (2012). Recent advances in the management of cutaneous lymphomas. Seminars in Oncology, 39(2):150-162.

Boro, Aleksandar; Prêtre, Kathya; Rechfeld, Florian; Thalhammer, Verena; Oesch, Susanne; Wachtel, Marco; Schäfer, Beat W; Niggli, Felix K (2012). Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma. International Journal of Cancer, 131(9):2153-2164.

Prchal, Alice; Landolt, Markus A (2012). How siblings of pediatric cancer patients experience the first time after diagnosis: a qualitative study. Cancer Nursing, 35(2):133-140.

Sudha, T; Philipps, P; Kanaan, C; Linhardt, R J; Borsig, L; Mousa, S A (2012). Inhibitory effect of non-anticoagulant heparin (S-NACH) on pancreatic cancer cell adhesion and metastasis in human umbilical cord vessel segment and in mouse model. Clinical & Experimental Metastasis, 29(5):431-439.

Imesch, Patrick; Goerens, Anouk; Fink, Daniel; Fedier, André (2012). MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine) in vitro. Oncology Letters, 3(2):441-444.

Brack, Eva; Bodmer, Nicole; Simon, Arne; Leibundgut, Kurt; Kühne, Thomas; Niggli, Felix K; Ammann, Roland A (2012). First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study. Pediatric Blood & Cancer, 59(3):423-430.

Dummer, R; Beyer, M; Hymes, K; Epping, M T; Bernards, R; Steinhoff, M; Sterry, W; Kerl, H; Heath, K; Ahern, J D; Hardwick, J S; Garcia-Vargas, J; Baumann, K; Rizvi, S; Frankel, S R; Whittacker, S J; Assaf, C (2012). Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition. Leukemia and Lymphoma, 53(8):1501-1508.

Widmer, D S; Cheng, P F; Eichhoff, O M; Benedetta, C B; Zipser, M C; Schlegel, N C; Javelaud, D; Mauviel, A; Dummer, R; Hoek, K S (2012). Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell & Melanoma Research, 25(3):343-353.

Eggermont, A M M; Suciu, S; Testori, A; Kruit, W H; Marsden, J; Punt, C J; Santinami, M; Salès, F; Schadendorf, D; Patel, P; Dummer, R; Robert, C; Keilholz, U; Yver, A; Spatz, A (2012). Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. European Journal of Cancer, 48(2):218-225.

Capper, D; Simon, M; Langhans, C D; Okun, J G; Tonn, J C; Weller, M; von Deimling, A; Hartmann, C (2012). 2-hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size. International Journal of Cancer, 131(3):766-768.

Stenner, Frank; Chastonay, Rahel; Liewen, Heike; Haile, Sarah R; Cathomas, Richard; Rothermundt, Christian; Siciliano, Raffaele D; Stoll, Susanna; Knuth, Alexander; Buchler, Tomas; Porta, Camillo; Renner, Christoph; Samaras, Panagiotis (2012). A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinoma. Oncology, 82(6):333-340.

Joerger, Markus; Thürlimann, Beat; Savidan, Anita; Frick, Harald; Bouchardy, Christine; Konzelmann, Isabelle; Probst-Hensch, Nicole; Ess, Silvia (2012). A population-based study on the implementation of treatment recommendations for chemotherapy in early breast cancer. Clinical Breast Cancer, 12(2):102-109.

Scagliotti, Giorgio; Stahel, Rolf A; Rosell, Rafael; Thatcher, Nick; Soria, Jean-Charles (2012). ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development. European Journal of Cancer, 48(7):961-973.

Ritte, Rebecca; Lukanova, Annekatrin; Berrino, Franco; Dossus, Laure; Tjønneland, Anne; Olsen, Anja; Overvad, Thure Filskov; Overvad, Kim; Clavel-Chapelon, Françoise; Fournier, Agnès; Fagherazzi, Guy; Rohrmann, Sabine; Teucher, Birgit; Boeing, Heiner; Aleksandrova, Krasimira; Trichopoulou, Antonia; Lagiou, Pagona; Trichopoulos, Dimitrios; Palli, Domenico; Sieri, Sabina; Panico, Salvatore; Tumino, Rosario; Vineis, Paolo; Quirós, José Ramón; Buckland, Genevieve; Sánchez, Maria-José; Amiano, Pilar; Chirlaque, María-Dolores; Ardanaz, Eva; Sund, Malin; Lenner, Per; Bueno-de-Mesquita, Bas; van Gils, Carla H; Peeters, Petra Hm; Krum-Hansen, Sanda; Gram, Inger Torhild; Lund, Eiliv; Khaw, Kay-Tee; Wareham, Nick; Allen, Naomi E; Key, Timothy J; Romieu, Isabelle; Rinaldi, Sabina; Siddiq, Afshan; Cox, David; Riboli, Elio; Kaaks, Rudolf (2012). Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Research, 14(3):R76.

Rebholz, Cornelia E; Kuehni, Claudia E; Strippoli, Marie-Pierre F; Rueegg, Corina S; Michel, Gisela; Hengartner, Heinz; Bergstraesser, Eva; von der Weid, Nicolas X (2012). Alcohol consumption and binge drinking in young adult childhood cancer survivors. Pediatric Blood & Cancer, 58(2):256-264.

Brandenberger, M; Simões-Wüst, A P; Rostock, M; Rist, L; Saller, R (2012). An exploratory study on the quality of life and individual coping of cancer patients during mistletoe therapy. Integrative Cancer Therapies, 11(2):90-100.

Weller, Michael (2012). Angiogenesis inhibition: quo vadis? Neuro-Oncology, 14(11):1315.

Nitzsche, B; Gloesenkamp, C; Schrader, M; Hoffmann, B; Zengerling, F; Balabanov, S; Honecker, F; Höpfner, M (2012). Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer. British Journal of Cancer, 107(11):1853-1863.

Riklin, C; Seystahl, K; Hofer, S; Happold, C; Winterhalder, R; Weller, M (2012). Antiangiogenic treatment for multiple CNS hemangioblastomas. Onkologie, 35(7-8):443-445.

Brandes, A A; Franceschi, E; Gorlia, T; Wick, W; Jacobs, A H; Baumert, B G; van den Bent, M; Weller, M; Stupp, R (2012). Appropriate end-points for right results in the age of antiangiogenic agents: future options for phase II trials in patients with recurrent glioblastoma. European Journal of Cancer, 48(6):896-903.

Poyet, C; Hof, D; Sulser, T; Müntener, M (2012). Artificial prostate-specific antigen persistence after radical prostatectomy. Journal of Clinical Oncology, 30(5):e62-3.

Linnebank, M; Moskau, S; Kowoll, A; Semmler, A; Bangard, C; Vogt-Schaden, M; Egerer, G; Schackert, G; Reichmann, H; Schmidt-Wolf, I G H; Pels, H; Schlegel, U (2012). Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma. British Journal of Cancer:1-4.

Zimmer, Lisa; Hillen, Uwe; Livingstone, Elisabeth; Lacouture, Mario E; Busam, Klaus; Carvajal, Richard D; Egberts, Friederike; Hauschild, Axel; Kashani-Sabet, Mohammed; Goldinger, Simone M; Dummer, Reinhard; Long, Georgina V; McArthur, Grant; Scherag, André; Sucker, Antje; Schadendorf, Dirk (2012). Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition. Journal of Clinical Oncology, 30(19):2375-2383.

Luetolf, U M (2012). Bedeutung der Strahlentherapie und Onkologie für die Schweizer Radioonkologie. Strahlentherapie und Onkologie, 188(Suppl. 3):356.

Stahel, Rolf (2012). Biomarker testing in non-small cell lung cancer: to move forward with quality. Clinical and Translational Oncology, 14(5):321-322.

Bretz, N; Noske, A; Keller, S; Erbe-Hofmann, N; Schlange, T; Salnikov, A V; Moldenhauer, G; Kristiansen, G; Altevogt, P (2012). CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion. Clinical and Experimental Metastasis, 29(1):27-38.

Attia, A; Tatter, S B; Weller, M; Marshall, K; Lovato, J F; Bourland, J D; Ellis, T L; McMullen, K P; Shaw, E G; Chan, M D (2012). CT-only planning for Gamma Knife radiosurgery in the treatment of trigeminal neuralgia: methodology and outcomes from a single institution. Journal of Medical Imaging and Radiation Oncology, 56(4):490-494.

Contassot, Emmanuel; Jankovic, Dragana; Schuler, Prisca; Preynat-Seauve, Olivier; Gehrke, Samuel; Kerl, Katrin; Beermann, Friedrich; French, Lars E (2012). Carcinogen treatment in mouse selectively expressing activated N-Ras Q61K in melanocytes recapitulates metastatic cutaneous melanoma development. Pigment Cell & Melanoma Research, 25(2):275-278.

Morra, L; Rechsteiner, M; Casagrande, S; von Teichman, A; Schraml, P; Moch, H; Soltermann, A (2012). Characterization of periostin isoform pattern in non-small cell lung cancer. Lung Cancer, 76(2):183-190.

Varga, Z; Tubbs, R R; Wang, Z; Sun, Y; Noske, A; Kradolfer, D; Bosshard, G; Jochum, W; Moch, H; Öhlschlegel, C (2012). Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer. Breast Cancer Research and Treatment, 132(3):925-935.

Rohrmann, S; Grote, V A; Becker, S; Rinaldi, S; Tjønneland, A; Roswall, N; Grønbæk, H; Overvad, K; Boutron-Ruault, M C; Clavel-Chapelon, F; Racine, A; Teucher, B; Boeing, H; Drogan, D; Dilis, V; Lagiou, P; Trichopoulou, A; Palli, D; Tagliabue, G; Tumino, R; Vineis, P; Mattiello, A; Rodríguez, L; Duell, E J; Molina-Montes, E; Dorronsoro, M; Huerta, J M; Ardanaz, E; Jeurnink, S; Peeters, P H M; Lindkvist, B; Johansen, D; Sund, M; Ye, W; Khaw, K T; Wareham, N J; Allen, N E; Crowe, F L; Fedirko, V; Jenab, M; Michaud, D S; Norat, T; Riboli, E; Bueno-de-Mesquita, H B; Kaaks, R (2012). Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. British Journal of Cancer, 106(5):1004-1010.

Ghadjar, P; Simcock, M; Studer, G; Allal, A; Ozsahin, M; Bernier, J; Töpfer, M; Zimmermann, F; Betz, M; Glanzmann, C; Aebersold, D (2012). Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94). International Journal of Radiation Oncology, Biology and Physics, 82(2):524-531.

Lemke, D; Pfenning, P N; Sahm, F; Klein, A C; Kempf, T; Warnken, U; Schnölzer, M; Tudoran, R; Weller, M; Platten, M; Wick, W (2012). Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness. Clinical Cancer Research, 18(1):105-117.

Raju, Uma; Riesterer, Oliver; Wang, Zhi-Qiang; Molkentine, David P; Molkentine, Jessica M; Johnson, Faye M; Glisson, Bonnie; Milas, Luka; Ang, K Kian (2012). Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways. Radiotherapy and Oncology, 105(2):241-249.

Schoenewolf, Nicola L; Dummer, Reinhard; Mihic-Probst, Daniela; Moch, Holger; Simcock, Mathew; Ochsenbein, Adrian; Gillessen, Silke; Schraml, Peter; von Moos, Roger (2012). Detecting BRAF mutations in formalin-fixed melanoma: experiences with two state-of-the-art techniques. Case Reports in Oncology, 5(2):280-289.

Melloul, Emmanuel; Lesurtel, Mickael; Carr, Brian I; Clavien, Pierre-Alain (2012). Developments in liver transplantation for hepatocellular carcinoma. Seminars in Oncology, 39(4):510-521.

Lanzer, M; Zemann, W; Lübbers, T H; Kruse, A; Reinisch, S (2012). Do patients with oral and oropharyngeal squamous cell carcinoma benefit from elective contralateral neck dissection? A long-term analysis. Head & Neck Oncology, 4(3):70.

Tanos, Tamara; Rojo, Lucia Jimenez; Echeverria, Pablo; Brisken, Cathrin (2012). ER and PR signaling nodes during mammary gland development. Breast Cancer Research, 14(4):210.

Pavlidis, N; Stahel, R; Pentheroudakis, G; Cervantes, A (2012). ESMO Consensus Conferences: another source of ESMO Clinical Practice Guidelines. Annals of Oncology, 23(Supp 7):vii7-vii10.

Barbir, Aline; Linseisen, Jakob; Hermann, Silke; Kaaks, Rudolf; Teucher, Birgit; Eichholzer, Monika; Rohrmann, Sabine (2012). Effects of phenotypes in heterocyclic aromatic amine (HCA) metabolism-related genes on the association of HCA intake with the risk of colorectal adenomas. Cancer Causes & Control, 23(9):1429-1442.

Wick, W; Weller, M (2012). Elderly people with glioblastoma - Authors' reply. Lancet Oncology, 13(8):e329.

Wolf, Monika Julia; Hoos, Alexandra; Bauer, Judith; Boettcher, Steffen; Knust, Markus; Weber, Achim; Simonavicius, Nicole; Schneider, Christoph; Lang, Matthias; Stürzl, Michael; Croner, Roland S; Konrad, Andreas; Manz, Markus G; Moch, Holger; Aguzzi, Adriano; van Loo, Geert; Pasparakis, Manolis; Prinz, Marco; Borsig, Lubor; Heikenwalder, Mathias (2012). Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway. Cancer Cell, 22(1):91-105.

Minner, S; Rump, D; Tennstedt, P; Simon, R; Burandt, E; Terracciano, L; Moch, H; Wilczak, W; Bokemeyer, C; Fisch, M; Sauter, G; Eichelberg, C (2012). Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma. Cancer, 118(5):1268-1275.

Weller, M; Stupp, R; Wick, W (2012). Epilepsy meets cancer: when, why, and what to do about it? Lancet Oncology, 13(9):e375-e382.

Soll, Christopher; Riener, Marc-Oliver; Oberkofler, Christian Eugen; Hellerbrand, Claus; Wild, Peter J; DeOliveira, Michelle L; Clavien, Pierre-Alain (2012). Expression of serotonin receptors in human hepatocellular cancer. Clinical Cancer Research, 18(21):5902-5910.

Creutzig, U; Zimmermann, M; Bourquin, J P; Dworzak, M N; Kremens, B; Lehrnbecher, T; von Neuhoff, C; Sander, A; von Stackelberg, A; Schmid, I; Starý, J; Steinbach, D; Vormoor, J; Reinhardt, D (2012). Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report. Leukemia, 26(4):654-661.

von Moos, R; Seifert, B; Simcock, M; Goldinger, S M; Gillessen, S; Ochsenbein, A; Michielin, O; Cathomas, R; Schläppi, M; Moch, H; Schraml, P H; Mihic-Probst, D; Mamot, C; Schönewolf, N; Dummer, R (2012). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Annals of Oncology, 23(2):531-536.

Dummer, R; Rozati, S; Eggmann, N; Rinderknecht, J; Goldinger, S M (2012). From chemotherapy to targeted treatment. Annals of Oncology, 23(Sup 10):x101-x103.

Muff, Roman; Ram Kumar, Ram Mohan; Botter, Sander M; Born, Walter; Fuchs, Bruno (2012). Genes regulated in metastatic osteosarcoma: evaluation by microarray analysis in four human and two mouse cell line systems. Sarcoma, 2012:1-13.

Grimminger, Peter P; Maus, Martin K H; Schneider, Paul M; Metzger, Ralf; Hölscher, Arnulf H; Sugita, Hirofumi; Danenberg, Peter V; Alakus, Hakan; Brabender, Jan (2012). Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC. Lung Cancer, 78(1):87-91.

Van Hemelrijck, Mieke; Rohrmann, Sabine; Steinbrecher, Astrid; Kaaks, Rudolf; Teucher, Birgit; Linseisen, Jakob (2012). Heterocyclic aromatic amine [HCA] intake and prostate cancer risk: effect modification by genetic variants. Nutrition and Cancer, 64(5):704-713.

Compter, I; Zaugg, K; et al (2012). High symptom improvement and local tumor control using stereotactic radiotherapy when given early after diagnosis of meningioma : A multicentre study. Strahlentherapie und Onkologie, 188(10):887-893.

Fankhauser, Niklaus; Cima, Igor; Wild, Peter; Krek, Wilhelm (2012). Identification of a gene expression signature common to distinct cancer pathways. Cancer Informatics, 11:139-146.

von Boehmer, Lotta; Draenert, Alice; Jungraithmayr, Wolfgang; Inci, Ilhan; Niklaus, Schäfer; Boehler, Annette; Hofer, Markus; Stahel, Rolf; Soltermann, Alex; van den Broek, Maries; Weder, Walter; Knuth, Alexander (2012). Immunosuppression and lung cancer of donor origin after bilateral lung transplantation. Lung Cancer, 76(1):118-122.

Pettengell, R; Johnson, H E; Lugtenburg, P J; Salar Silvestre, A; Dührsen, U; Rossi, F G; Schwenkglenks, M; Bendall, K; Szabo, Z; Jaeger, U (2012). Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma. Supportive Care in Cancer, 20(3):647-652.

Schmidt, A-M; Imesch, P; Fink, Daniel; Egger, H (2012). Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecologic oncology, 125(3):604-609.

Weller, M; Stupp, R; Hegi, M; Wick, W (2012). Individualized targeted therapy for glioblastoma: fact or fiction? Cancer Journal, 18(1):40-44.

Grote, V A; Kaaks, R; Nieters, A; Tjønneland, A; Halkjær, J; Overvad, K; Skjelbo Nielsen, M R; Boutron-Ruault, M C; Clavel-Chapelon, F; Racine, A; Teucher, B; Becker, S; Pischon, T; Boeing, H; Trichopoulou, A; Cassapa, C; Stratigakou, V; Palli, D; Krogh, V; Tumino, R; Vineis, P; Panico, S; Rodríguez, L; Duell, E J; Sánchez, M J; Dorronsoro, M; Navarro, C; Gurrea, A B; Siersema, P D; Peeters, P H M; Ye, W; Sund, M; Lindkvist, B; Johansen, D; Khaw, K T; Wareham, N; Allen, N E; Travis, R C; Fedirko, V; Jenab, M; Michaud, D S; Chuang, S C; Romaguera, D; Bueno-de-Mesquita, H B; Rohrmann, S (2012). Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. British Journal of Cancer, 106(11):1866-1874.

Kuonen, François; Laurent, Julien; Secondini, Chiara; Lorusso, Girieca; Stehle, Jean-Christophe; Rausch, Thierry; Faes-Van't Hull, Eveline; Bieler, Grégory; Alghisi, Gian-Carlo; Schwendener, Reto; Andrejevic-Blant, Snezana; Mirimanoff, René-Olivier; Rüegg, Curzio (2012). Inhibition of the Kit Ligand/c-Kit Axis Attenuates Metastasis in a Mouse Model Mimicking Local Breast Cancer Relapse after Radiotherapy. Clinical Cancer Research, 18(16):4365-4374.

Rusch, Valerie W; Giroux, Dorothy; Kennedy, Catherine; Ruffini, Enrico; Cangir, Ayten K; Rice, David; Pass, Harvey; Asamura, Hisao; Waller, David; Edwards, John; Weder, Walter; Hoffmann, Hans; van Meerbeeck, Jan P (2012). Initial analysis of the international association for the study of lung cancer mesothelioma database. Journal of Thoracic Oncology, 7(11):1631-1639.

Horneber, M; Mehnert, A; Roser, T; Rostock, M (2012). Integrative Aspekte der Thoraxonkologie. Onkologie, 35(Suppl 3):2-5.

Beleut, Manfred; Zimmermann, Philip; Baudis, Michael; Bruni, Nicole; Bühlmann, Peter; Laule, Oliver; Luu, Van-Duc; Gruissem, Wilhelm; Schraml, Peter; Moch, Holger (2012). Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome. BMC Cancer, 12:310.

Bonde, Anne-Katrine; Tischler, Verena; Kumar, Sushil; Soltermann, Alex; Schwendener, Reto (2012). Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors. BMC Cancer, 12:35.

Petrausch, Ulf; Tischler, Verena; Weder, Walter; Soltermann, Alex (2012). Is distinct EGFR mutation status proof of second simultaneous primary non-small cell lung cancer? memo - Magazine of European Medical Oncology, 5(2):154-156.

Eggermont, Alexander M M; Suciu, Stefan; Testori, Alessandro; Santinami, Mario; Kruit, Wim H J; Marsden, Jeremy; Punt, Cornelis J A; Salès, François; Dummer, Reinhard; Robert, Caroline; Schadendorf, Dirk; Patel, Poulam M; de Schaetzen, Gaetan; Spatz, Alan; Keilholz, Ulrich (2012). Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma. Journal of Clinical Oncology, 30(31):3810-3818.

Clifford, G M; Lise, M; Franceschi, S; Egger, M; Bouchardy, C; Korol, D; Levi, F; Ess, S; Jundt, G; Wandeler, G; Fehr, J; Schmid, P; Battegay, M; Bernasconi, E; Cavassini, M; Calmy, A; Keiser, O; Schöni-Affolter, F (2012). Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. British Journal of Cancer, 106(3):447-452.

Lanzer, M; Kruse, A; Lübbers, H T; Zemann, W; Reinisch, S (2012). Lymph node ratio and capsule penetration as independent risk factors in head and neck squamous cell carcinoma. Head & Neck Oncology, 4(5):89.

Gridelli, Cesare; de Marinis, Filippo; Di Maio, Massimo; Ardizzoni, Andrea; Belani, Chandra P; Cappuzzo, Federico; Ciardiello, Fortunato; Fidias, Panagiotis; Paz-Ares, Luis; Perrone, Francesco; Pirker, Robert; De Petris, Luigi; Stahel, Rolf (2012). Maintenance treatment of advanced non-small-cell lung cancer: Results of an international expert panel meeting of the Italian Association of Thoracic Oncology. Lung Cancer, 76(3):269-279.

Kwanhian, Wiyada; Lenze, Dido; Alles, Julia; Motsch, Natalie; Barth, Stephanie; Döll, Celina; Imig, Jochen; Hummel, Michael; Tinguely, Marianne; Trivedi, Pankaj; Lulitanond, Viraphong; Meister, Gunter; Renner, Christoph; Grässer, Friedrich A (2012). MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Medicine, 1(2):141-155.

Weller, M (2012). Microglia: a novel treatment target in gliomas. Neuro-Oncology, 14(8):957.

Wojakowski, W; Landmesser, U; Bachowski, R; Jadczyk, T; Tendera, M (2012). Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia, 26(1):23-33.

Maglietta, Rosalia; Liuzzi, Vania Cosma; Cattaneo, Elisa; Laczko, Endre; Piepoli, Ada; Panza, Anna; Carella, Massimo; Palumbo, Orazio; Staiano, Teresa; Buffoli, Federico; Andriulli, Angelo; Marra, Giancarlo; Ancona, Nicola (2012). Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon. BMC Cancer, 12:608.

Hasenbach, K; Wiehr, S; Herrmann, C; Mannheim, J; Cay, F; von Kürthy, G; Bolmont, T; Grathwohl, S A; Weller, M; Lengerke, C; Pichler, B J; Tabatabai, G (2012). Monitoring the glioma tropism of bone marrow-derived progenitor cells by 2-photon laser scanning microscopy and positron emission tomography. Neuro-oncology, 14(4):471-481.

Weller, M (2012). More on the immune privilege of glioblastoma. Neuro-Oncology, 14(5):527-528.

Hofer, S; Marosi, C (2012). News from the Neuro-Oncology front. memo - Magazine of European Medical Oncology, 5(3):169-170.

Spilka, Rita; Laimer, Klaus; Bachmann, Felix; Spizzo, Gilbert; Vogetseder, Alexander; Wieser, Manuel; Müller, Heimo; Haybaeck, Johannes; Obrist, Peter (2012). Overexpression of eIF3a in squamous cell carcinoma of the oral cavity and its putative relation to chemotherapy response. Journal of Oncology, 2012:901956.

Burger, M C; Brucker, D P; Baumgarten, P; Ronellenfitsch, M W; Wanka, C; Hasselblatt, M; Eccles, M R; Klingebiel, T; Weller, M; Rieger, J; Mittelbronn, M; Steinbach, J P (2012). PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma. International Journal of Oncology, 41(1):235-241.

Roth, P; Korfel, A; Martus, P; Weller, M (2012). Pathogenesis and management of primary CNS lymphoma. Expert Review of Anticancer Therapy, 12(5):623-633.

Oehler, C; Frei, K; Rushin, E J; McSheehy, P M J; Weber, D; Allegrini, P R; Weniger, D; Lütolf, U M; Knuth, A; Yonekawa, Y; Barath, K; Broggini-Tenzer, A; Pruschy, M; Hofer, S (2012). Patupilone (Epothilone B) for recurrent glioblastoma: Clinical outcome and translational analysis of a single-institution phase I/II trial. Oncology, 83(1):1-9.

Weller, M; Stupp, R; Hegi, M E; van den Bent, M; Tonn, J C; Sanson, M; Wick, W; Reifenberger, G (2012). Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice. Neuro-Oncology, 14(Suppl. 4):iv100-iv108.

Galanis, E; Wu, W; Cloughesy, T; Lamborn, K; Mann, B; Wen, P Y; Reardon, D A; Wick, W; Macdonald, D; Armstrong, T S; Weller, M; Vogelbaum, M; Colman, H; Sargent, D J; van den Bent, M J; Gilbert, M; Chang, S (2012). Phase 2 trial design in neuro-oncology revisited: a report from the RANO group. Lancet Oncology, 13(5):e196-e204.

Kirkwood, J M; Bastholt, L; Robert, C; Sosman, J; Larkin, J; Hersey, P; Middleton, M; Cantarini, M; Zazulina, V; Kemsley, K; Dummer, R (2012). Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma. Clinical Cancer Research, 18(2):555-567.

Reifenberger, G; Hentschel, B; Felsberg, J; Schackert, G; Simon, M; Schnell, O; Westphal, M; Wick, W; Pietsch, T; Loeffler, M; Weller, M (2012). Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. International Journal of Cancer, 131(6):1342-1350.

Schraml, P; von Teichman, A; Mihic-Probst, D; Simcock, M; Ochsenbein, A; Dummer, R; Michieilin, O; Seifert, B; Schläppi, M; Moch, H; von Moos, R (2012). Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07. Oncology Reports, 28(2):654-658.

Ghadjar, P; Simcock, M; Zimmermann, F; Betz, M; Bodis, S; Bernier, J; Studer, G; Aebersold, M (2012). Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94). Radiotherapy and Oncology, 104(2):213-218.

Beer, M; Montani, M; Gerhardt, J; Wild, P J; Hany, T F; Hermanns, T; Müntener, M; Kristiansen, G (2012). Profiling gastrin-releasing peptide receptor in prostate tissues: Clinical implications and molecular correlates. Prostate, 72(3):318-325.

Korfel, A; Weller, M; Martus, P; Roth, P; Klasen, H A; Roeth, A; Rauch, M; Hertenstein, B; Fischer, T; Hundsberger, T; Leithäuser, M; Birnbaum, T; Kirchen, H; Mergenthaler, H G; Schubert, J; Berdel, W; Birkmann, J; Hummel, M; Thiel, E; Fischer, L (2012). Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial. Annals of Oncology, 23(9):2374-2380.

Huellner, M W; Hennedige, T P; Winterhalder, R; Zander, T; Venkatesh, S K; Yong, W P; Soo, R A; Seifert, Burkhardt; Treumann, T C; Strobel, K; Veit-Haibach, P (2012). Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer. Cancer Imaging, 12(1):212-224.

Dummer, Reinhard; Quaglino, Pietro; Becker, Jürgen C; Hasan, Baktiar; Karrasch, Matthias; Whittaker, Sean; Morris, Stephen; Weichenthal, Michael; Stadler, Rudolf; Bagot, Martine; Cozzio, Antonio; Bernengo, Maria G; Knobler, Robert (2012). Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012. Journal of Clinical Oncology, 30(33):4091-4097.

Ziegler, A; Cerciello, F; Bigosch, C; Bausch-Fluck, D; Felley-Bosco, E; Ossola, R; Soltermann, A; Stahel, R A; Wollscheid, B (2012). Proteomic surfaceome analysis of mesothelioma. Lung Cancer, 75(2):189-196.

Agurs-Collins, Tanya; Rohrmann, Sabine; Sutcliffe, Catherine; Bienstock, Jessica L; Monsegue, Deborah; Akereyeni, Folasade; Bradwin, Gary; Rifai, Nader; Pollak, Michael N; Platz, Elizabeth A (2012). Racial variation in umbilical cord blood sex steroid hormones and the insulin-like growth factor axis in African-American and white female neonates. Cancer Causes & Control, 23(3):445-454.

Lemm, Doreen; de Oliveira, Francine Hehn; Bernays, René-Ludwig; Kockro, Ralf Alfons; Kollias, Spyros; Fischer, Ingeborg; Rushing, Elisabeth J (2012). Rare suprasellar glioblastoma: report of two cases and review of the literature. Brain Tumor Pathology, 29(4):216-20.

Clavien, P A; Lesurtel, M; Bossuyt, P M M; Gores, G J; Langer, B; Perrier, A (2012). Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncology, 13(1):e11-e22.

Dummer, Reinhard; Flaherty, Keith T (2012). Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights. Current Opinion in Oncology, 24(2):150-154.

Nasser, M W; Qamri, Z; Deol, Y S; Ravi, J; Powell, C A; Trikha, P; Schwendener, R A; Bai, X F; Shilo, K; Zou, X; Leone, G; Wolf, R; Yuspa, S H; Ganju, R K (2012). S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways. Cancer Research, 72(3):604-615.

Pezier, T; Nixon, I J; Gurney, B; Schilling, C; Hussain, K; Lyons, A J; Oakley, R; Simo, R; Jeannon, J P; McGurk, M (2012). Sentinel lymph node biopsy for t1/t2 oral cavity squamous cell carcinoma - a prospective case series. Annals of Surgical Oncology, 19(11):3528-3533.

Jacob, F; Goldstein, D R; Bovin, N V; Pochechueva, T; Spengler, M; Caduff, R; Fink, D; Vuskovic, M I; Huflejt, M E; Heinzelmann-Schwarz, V (2012). Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. International Journal of Cancer, 130(1):138-146.

Schoenewolf, N L; Bull, C; Belloni, B; Holzmann, D; Tonolla, S; Lang, R; Mihic-Probst, D; Andres, C; Dummer, R (2012). Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations. European Journal of Cancer, 48(12):1842-1852.

Shi, Yandong; Felley-Bosco, Emanuela; Marti, Thomas M; Orlowski, Katrin; Pruschy, Martin; Stahel, Rolf A (2012). Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin. BMC Cancer, 12:571.

Weller, M; Martus, P; Roth, P; Thiel, E; Korfel, A (2012). Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro-Oncology, 14(12):1481-1484.

Craig, V J; Tzankov, A; Flori, M; Schmid, C A; Bader, A G; Müller, A (2012). Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia, 26(11):2421-2424.

Mertens, Joachim C; Gores, Gregory J (2012). Targeting tumor stroma: exploiting apoptotic priming. OncoTarget, 3(12):1501-1502.

Arlt, Matthias J E; Born, Walter; Fuchs, Bruno (2012). Taurolidine: Mode of administration in mouse tumor models. International Journal of Cancer, 131(6):E1053-E1054.

Wick, W; Platten, M; Meisner, C; Felsberg, J; Tabatabai, G; Simon, M; Nikkhah, G; Papsdorf, K; Steinbach, J P; Sabel, M; Combs, S E; Vesper, J; Braun, C; Meixensberger, J; Ketter, R; Mayer-Steinacker, R; Reifenberger, G; Weller, M (2012). Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncology, 13(7):707-715.

Trojan, Andreas; Vergopoulos, Athanasios; Breitenstein, Urs; S